NOGATECH INC
S-1/A, 2000-05-09
ELECTRONIC PARTS & EQUIPMENT, NEC
Previous: WEST COAST ENTERTAINMENT CORP, NT 10-K, 2000-05-09
Next: GUMTECH INTERNATIONAL INC T, 8-K, 2000-05-09



<PAGE>

      AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON MAY 9, 2000

                                            REGISTRATION STATEMENT NO. 333-32372
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                           --------------------------


                                AMENDMENT NO. 3
                                       TO
                                    FORM S-1

                             REGISTRATION STATEMENT
                                     UNDER
                           THE SECURITIES ACT OF 1933
                           --------------------------

                                 NOGATECH, INC.
             (Exact name of registrant as specified in its charter)

<TABLE>
<S>                                 <C>                                 <C>
             Delaware                              3674                             77-0525268
 (State or Other Jurisdiction of       (Primary Standard Industrial              (I.R.S. Employer
  Incorporation or Organization)       Classification Code Number)            Identification Number)
</TABLE>

                            ------------------------

                           5201 Great America Parkway
                         Santa Clara, California 95054
                                 (408) 562-6200
               (Address, Including Zip Code, and Telephone Number
       Including Area Code, of Registrant's Principal Executive Offices)
                           --------------------------

                                   Nathan Hod
                             Chairman of the Board
                                 Nogatech, Inc.
                           5201 Great America Parkway
                         Santa Clara, California 95054
                                 (408) 562-6200
            (Name, Address, Including Zip Code, and Telephone Number
                   Including Area Code, of Agent for Service)
                           --------------------------
                                   COPIES TO:

<TABLE>
<S>                                               <C>
          Donald C. Reinke, Esq.                             Bruce A. Mann, Esq.
           James L. Berg, Esq.                               Lloyd Harmetz, Esq.
          Nicola R. Knight, Esq.                           Morrison & Foerster LLP
         Gizelle A. Barany, Esq.                              425 Market Street
         Bay Venture Counsel, LLP                    San Francisco, California 94105-2482
     1999 Harrison Street, Suite 1300                           (415) 268-7584
        Oakland, California 94612
              (510) 273-8750
</TABLE>

                            ------------------------
        Approximate date of commencement of proposed sale to the public:
As soon as practicable after the effective date of this Registration Statement.
                           --------------------------
    If any of the securities being registered on this form are to be offered on
a delayed or continuous basis pursuant under Rule 415 of the Securities Act of
1933, check the following box. / /
    If this form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, check the following box and
list the Securities Act registration statement number of the earlier effective
registration statement for the same offering. / /
    If this form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. / /
    If this form is a post-effective amendment filed pursuant to Rule 462(d)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. / /
    If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. / /
                           --------------------------

                        CALCULATION OF REGISTRATION FEE

<TABLE>
<CAPTION>
                                                           PROPOSED MAXIMUM     PROPOSED MAXIMUM
      TITLE OF EACH CLASS OF          AGGREGATE AMOUNT      OFFERING PRICE     AGGREGATE OFFERING        AMOUNT OF
    SECURITIES TO BE REGISTERED       TO BE REGISTERED       PER SHARE(1)           PRICE(1)         REGISTRATION FEE
<S>                                  <C>                  <C>                  <C>                  <C>
Common Stock, par value
  $0.001 per share.................       4,025,000             $16.00             $64,400,000          $17,002(2)
</TABLE>

(1) Estimated solely for purposes of calculating the registration fee.


(2) Previously paid.

                            ------------------------
    THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR
DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL
FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION
STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(a) OF
THE SECURITIES ACT OF 1933 OR UNTIL THIS REGISTRATION STATEMENT SHALL BECOME
EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING PURSUANT TO SAID SECTION 8(a),
MAY DETERMINE.

- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE>

                    3-FOLD PART INSIDE FRONT COVER GRAPHICS



    1(st) Page -- Nogatech Logo.



    2(nd) and 3(rd) Pages gatefold -- These pages contain the caption "Providing
Compression Chips for Video Connectivity." The graphic is a Nogatech chip with
six different pictures surrounding the chip identifying various uses of
Nogatech's chips. The six pictures include two men with a TV camera, a man at a
keyboard, a woman, a computer monitor, a portable computer and a woman next to a
computer monitor.



    A caption at the bottom of the page states "Our chips are designed into a
range of products enabling video connectivity to personal computers, notebooks
and hand-held personal computing devices through the Universal Serial Bus
interface." An additional caption states "The trademarks and tradenames
displayed are the property of their respective owners."

<PAGE>
    You should rely only on the information contained in this prospectus. We
have not authorized anyone to provide you with information different from that
contained in this prospectus. We are offering to sell, and seeking offers to
buy, shares of our common stock only in jurisdictions where offers and sales are
permitted. The information contained in this prospectus is accurate only as of
the date of this prospectus, regardless of the time of delivery of this
prospectus or of any sale of our common stock.

                            ------------------------

                               TABLE OF CONTENTS

<TABLE>
<CAPTION>
                                                                PAGE
                                                              --------
<S>                                                           <C>
Prospectus Summary..........................................       3
The Offering................................................       4
Summary Consolidated Financial Data.........................       5
Risk Factors................................................       6
Cautionary Note on Forward-Looking Statements...............      17
Use of Proceeds.............................................      18
Dividend Policy.............................................      18
Capitalization..............................................      19
Dilution....................................................      20
Selected Consolidated Financial Data........................      21
Management's Discussion and Analysis of Financial Condition
  and Results of Operations.................................      22
Business....................................................      28
Management..................................................      39
Certain Relationships and Related Transactions..............      48
Principal Stockholders......................................      50
Description of Capital Stock................................      53
Shares Eligible for Future Sale.............................      55
Plan of Distribution........................................      57
Legal Matters...............................................      63
Experts.....................................................      63
Where You Can Get More Information..........................      63
Index to Consolidated Financial Statements..................     F-1
</TABLE>

                            ------------------------

    Our logo is our registered trademark. Other service marks, trademarks and
trade names referred to in this prospectus are the property of their respective
owners.
<PAGE>
                               PROSPECTUS SUMMARY

    THE FOLLOWING SUMMARY IS QUALIFIED IN ITS ENTIRETY BY THE MORE DETAILED
INFORMATION AND THE FINANCIAL STATEMENTS AND NOTES APPEARING ELSEWHERE IN THIS
PROSPECTUS. THIS SUMMARY MAY NOT CONTAIN ALL OF THE INFORMATION THAT YOU SHOULD
CONSIDER BEFORE INVESTING IN OUR COMMON STOCK. YOU SHOULD READ THE ENTIRE
PROSPECTUS CAREFULLY. ALL INFORMATION IN THIS PROSPECTUS GIVES EFFECT TO A
ONE-FOR-TWO REVERSE STOCK SPLIT WITH RESPECT TO OUR COMMON STOCK THAT WILL BE
EFFECTED PRIOR TO THE CLOSING OF THIS OFFERING.

                                    NOGATECH

    We provide computer chips that compress digital video images and establish
connections, or video connectivity, between video devices and computers, as well
as between video devices across a variety of networks. Our products enable
real-time transmission of video, audio and data signals into personal computers
and hand-held personal computing devices known as personal digital assistants.
Our chips are small, power efficient and work together with our related
decompression software for use in processing video images on all major operating
systems. Our products are based on our proprietary mathematical procedures,
known as algorithms, and enable communication of video and other data from a
variety of video sources through standard interfaces into PCs. Our chips and
software provide high quality video while efficiently using the resources of the
PC's central processing unit.

    We principally sell our chips on a stand-alone basis to original equipment
manufacturers, who design them into products such as PC digital video cameras,
video capture devices and PC-TVs. In addition, we sell to original equipment
manufacturers our own video devices that incorporate our chips. In 1999,
purchasers of our products included AME Group, Camtel Technology, Fujitsu
General, Hauppauge Computer Works, Interex, IO Data, Pinnacle Systems, Sharp
Electronics and X-10.com. Our chips are manufactured and tested by
subcontractors.

    The convergence of TV and PC applications, the growth of the Internet and
the establishment of high speed broadband communication networks have created an
increased demand for high quality video connections. We believe that the
marketplace will demand additional digital video compression chips that are
compatible with the new industry standard for video compression, known as
MPEG-4. We are developing chips based on the MPEG-4 standard that will enable a
variety of applications, including processing and storing digital video data
across the Internet and mobile and broadcast networks.

    Our objective is to be a leading provider of video connection chips for
computer products using advanced video compression technology and standard
computer connections between PCs and video accessories, known as plug-and-play
interfaces. Key elements of our strategy are to:

    - maintain our expertise in video compression technology;

    - focus on high volume applications;

    - create and strengthen relationships with key customers; and

    - build upon existing technologies to penetrate new markets.

    Our sales were $3.2 million in 1998, $8.9 million in 1999 and $2.9 million
in the three months ended March 31, 2000, with net losses of $1.8 million in
1998 and $1.1 million in 1999, and net income of $93,000 in the three months
ended March 31, 2000.

    We were initially incorporated in California in 1993 and reincorporated in
Delaware in 1999. Our principal executive offices are located at 5201 Great
America Parkway, Santa Clara, California, 95054, and our telephone number is
(408) 562-6200. The address of our office in Israel is 3 Gavish Street, Kfar
Saba 44641. Our world wide web address is www.nogatech.com. The information on
our website does not constitute part of this prospectus.

                                       3
<PAGE>
                                  THE OFFERING

<TABLE>
<CAPTION>

<S>                                            <C>
Common stock offered.........................  3,500,000 shares

Common stock to be outstanding after this
  offering...................................  14,734,669 shares

Use of proceeds..............................  We expect to use the net proceeds from this
                                               offering for working capital and other
                                               general corporate purposes. We may use a
                                               portion of the net proceeds to acquire
                                               complementary products, technologies or
                                               businesses.

Proposed Nasdaq National Market symbol.......  NGTC
</TABLE>

    The common stock to be outstanding after this offering is based on
11,234,669 shares outstanding as of March 31, 2000, after giving effect to:

    - the conversion of our outstanding shares of Series A preferred stock into
      8,609,783 shares of common stock;

    - the conversion of our outstanding shares of Series B preferred stock into
      an estimated 683,527 shares of common stock; and

    - the assumed issuance of 1,213,319 shares of common stock upon the exercise
      of options and warrants at a weighted average exercise price of $1.57 per
      share that terminate upon the closing of this offering, a portion of which
      are exercisable on a cashless basis.

    The common stock to be outstanding after this offering excludes:

    - 1,065,014 shares of common stock issuable as of March 31, 2000 upon the
      exercise of outstanding stock options issued under our 1999 Stock Option
      Plan at a weighted average exercise price of $1.47 per share;

    - 3,850,000 shares of common stock reserved for issuance under our 2000
      Equity Incentive Plan and 2000 Stock Purchase Plan; and

    - 350,000 shares of common stock issuable as of March 31, 2000 upon the
      exercise of warrants at an exercise price of $0.13 per share.

    This offering will be made through the OpenIPO process, in which the
allocation of shares and the public offering price are primarily based on an
auction in which prospective purchasers are required to bid for the shares. This
process is described under "Plan of Distribution." Except as otherwise
indicated, the information in this prospectus assumes no exercise of the
underwriters' over-allotment option.

                                       4
<PAGE>
                      SUMMARY CONSOLIDATED FINANCIAL DATA

    The following table summarizes the consolidated financial data of our
business. The pro forma 2000 statement of operations data gives effect to the
automatic conversion of our Series A and Series B preferred stock. The
statements of operations data assume a one-for-two reverse stock split with
respect to our common stock that will be effected prior to the closing of this
offering. See note 1(k) to our consolidated financial statements for a
discussion of our pro forma basic and diluted net loss per share.


<TABLE>
<CAPTION>
                                                                                      THREE MONTHS ENDED
                                                     YEAR ENDED DECEMBER 31,               MARCH 31,
                                                 --------------------------------   -----------------------
                                                   1997       1998        1999         1999         2000
                                                 --------   --------   ----------   ----------   ----------
                                                      (IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)
<S>                                              <C>        <C>        <C>          <C>          <C>
STATEMENT OF OPERATIONS DATA:
Sales..........................................  $  2,551   $  3,205   $    8,856   $      870   $   $2,945
Gross profit...................................       852      1,167        3,745          352        1,284
Operating income (loss)........................    (1,430)    (1,913)      (1,107)        (814)         105
Net income (loss)..............................    (1,462)    (1,823)      (1,096)        (817)          93
Charge for beneficial conversion feature of
  Series B preferred stock.....................        --         --           --           --       (4,570)
Accretion of redemption value of Series A
  redeemable convertible preferred stock.......      (300)      (383)        (427)        (107)        (165)
Net loss applicable to common stock............    (1,762)    (2,206)      (1,523)        (924)      (4,642)
Net loss per share of common stock, basic and
  diluted......................................  $  (5.86)  $  (7.13)  $    (4.50)  $    (2.97)  $    (8.14)
Weighted average number of shares of common
  stock outstanding............................   300,709    309,536      338,295      310,995      570,557
                                                 ========   ========   ==========   ==========   ==========
Pro forma net income (loss) per share of common
  stock, basic and diluted.....................                        $    (0.12)  $    (0.09)  $     0.01
                                                                       ==========   ==========   ==========
Pro forma weighted average number of shares of
  common stock outstanding.....................                         8,948,078    8,920,778    9,749,945
                                                                       ==========   ==========   ==========
</TABLE>


    The following table summarizes our balance sheet data as of March 31, 2000.
This balance sheet data is presented:

    - on an actual basis;

    - on an as adjusted basis to give effect to:

       - the conversion of all outstanding shares of preferred stock into an
         estimated 9,293,310 shares of common stock upon the closing of this
         offering;

       - the assumed exercise of options and warrants to purchase up to
         1,213,319 shares of our common stock upon completion of this offering
         at a weighted average exercise price of $1.57 per share; and

       - the sale of the shares of common stock in this offering at the assumed
         initial public offering price of $14.00 per share, after deducting the
         estimated underwriting discounts and commissions and offering expenses.


<TABLE>
<CAPTION>
                                                               AS OF MARCH 31, 2000
                                                              ----------------------
                                                               ACTUAL    AS ADJUSTED
                                                              --------   -----------
                                                                  (IN THOUSANDS)
<S>                                                           <C>        <C>
BALANCE SHEET DATA:
Cash and cash equivalents...................................  $ 6,612      $53,017
Working capital.............................................    8,627       55,032
Total assets................................................   10,950       57,355
Series A redeemable convertible preferred stock.............    8,408           --
Series B redeemable convertible preferred stock.............    5,000           --
Stockholders' equity (capital deficiency)...................   (4,555)      55,258
</TABLE>


                                       5
<PAGE>
                                  RISK FACTORS

    YOU SHOULD CAREFULLY CONSIDER THE FOLLOWING RISKS AND ALL OTHER INFORMATION
CONTAINED IN THIS PROSPECTUS BEFORE YOU DECIDE TO BUY OUR COMMON STOCK. WE HAVE
INCLUDED A DISCUSSION OF EACH MATERIAL RISK THAT WE HAVE IDENTIFIED AS OF THE
DATE OF THIS PROSPECTUS. HOWEVER, ADDITIONAL RISKS AND UNCERTAINTIES NOT
PRESENTLY KNOWN TO US OR THAT WE CURRENTLY DEEM IMMATERIAL MAY ALSO IMPAIR OUR
BUSINESS OPERATIONS. IF ANY OF THE FOLLOWING RISKS ACTUALLY OCCUR, OUR BUSINESS,
FINANCIAL CONDITION OR OPERATING RESULTS COULD SUFFER. IF THIS OCCURS, THE
TRADING PRICE OF OUR COMMON STOCK COULD DECLINE, AND YOU COULD LOSE ALL OR PART
OF THE MONEY YOU PAID TO BUY OUR COMMON STOCK.

                           RISKS RELATING TO NOGATECH

OUR SALES WILL BE REDUCED IF WE ARE UNABLE TO KEEP PACE WITH TECHNOLOGICAL
CHANGES.

    The emerging video compression and video image processing industry is
characterized by:

    - rapidly changing technologies;

    - frequent new product introductions; and

    - rapid changes in customer requirements.

    Video compression and video image processing technologies have reached
commercially acceptable levels only in the last several years and continue to
experience numerous changes. As a result, we must be able to sell products that
incorporate the technological advances in our industry in order to ensure that
they remain commercially viable.

    Our future success will depend on our ability to enhance our existing
products and to develop and introduce new products and product features. These
products and features must be cost-effective and keep pace with technological
developments and address the increasingly sophisticated needs of our customers.
We may not be successful at these tasks. We may also experience difficulties
that could delay or prevent the successful development, introduction and
marketing of these new products and features. In either case, our sales would be
reduced.

WE MAY NOT BE ABLE TO TIMELY ADOPT EMERGING INDUSTRY STANDARDS, WHICH MAY MAKE
OUR PRODUCTS UNACCEPTABLE TO POTENTIAL CUSTOMERS, DELAY OUR PRODUCT
INTRODUCTIONS OR INCREASE OUR COSTS.

    Our products must comply with a number of current industry standards and
practices established by various international bodies. Our failure to comply
with evolving standards, including video compression and computer interface
standards, will limit acceptance of our products by market participants. In
particular, the MPEG-4 standard is becoming the primary standard for PC
applications requiring video compression, but we have not yet completed our
development of any products that are based upon MPEG-4. Although we expect to
introduce products based upon MPEG-4 during the second half of 2001, we may not
succeed in doing so either within that time frame, or at all. If new standards
are adopted in our industry, we may be required to adopt those standards in our
products. It may take us a significant amount of time to develop and design
products incorporating these new standards, and we may not succeed in doing so.
We may also become dependent upon products developed by third parties and have
to pay royalty fees, which may be substantial, to the developers of the
technology that constitutes the newly adopted standards.

IF WE DO NOT DEVELOP NEW PRODUCTS OR NEW PRODUCT FEATURES IN RESPONSE TO
CUSTOMER REQUIREMENTS OR IN A TIMELY WAY, CUSTOMERS MAY NOT BUY OUR PRODUCTS.

    Our customers' products tend to have short life cycles, which require both
them and us to design and introduce new products within a relatively limited
period of time. We must, therefore, coordinate our sales cycle with the sales
and development cycles of our customers. If we experience development, design or
manufacturing difficulties that delay or prevent our timely introduction or
marketing of a new

                                       6
<PAGE>
chip, we would miss the opportunity to have the chip incorporated into a
customer's new product, which would cause us to lose sales.

WE RELY UPON OUR SALES OF A SMALL NUMBER OF PRODUCTS, AND THE FAILURE OF ANY ONE
OF OUR PRODUCTS TO BE SUCCESSFUL IN THE MARKET COULD SUBSTANTIALLY REDUCE OUR
SALES.

    We currently rely upon sales from two products, our NT1003 and NT1004 chips,
to generate most of our sales. Sales of these products amounted to 41% of our
sales in 1999, and 68% of our sales in the three months ended March 31, 2000. We
are developing additional chips, but there can be no assurance that we will be
successful in doing so. Consequently, if our existing products are not
successful, our sales could decline substantially, which would adversely affect
our financial performance, and could cause us to incur significant losses.

THE LOSS OF ANY OF OUR LARGE CUSTOMERS, OR THE FAILURE OF ONE OF THESE CUSTOMERS
TO SELL A SUBSTANTIAL AMOUNT OF ITS PRODUCTS INCORPORATING OUR CHIPS, COULD
SUBSTANTIALLY REDUCE OUR SALES.

    Historically, a substantial portion of our sales has come from purchases by
a few large customers. We expect this trend to continue. For example, our top
three customers accounted for approximately 51% of our sales in 1999, and 54% of
our sales in the three months ended March 31, 2000. Accordingly, our future
operating results depend on the ability of our largest customers to sell
products incorporating our chips and on our success in selling large quantities
of our products to them. We have not entered into long-term agreements with any
of our customers, nor have we obtained their commitment to purchase any specific
quantities of our products. Our customers may cancel or reschedule orders on
short notice or may discontinue using our products at any time. If we lose a
large customer and fail to add new customers to replace lost sales, our
operating results may not recover.

    The concentration of our sales with a few customers makes us particularly
dependent on commercial factors affecting those customers. For example, if
demand for their products decreases, or if they identify alternative sources for
our chips, they may stop purchasing our products and our operating results will
suffer. These customers often have the resources to design and/or manufacture
products like ours internally, and if they elect to do so, they may cease to do
business with us. Additionally, if our target markets undergo a consolidation,
we may lose existing customers or have difficulties in obtaining new ones.

WE RELY ON OTHERS TO MANUFACTURE OUR CHIPS AND THEREFORE HAVE ONLY A LIMITED
ABILITY TO CONTROL MANUFACTURING COSTS, CHIP DELIVERY SCHEDULES OR MANUFACTURING
QUALITY.

    Our chips are manufactured and tested by subcontractors located in Korea and
Japan, each of which provides a single type of chip. An affiliate of Hyundai in
Korea manufactures our NT1003 chip, and an affiliate of Fujitsu in Japan
manufactures our NT1004 chip. As a result of our reliance on subcontractors, we
cannot directly control chip delivery schedules. Recently, chip fabricating
subcontractors have not had sufficient capacity to keep up with chip fabrication
demand. This has led to longer chip manufacturing cycles and longer lead times
on orders. Any problems that occur and persist in connection with the delivery,
quality or costs of assembly of our chips could cause us to lose customers or
increase the expenses that we incur. Our reliance on subcontractors could lead
to product shortages or quality assurance problems. In addition, these
manufacturers could significantly increase the prices that they charge us, and
we may be unable to obtain alternative sources of supplies. We may need to hold
more inventory than is immediately required to compensate for potential
component shortages or discontinuation. These factors could lead to an increase
in the costs of manufacturing or assembling our chips.

    We are in the process of qualifying additional subcontractors in order to
satisfy the demand for our products. However, qualification of new
subcontractors will require a significant period of time. Therefore, we may not
be able to obtain new subcontractors within a period of time that is sufficient
to respond to the needs of our customers.

                                       7
<PAGE>
WE ACCUMULATE INVENTORY TO MINIMIZE THE IMPACT OF SHORTAGES FROM MANUFACTURERS,
AND MAY HAVE OBSOLETE INVENTORY THAT WE HAVE TO WRITE OFF AND SUFFER RESULTING
LOSSES.

    Managing our inventory is complicated by fluctuations in the demand for our
products; however, we must have sufficient quantities of our products available
to satisfy our customers' demand. As a result, we generally accumulate inventory
for a period of time to minimize the impact of undercapacity at our suppliers'
plants. Although we expect to sell the inventory within a short period of time,
products may remain in inventory for extended periods of time and may become
obsolete because of the passage of time and the introduction of new products. In
these situations, we would be required to write off obsolete inventory and would
suffer losses accordingly.

IF WE MAY FAIL TO ADEQUATELY PROTECT OUR PROPRIETARY TECHNOLOGY, IT MAY BE
MISAPPROPRIATED BY OTHERS, INVALIDATED OR CHALLENGED, WHICH WOULD MATERIALLY
HARM OUR ABILITY TO SELL OUR PRODUCTS.

    Our success and ability to compete depend primarily upon our proprietary
technology. We rely on a combination of trade secrets, copyright and trademark
laws, nondisclosure and other contractual agreements and technical measures to
protect our proprietary rights. Currently, we have three U.S. patents pending
that relate to our video technology. However, we have not obtained patent
protection for our proprietary algorithms, and the absence of patent protection
may increase the risk that those algorithms will be misappropriated.

    We are subject to a number of risks relating to intellectual property
rights, including the following:

    - the means by which we seek to protect our proprietary rights may not be
      adequate to prevent others from misappropriating our technology or from
      independently developing or selling technology or products with features
      based on or similar to ours;

    - our products may be sold in foreign countries that provide less protection
      to intellectual property than is provided under U.S., Japanese or Israeli
      laws;

    - our intellectual property rights may be challenged, invalidated, violated
      or circumvented and may not provide us with any competitive advantage; and

    - our patents pending may not be approved or may be only partially approved.

IF OUR PROPRIETARY TECHNOLOGY INFRINGES UPON THE INTELLECTUAL PROPERTY RIGHTS OF
OTHERS, OUR COSTS COULD INCREASE AND OUR ABILITY TO SELL OUR PRODUCTS COULD BE
LIMITED.

    Other companies may hold or obtain patents or may otherwise claim
proprietary rights to technology that is necessary to our business. Particular
aspects of our technology could be found to violate the intellectual property
rights of other parties. The resulting risks include the following:

    - if we violate the intellectual property rights of other parties, we may be
      required to modify our products or intellectual property or to obtain a
      license to permit their continued use; and

    - any future litigation to defend us against allegations that we have
      infringed upon the rights of others could result in substantial costs to
      us, even if we ultimately prevail.

    There are a number of companies that hold patents for various aspects of the
technology incorporated in our industry's standards. We expect that companies
seeking to gain competitive advantages will increase their efforts to enforce
any patent rights that they may have. The holders of patents from which we have
not obtained licenses may take the position that we are required to obtain a
license from them. We cannot be certain that we would be able to negotiate any
license at an acceptable price. Our inability to do so could substantially
increase our operating expenses or require us to seek and obtain alternative
sources of technology necessary to produce our products.

                                       8
<PAGE>
WE BEGAN SELLING OUR CURRENT PRODUCT LINE OF CHIPS ONLY RECENTLY AND, AS A
RESULT, YOUR ABILITY TO EVALUATE OUR PROSPECTS MAY BE LIMITED.

    Although we have been operating since 1993, we did not begin commercial
shipments of our present product line of video compression chips until 1998.
Prior to that time, we sold different products, which we do not anticipate
selling after 2000. As a result, our future success will depend primarily upon
the sales of our chips. Our limited operating history with respect to our chips
may limit your ability to evaluate our prospects because of:

    - our limited historical financial data relating to sales of our chips;

    - our unproven potential to generate profits from sales of our chips; and

    - our limited experience in addressing emerging trends that may affect our
      chip business.

    As a young company that recently commenced a new product line, we face risks
and uncertainties relating to our ability to implement our business plan
successfully. You should consider our prospects in light of the risks, expenses
and difficulties we may encounter.

WE HAVE ONLY RECORDED NET INCOME DURING THE LAST THREE QUARTERS, AND MAY NOT BE
PROFITABLE IN THE FUTURE.


    We incurred net losses of $1.8 million in 1998 and $1.1 million in 1999. As
of December 31, 1999, we had an accumulated deficit of $10.6 million. Our sales
may not grow or even continue at their current level. Although we have recorded
net income for the last three quarters, if our sales do not increase or if our
expenses increase at a greater pace than our sales, we will not remain
profitable. In addition, we recognized a beneficial conversion charge of
$4.6 million in the first three months of 2000 on account of our issuance of
Series B preferred stock, which increased our net loss applicable to our common
stock in that period, and which will adversely affect our operating results
during the fiscal year ending December 31, 2000. Any losses that we incur could
be substantial.


OUR INABILITY TO MANAGE EFFECTIVELY OUR RECENT GROWTH, AND OUR EXPECTED
CONTINUING INCREASED GROWTH, COULD INCREASE OUR COSTS AND IMPAIR OUR ABILITY TO
MAINTAIN OR INCREASE OUR CUSTOMER BASE.

    The growth in our business has placed, and is expected to continue to place,
a significant strain on our management and operations. To manage our growth, we
must continue to implement and improve our operational, financial and management
information systems and expand, train and manage our employees. We may not have
made adequate allowances for the costs and risks associated with this expansion,
and our systems, procedures or controls may not be adequate to support our
operations. Our failure to manage growth effectively could cause us to incur
substantial additional costs, lose opportunities to generate sales or impair our
ability to maintain our customers.

WE ARE SUBJECT TO RISKS FROM INTERNATIONAL SALES, INCLUDING THE RISK THAT THE
PRICES OF OUR PRODUCTS MAY BECOME LESS COMPETITIVE BECAUSE OF FOREIGN EXCHANGE
FLUCTUATIONS.

    Sales to customers located outside the U.S. accounted for 51.8% of our sales
in 1997, 57.2% of our sales in 1998, 38.6% of our sales in 1999 and 50.4% of our
sales in the three months ended March 31, 2000. We expect that international
sales will continue to be significant. International sales are subject to a
variety of risks, including risks arising from currency fluctuations, trading
restrictions, tariffs, trade barriers and taxes.

    Because most of our sales are denominated in dollars, our products become
less price competitive in countries with currencies that are low or are
declining in value against the dollar. In addition, our international customers
may not continue to place orders denominated in dollars. If they do not, our
reported sales and earnings will be subject to foreign exchange fluctuations.

                                       9
<PAGE>
WE MAY EXPERIENCE FLUCTUATIONS IN OUR FUTURE OPERATING RESULTS, WHICH WILL MAKE
PREDICTING OUR FUTURE RESULTS DIFFICULT.

    Historically, our quarterly and annual operating results have varied
significantly from period to period, and we expect that they will continue to do
so. These fluctuations result from a variety of factors, including:

    - market acceptance of our products, including changes in order flow from
      our largest customers, and our customers' ability to forecast their needs;

    - the timing of new product announcements by us and our competitors, such as
      chips that are compatible with the MPEG-4 standard;

    - the lengthy sales cycle of our products;

    - increased competition between chip manufacturers, including changes in
      pricing by us or our competitors; and

    - delays in deliveries by our limited number of suppliers and
      subcontractors.


    In addition, we expect that our revenues will be higher in the last two
quarters of each fiscal year than in the first two fiscal quarters of each
fiscal year, because our customers tend to purchase greater quantities of
components such as chips towards the end of each year. Accordingly, any sales or
net income in any particular period may be lower than our sales and net income
in a preceding or comparable period. Period-to-period comparisons of our results
of operations may not be meaningful, and you should not rely upon them as
indications of our future performance. In addition, our operating results may be
below the expectations of securities analysts and investors in future periods.
Our failure to meet these expectations will likely cause our share price to
decline.


WE RELY ON A SINGLE DISTRIBUTOR FOR MOST OF OUR SALES IN JAPAN, AND THE LOSS OF
THIS DISTRIBUTOR COULD SUBSTANTIALLY REDUCE OUR SALES.

    Our future performance depends on our ability to compete successfully in
Japan, where all of our sales to date have been made through a single
distributor, Tomen Electronics Corporation. Upon completion of this offering,
Tomen will own approximately 8.5% of our common stock. We do not have a
distribution agreement with Tomen, and Tomen could terminate its relationship
with us at any time. In addition, Tomen is free to distribute the products of
our competitors as well as our products, and it is not required to maintain any
minimum sales levels. The loss of our relationship with Tomen, or any inability
or failure by Tomen to sell our products, could substantially reduce our sales.
In addition, we may not succeed in attracting new distributors for the Japanese
market or in replacing Tomen in the event that we do not continue our
relationship.

WE DEPEND ON A LIMITED NUMBER OF KEY PERSONNEL, IN PARTICULAR NATHAN HOD, OUR
CHAIRMAN, AND ARIE HEIMAN, OUR PRESIDENT AND CHIEF EXECUTIVE OFFICER, AND THE
LOSS OF ANY OF THEIR SERVICES COULD ADVERSELY AFFECT OUR FUTURE GROWTH AND
PROFITABILITY AND COULD SUBSTANTIALLY INTERFERE WITH OUR OPERATIONS.

    Because our products are complex and our market is new and evolving, the
success of our business depends in large part upon the continuing contributions
of our management and technical personnel. The loss of the services of several
of our key officers, including Nathan Hod, our Chairman of the Board, and Arie
Heiman, our President and Chief Executive Officer, could adversely affect our
future growth and profitability and could substantially interfere with our
operations. Our dependence upon these officers is increased by the fact that
they are responsible for our sales and marketing efforts, as well as our overall
operations. We do not have key person life insurance policies covering any of
our employees other than Arie Heiman. The insurance coverage that we have on Mr.
Heiman is likely to be insufficient to compensate us for any loss of his
services.

                                       10
<PAGE>
WE WILL NOT INCREASE OUR SALES OR GROW OUR BUSINESS IF WE ARE UNABLE TO ATTRACT,
TRAIN AND RETAIN QUALIFIED ENGINEERS AND SALES AND MARKETING AND TECHNICAL
SUPPORT PERSONNEL.

    We will need to hire additional engineers and highly trained technical
support personnel in order to succeed. We will need to increase our technical
staff to support new customers and the expanding needs of existing customers, as
well as our continued research and development operations. We will need to hire
additional sales and marketing personnel to target our potential customers.
Hiring engineers and sales and marketing and technical support personnel is very
competitive in our industry because of the limited number of people available
with the necessary skills and understanding of our products. This is
particularly true in Israel and California, where the competition for qualified
personnel is intense. If we are unable to hire and retain necessary personnel,
our business will not develop, we may lose customers and we may incur
substantial losses.

OUR PRODUCTS COULD CONTAIN DEFECTS, WHICH COULD RESULT IN DELAYS IN RECOGNITION
OR LOSS OF SALES, LOSS OF MARKET SHARE OR MARKET ACCEPTANCE, OR CLAIMS AGAINST
US.

    We develop complex chips and related software for video compression and
video image processing. Despite testing by our subcontractors and our customers,
errors may be found in our existing or future products. This could result in,
among other things, a delay in recognition or loss of sales, loss of market
share, failure to achieve market acceptance or substantial damage to our
reputation. We could be subject to material claims by customers, and we may need
to incur substantial expenses to correct any product defects. We do not have
product liability insurance to protect us against losses caused by defects in
our products, and we do not have "errors and omissions" insurance. As a result,
any payments that we may need to make to satisfy our customers may be
substantial.

FUTURE ACQUISITIONS BY US COULD DIVERT SUBSTANTIAL MANAGEMENT RESOURCES, GIVE
RISE TO UNKNOWN OR UNANTICIPATED LIABILITIES AND LEAD TO ADVERSE MARKET
CONSEQUENCES FOR OUR STOCK.

    We may acquire or make substantial investments in other companies or
businesses in order to maintain our technological leadership or to obtain other
commercial advantages. Identifying and negotiating these transactions may divert
substantial management resources. An acquisition could require us to expend
substantial cash resources, to incur or assume debt obligations, or to issue
additional common or preferred stock. These additional equity securities would
dilute your holdings, and could have rights that are senior to or greater than
the shares that you purchase in this offering. We have no experience in making
acquisitions and we may not be successful in executing an acquisition
transaction or integrating an acquired entity into our operations. An
acquisition could involve significant one-time non-cash write offs, or could
involve the amortization of goodwill over a number of years, which would
adversely affect earnings in those years. Acquisitions outside our current
business may be viewed by market analysts as a diversion of our focus. For these
and other reasons, the market for our stock may react negatively to the
announcement of any acquisition. An acquisition will continue to require
attention from our management to integrate the acquired entity into our
operations, may require us to develop expertise in fields outside our current
area of focus, and may result in departures of management of the acquired
entity. An acquired entity may have unknown liabilities, and its business may
not achieve the results anticipated at the time of the acquisition.

                         RISKS RELATING TO OUR INDUSTRY

IF VIDEO COMPRESSION TECHNOLOGY OR OUR IMPLEMENTATION OF THIS TECHNOLOGY IS NOT
ACCEPTED, WE WILL NOT BE ABLE TO SUSTAIN OR EXPAND OUR BUSINESS.

    Our future success depends on the growing use and acceptance of video
applications for PCs, including the growth of video on the Internet. The market
for these applications is new and is still evolving, and may not develop to the
extent necessary to enable us to expand our business. We have recently invested
and expect to continue to invest significant time and resources in the
development of new products for this market. Our dependence on sales of chips
and lack of product diversification

                                       11
<PAGE>
exposes us to a substantial risk of loss in the event that the video compression
market does not develop or if a competing technology replaces our chips. If the
target market for our products does not grow, we may not obtain any benefits
from these investments.

WE ARE HEAVILY DEPENDENT ON THE U.S. AND ASIAN MARKETS FOR SALES OF OUR
PRODUCTS, AND ADVERSE CHANGES IN THESE MARKETPLACES COULD REDUCE OUR SALES.

    Our future performance will be dependent, in large part, on our ability to
continue to compete successfully in the U.S. and Asian markets, particularly
Japan and Taiwan, where a large portion of our current and potential customers
are located. Our ability to compete in these markets will depend on several
factors, including:

    - the state of trade relations among Japan, Taiwan, Israel and the United
      States;

    - the imposition of tariffs by the U.S., Taiwan or Japan on products of the
      type that we develop;

    - adverse changes in the political, economic or regulatory environments of
      Taiwan, Japan or the U.S.;

    - adverse changes in the relationships between major Asian countries;

    - our ability to develop video compression products that meet the technical
      requirements of Japanese, Taiwanese and American customers;

    - our ability to maintain satisfactory relationships with our Japanese,
      Taiwanese and American customers and distributors; and

    - our ability to enforce our agreements and other rights in Japan or Taiwan.

THE MARKETS IN WHICH WE OPERATE ARE HIGHLY COMPETITIVE, AND MANY OF OUR
COMPETITORS HAVE MUCH GREATER RESOURCES THAN WE DO, WHICH MAY MAKE IT DIFFICULT
FOR US TO REMAIN PROFITABLE.

    Competition in our industry is intense, and we expect competition to
increase. Competition could force us to charge lower prices for our products,
reduce demand for our products and reduce our ability to recover development and
manufacturing costs.

Some of our competitors:

    - have greater financial, personnel and other resources than we have;

    - offer a broader range of products and services than we offer;

    - may be able to respond faster to new or emerging technologies or changes
      in customer requirements than we can;

    - may have a more substantial distribution network than we do;

    - benefit from greater purchasing economies than we do;

    - offer more aggressive pricing than we offer; and

    - devote greater resources to the promotion of their products than we do.

We will not be able to compete effectively if we are not able to develop and
implement appropriate strategies to address these factors.

INTERNAL DEVELOPMENT EFFORTS BY OUR CUSTOMERS AND NEW ENTRANTS TO THE MARKET MAY
INCREASE COMPETITION, AND MAKE IT MORE DIFFICULT FOR US TO INCREASE OUR
PROFITABILITY.

    In the future, some of our customers may internally develop products that
will replace the products that we currently sell to them. In addition, some
leading companies, with substantially greater resources than we have, may
attempt to enter our market. The recent substantial growth in the market for
video compression and related technologies is attracting large entrants. We
believe that some large companies may have already begun to develop internally
the technology that we provide. Furthermore,

                                       12
<PAGE>
alliances between semiconductor companies and companies providing software to
them could increase our competition. These factors could make it more difficult
for us to increase our profitability.

WE HAVE EXPERIENCED, AND EXPECT TO CONTINUE TO EXPERIENCE, INTENSE DOWNWARD
PRICING PRESSURE ON OUR PRODUCTS, WHICH COULD SUBSTANTIALLY IMPAIR OUR OPERATING
PERFORMANCE.

    We are experiencing, and are likely to continue to experience, downward
pricing pressure on our chips. As a result, we have experienced, and expect to
continue to experience, declining average sales prices for our products.
Increases in the number of units that we are able to sell or reductions in per
unit costs may not be sufficient to offset reductions in per unit sales prices,
in which case our net income could be reduced or we could incur losses. Since we
must typically negotiate supply arrangements far in advance of delivery dates,
we may need to commit to price reductions for our products before we are aware
of how, or if, these cost reductions can be obtained. As a result, any current
or future price reduction commitments and any inability of our company to
respond to increased price competition could result in substantially reduced
revenues and significant losses.

OUR PRODUCTS GENERALLY HAVE LONG SALES CYCLES AND IMPLEMENTATION PERIODS, WHICH
INCREASE OUR COSTS IN OBTAINING ORDERS AND REDUCES THE PREDICTABILITY OF OUR
EARNINGS, AND WE MAY NOT BE ABLE TO RECOUP COSTS FOR PROPOSALS THAT ARE NOT
ACCEPTED.

    Our products are technologically complex and are typically designed into
applications and products that may be critical to the business of our customers.
Prospective customers generally must make a significant commitment of resources
to test and evaluate our chips and to integrate them into their products. As a
result, our sales process is often subject to delays associated with lengthy
approval processes that typically accompany the design and testing of new
computer accessories. For these and other reasons, the sales cycles of our
products to new customers are often lengthy, recently averaging approximately
six to nine months.

    Long sales cycles are also subject to a number of significant risks over
which we have little or no control. These risks include our customers' budgetary
constraints, internal acceptance reviews and cancellations. In addition, orders
expected in one quarter could shift to another because of the timing of our
customers' procurement decisions. This complicates our planning process and
reduces the predictability of our financial results. We could incur costs that
might not be recouped if we respond to a request for proposals from a potential
customer who does not purchase our chips.

                        RISKS RELATING TO THIS OFFERING

OUR MANAGEMENT HAS BROAD DISCRETION AS TO THE USE OF THE NET PROCEEDS OF THIS
OFFERING AND, IF WE DO NOT ALLOCATE THESE PROCEEDS EFFECTIVELY, YOUR INVESTMENT
COULD SUFFER.

    We intend to use the net proceeds from this offering for working capital and
general corporate purposes, including funding additional research and
development projects and expanding our sales and marketing activities. We may
also use a portion of the net proceeds to acquire complementary products,
technologies or businesses. However, there is no specific allocation of the
proceeds, and our management retains the right to use the net proceeds as they
determine. There can be no assurance that management will be able to use the
proceeds to continue the growth of our business effectively or to increase our
market value.

WE MAY NEED ADDITIONAL FINANCING, AND MAY NOT BE ABLE TO RAISE ADDITIONAL
FINANCING ON FAVORABLE TERMS OR AT ALL, WHICH COULD LIMIT OUR ABILITY TO GROW
AND INCREASE OUR COSTS.

    We anticipate that we may need to raise additional capital in the future to
continue our longer term expansion plans, to respond to competitive pressures or
to respond to unanticipated requirements. We cannot be certain that we will be
able to obtain additional financing on commercially reasonable terms or at all.
Our failure to obtain additional financing or our inability to obtain financing
on acceptable terms could require us to limit our plans for expansion, incur
indebtedness that has high

                                       13
<PAGE>
rates of interest or substantial restrictive covenants, issue equity securities
that will dilute your holdings or discontinue a portion of our operations.

THERE HAS BEEN NO PRIOR MARKET FOR OUR COMMON STOCK, AN ACTIVE MARKET MAY NOT
DEVELOP, THE MARKET PRICE OF OUR COMMON STOCK MAY FLUCTUATE SIGNIFICANTLY, AND
THE MARKET PRICE MAY NOT EXCEED THE INITIAL PUBLIC OFFERING PRICE.

    Before this offering, our common stock did not trade in any market, and we
cannot be certain that an active market will develop. The initial public
offering price may not be indicative of our actual value. Numerous factors, many
of which are beyond our control, may cause the market price of the common stock
to fluctuate significantly. These factors include, but are not limited to, the
following:

    - fluctuations in our quarterly sales and operating results;

    - shortfalls in our operating results from levels forecast by securities
      analysts;

    - announcements concerning us, our competitors or our customers;

    - expectations and forecasts regarding the demand for the products produced
      by our customers;

    - announcements of technological innovations, new industry standards or
      changes in product price by us or our competitors; and

    - market conditions in the industry and the general state of the securities
      markets, particularly the technology and Israeli sectors.

    In addition, the stock prices of many technology companies fluctuate
significantly for reasons that may be unrelated to operating results. These
fluctuations, as well as general economic, political and market conditions,
including recession, international instability or military tension or conflicts,
or any such conditions specifically affecting Israel, may adversely affect the
market price of our common stock. If we are named as a defendant in any
securities-related litigation as a result of decreases in the market price of
our shares, we may incur substantial costs, and our management's attention may
be diverted, for lengthy periods of time. The market price of our common stock
may not increase above the initial public offering price or maintain its price
at or above any particular level.

FUTURE SALES OF OUR COMMON STOCK IN THE PUBLIC MARKET MAY DEPRESS OUR STOCK
PRICE.

    After this offering, we will have outstanding 14,734,669 shares of common
stock. Sales of a substantial number of shares of our common stock in the public
market following this offering could cause our stock price to decline. All the
shares sold in this offering will be freely tradable. Of the 11,234,669
remaining shares of common stock outstanding after this offering, an estimated
9,337,823 shares will be eligible for sale in the public market beginning 180
days after the effective date of this offering. The remaining 1,896,846 shares
will become freely tradable at various times thereafter. The holders of these
1,896,846 restricted shares of our common stock will have the right to require
us to register their shares for resale beginning 180 days after the effective
date of this offering. We intend to file a registration statement registering
shares of common stock subject to outstanding options or reserved for future
issuance under our stock option and purchase plans. As of March 31, 2000,
options to purchase a total of 1,446,514 shares were outstanding under our 1999
Stock Option Plan. As a result, common stock issuable upon exercise of
outstanding vested options, other than common stock issuable to our affiliates,
will be available for immediate resale in the open market. In addition, the sale
or registration of these shares could impair our ability to raise capital
through the sale of additional stock. See "Shares Eligible for Future Sale."

                                       14
<PAGE>
BECAUSE OUR PRINCIPAL STOCKHOLDERS, EXECUTIVE OFFICERS AND DIRECTORS HAVE
SUBSTANTIAL CONTROL OVER MOST MATTERS SUBMITTED TO A VOTE OF THE STOCKHOLDERS,
YOUR ABILITY TO CONTROL OUR MANAGEMENT WILL BE LIMITED, AND ANY PREMIUM OVER
MARKET PRICE THAT AN ACQUIROR MIGHT OTHERWISE PAY MAY BE REDUCED AND ANY MERGER
OR TAKEOVER MAY BE DELAYED.

    We anticipate that after this offering our officers, directors and present
stockholders will beneficially own 76.2% of our common stock, or 73.6% if the
underwriters' over-allotment option is exercised in full. As a result, these
stockholders will have the power to control the outcome of most matters
submitted to a vote of stockholders, including the election of members of our
board, and the approval of significant corporate transactions. The stockholders
purchasing shares in this offering will have little influence on these matters.
This concentration of ownership may also impede a merger, consolidation,
takeover or other business consolidation involving us, or discourage a potential
acquiror from making a tender offer for our shares. This concentration of our
ownership could also negatively affect our stock's market price or decrease any
premium over market price that an acquiror might otherwise pay.

THE EFFECTS OF ANTI-TAKEOVER PROVISIONS IN OUR CERTIFICATE OF INCORPORATION AND
BYLAWS MAY DISCOURAGE, DELAY OR PREVENT AN ACQUISITION OF US THAT A STOCKHOLDER
MAY CONSIDER FAVORABLE.

    Several provisions of our certificate of incorporation and bylaws could
discourage potential acquisition proposals and could delay or prevent a change
in control of our company even if that change in control would be beneficial to
our stockholders. For example, only one-third of our board of directors will be
elected at each of our annual meetings of stockholders, which will make it more
difficult for a potential acquirer to change the management of our company, even
after acquiring a majority of the shares of our common stock. These provisions,
which cannot be amended without the approval of two-thirds of our stockholders,
could diminish the opportunities for a stockholder to participate in tender
offers, including tender offers at a price above the then current market value
of our common stock. In addition, our board of directors, without further
stockholder approval, may issue preferred stock, with such terms as the board of
directors may determine, that could have the effect of delaying or preventing a
change in control of our company. The issuance of preferred stock could also
adversely affect the voting powers of the holders of common stock, including the
loss of voting control to others. We are also afforded the protections of
Section 203 of the Delaware General Corporation Law, which could delay or
prevent a change in control of our company or could impede a merger,
consolidation, takeover or other business combination involving our company or
discourage a potential acquirer from making a tender offer or otherwise
attempting to obtain control of our company.

                   RISKS RELATING TO OUR OPERATIONS IN ISRAEL

POLITICAL OR ECONOMIC INSTABILITY OR MILITARY HOSTILITIES IN ISRAEL COULD RESULT
IN A LOSS OF SALES OR THE DISRUPTION OF OUR OPERATIONS.

    The offices of our principal operating subsidiary are located in Israel.
This facility is the location of, among other things, our research and
development efforts. As a result, political, economic and military conditions in
Israel directly affect our operations. Accordingly, any major hostilities
involving Israel, the interruption or curtailment of trade between Israel and
its present trading partners or a significant downturn in the economic or
financial condition of Israel could result in a loss of sales or the disruption
of our operations. Despite the progress towards peace among Israel, neighboring
countries and the Palestinians, the future of these peace efforts is uncertain.
A number of countries continue to restrict or ban business with Israel or
Israeli companies. Restrictive laws or policies directed towards Israel or
Israeli businesses could impair our ability to increase our international sales.
Additionally, some of our officers and employees in Israel are obligated to
perform up to 39 days of military reserve duty annually. The absence of these
employees for significant periods during the workweek may cause us to operate
inefficiently during these periods.

                                       15
<PAGE>
CURRENCY FLUCTUATIONS AND THE RATE OF INFLATION IN ISRAEL MAY INCREASE OUR
EXPOSURE TO VOLATILITY IN INTERNATIONAL MARKETS AND NEGATIVELY IMPACT OUR
FINANCIAL PERFORMANCE.

    Most of our sales are in dollars or linked to dollars, and approximately
26.5% of our expenses were incurred in New Israeli Shekels (NIS) in the three
months ended March 31, 2000. As a result, we bear the risk that the rate of
inflation in Israel will differ from the rate of devaluation of the NIS in
relation to the dollar. For example, the annual rate of inflation in Israel was
an increase 7.0% in 1997, 8.6% in 1998, 1.3% in 1999 and a decrease of 1.2% in
the three months ended March 31, 2000, while the NIS was devalued against the
dollar by 8.8% in 1997 and 17.6% in 1998, and the dollar was devalued against
the NIS by 0.2% in 1999 and by 3.05% in the three months ended March 31, 2000.
The recent devaluation may be followed by an increased rate of inflation in
Israel, but the current economic outlook in Israel is uncertain. We may incur
losses in the future if the rate of inflation in Israel exceeds the devaluation
of the NIS against the dollar or if the timing of a devaluation lags behind
increases in inflation in Israel.

    To date, we have not engaged in hedging transactions. In the future, we may
enter into currency hedging transactions to decrease the risk of financial
exposure from fluctuations in the exchange rate of the dollar against the NIS.
These measures may not adequately protect us against these risks.

THE GOVERNMENT PROGRAMS AND TAX BENEFITS THAT WE CURRENTLY PARTICIPATE IN OR
RECEIVE REQUIRE US TO MEET SEVERAL CONDITIONS AND MAY BE TERMINATED OR REDUCED
IN THE FUTURE, WHICH WOULD INCREASE OUR COSTS.

    We benefit from a variety of government programs and tax benefits,
particularly as a result of exemptions and reductions resulting from the
"Approved Enterprise" status of our existing facility in Israel. To be eligible
for these programs and tax benefits, we must continue to meet specific
conditions, including making specified investments in fixed assets and financing
a percentage of investments with share capital. If we fail to meet these
conditions in the future, the tax benefits would be canceled and we could be
required to refund the tax benefits to which we are entitled. Israeli
governmental authorities have indicated that these programs and tax benefits may
not be continued in the future at their current levels or at any level. The
termination or reduction of these programs and tax benefits could increase our
expenses substantially.

    Prior to 1995, we obtained royalty-bearing grants from the Office of the
Chief Scientist in Israel's Ministry of Industry and Trade to fund a portion of
our research and development. The terms of the grants from the Chief Scientist
prohibit the transfer of technology developed under these grants to any person
without the prior written consent of the Chief Scientist. We may apply for such
grants for the development of new products in the future.

IT MAY BE DIFFICULT TO ENFORCE A U.S. JUDGMENT AGAINST US, OUR OFFICERS AND
DIRECTORS AND SOME OF THE EXPERTS NAMED IN THIS PROSPECTUS, OR TO ASSERT U.S.
SECURITIES LAWS CLAIMS IN ISRAEL.

    Substantially all of our executive officers and directors and some of the
experts named in this prospectus are nonresidents of the U.S., and a substantial
portion of our assets and the assets of these persons are located outside the
U.S. Therefore, it may be difficult to enforce a judgment obtained in the U.S.
against us or any of those persons or to effect service of process on them
outside the U.S. Additionally, it may be difficult for you to enforce civil
liabilities under U.S. federal securities laws in original actions instituted in
Israel.

                                       16
<PAGE>
                 CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTS

    Some of the matters discussed under the captions "Prospectus Summary," "Risk
Factors," "Management's Discussion and Analysis of Financial Condition and
Results of Operations," "Business" and elsewhere in this prospectus include
forward-looking statements. We have based these forward-looking statements on
our current expectations and projections about future events, including, among
other things:

    - implementing our business strategy;

    - attracting and retaining customers;

    - obtaining and expanding market acceptance of the products and services we
      offer;

    - forecasts of Internet usage and the size and growth of relevant markets;

    - rapid technological changes in our industry and relevant markets; and

    - competition in our market.

    In some cases, you can identify forward-looking statements by terminology
such as "may," "will," "should," "could," "predicts," "potential," "continue,"
"expects," "anticipates," "future," "intends," "plans," "believes," "estimates"
and similar expressions. These statements are based on our current beliefs,
expectations and assumptions and are subject to a number of risks and
uncertainties. Actual results, levels of activity, performance, achievements and
events may vary significantly from those implied by the forward-looking
statements. A description of risks that could cause our results to vary appears
under the caption "Risk Factors" and elsewhere in this prospectus. These
forward-looking statements are made as of the date of this prospectus, and
except as required under applicable securities law, we assume no obligation to
update them or to explain the reasons why actual results may differ.

                                       17
<PAGE>
                                USE OF PROCEEDS

    We estimate that we will receive net proceeds from the sale of shares of our
common stock in this offering of approximately $44.5 million, and $51.4 million
if the underwriters exercise their over-allotment option in full, based upon an
assumed offering price of $14.00 per share and after deducting estimated
underwriting discounts and commissions and offering expenses. The principal
purposes of this offering are to obtain additional capital and to create a
public market for our common stock. We expect to use the net proceeds from this
offering for working capital and other general corporate purposes. We may use a
portion of the net proceeds to acquire complementary products, technologies or
businesses; however, we currently have no commitments or agreements relating to
any of these types of transactions.

    We will have significant discretion in the use of the net proceeds of this
offering. Investors will be relying on the judgment of our management regarding
the application of the proceeds of this offering. Pending use of the net
proceeds as discussed above, we intend to invest these funds in short-term,
interest-bearing, investment-grade obligations.

                                DIVIDEND POLICY

    We have never declared or paid any dividends on our capital stock. We expect
to retain any future earnings to fund the development and expansion our
business. Therefore, we do not anticipate paying cash dividends on our common
stock in the foreseeable future. Through our subsidiary, Nogatech Ltd., we
participate in the "alternative benefits program" under the Israeli Law for the
Encouragement of Capital Investments--1959, under which we receive a number of
tax exemptions. These tax exemptions will apply only after our net operating
losses are utilized. As a result, we have not yet benefited from these
exemptions. If Nogatech Ltd. distributes a cash dividend to us from income which
is tax exempt, it would have to pay corporate tax at the rate of between 10% to
15% on an amount equal to the amount distributed and the corporate tax which
would have been due in the absence of the tax exemption. As a result, we may
determine that it is not in your best interests to cause Nogatech Ltd. to
declare a dividend on any of its own profits to us in order to enable us to pay
a dividend to our stockholders.

                                       18
<PAGE>
                                 CAPITALIZATION

    The following table summarizes our balance sheet data as of March 31, 2000.
This balance sheet data is presented:

    - on an actual basis;

    - on an as adjusted basis to give effect to:

       - the conversion of all outstanding shares of preferred stock into an
         estimated 9,293,310 shares of common stock upon the closing of this
         offering;

       - the assumed exercise of options and warrants to purchase up to
         1,213,319 shares of our common stock upon completion of this offering
         at a weighted average exercise price of $1.57 per share; and

       - the sale of the shares of common stock in this offering at the assumed
         initial public offering price of $14.00 per share, after deducting the
         estimated underwriting discounts and commissions and offering expenses.


<TABLE>
<CAPTION>
                                                               AS OF MARCH 31, 2000
                                                              ----------------------
                                                               ACTUAL    AS ADJUSTED
                                                              --------   -----------
                                                                  (IN THOUSANDS,
                                                                EXCEPT SHARE DATA)
<S>                                                           <C>        <C>
Series A redeemable convertible preferred stock, $0.001 par
  value, at redemption value; 30,000,000 shares authorized,
  actual; no shares authorized, as adjusted; 15,906,304
  shares issued and outstanding, actual; no shares issued
  and outstanding, as adjusted (1)..........................  $ 8,408     $     --
Series B redeemable convertible preferred stock, $0.001 par
  value, at redemption value; 1,196,172 shares authorized,
  issued and outstanding, actual; no shares authorized,
  issued and outstanding, as adjusted(1)....................    5,000           --
Stockholders' equity:
Common stock, $0.001 par value; 40,000,000 shares
  authorized; 728,040 shares issued and outstanding, actual;
  14,734,669 shares issued and outstanding, as adjusted.....        1           15
Additional paid-in-capital..................................   11,024       70,823
Deferred compensation.......................................     (343)        (343)
Accumulated deficit.........................................  (15,237)     (15,237)
                                                              -------     --------
Total stockholders' equity (capital deficiency)                (4,555)      55,258
                                                              -------     --------
                                                              -------     --------
Total capitalization........................................  $ 8,853     $ 55,258
                                                              =======     ========
</TABLE>


- ------------------------------

(1) Our shares of Series A and Series B preferred stock entitle their holders to
    a liquidation preference in the event that our operations terminate. The
    terms of the preferred stock provide that events such as a change of control
    are considered a liquidation that entitles the holders to the liquidation
    preference.

    The previous information should be read together with our consolidated
financial statements and the related notes and "Management's Discussion and
Analysis of Financial Condition and Results of Operations" appearing elsewhere
in this prospectus.

    The shares of common stock outstanding in the pro forma as adjusted columns
exclude:

    - 1,065,014 shares of common stock issuable as of March 31, 2000 upon the
      exercise of outstanding stock options issued under our 1999 Stock Option
      Plan at a weighted average exercise price of $1.47 per share;

    - 3,850,000 shares of common stock reserved for issuance under our 2000
      Equity Incentive Plan and 2000 Stock Purchase Plan; and

    - 350,000 shares of common stock issuable as of March 31, 2000 upon the
      exercise of outstanding warrants at an exercise price of $0.13 per share.

                                       19
<PAGE>
                                    DILUTION


    Our pro forma net tangible book value as of March 31, 2000 was approximately
$8,853,000, or $0.88 per share of common stock. Pro forma net tangible book
value per share represents the amount of total tangible assets less total
liabilities, divided by 10,021,350, the number of shares of common stock treated
as outstanding on a pro forma basis after giving effect to the conversion of our
Series A and Series B preferred stock. After giving effect to the sale of the
shares of common stock offered in this offering at the assumed public offering
price, net of offering expenses, our pro forma net tangible book value at March
31, 2000 would have been $53,353,000, or $3.95 per share of common stock. This
represents an immediate increase in net pro forma tangible book value to
existing stockholders of $3.07 per share and an immediate dilution of $10.05 per
share to new investors. The following table illustrates the per share dilution:



<TABLE>
<S>                                                           <C>        <C>
  Assumed initial public offering price per share...........              $14.00
    Pro forma net tangible book value per share before this
      offering as of March 31, 2000.........................   $ 0.88
    Increase per share attributable to new investors........     3.07
                                                               ------
  Pro forma net tangible book value per share after this
    offering................................................                3.95
                                                                          ------
  Dilution per share to new investors.......................
                                                                          $10.05
                                                                          ======
</TABLE>


    The following table summarizes on a pro forma basis, after giving effect to
the conversion of our Series A and Series B preferred stock, the total number of
shares of common stock purchased from us, the total consideration paid to us and
the average price per share paid by existing stockholders and by new investors,
in each case based upon the number of shares of common stock and Series A and
Series B preferred stock outstanding as of March 31, 2000, and assuming that
this offering is completed prior to May 30, 2000.

<TABLE>
<CAPTION>
                                              SHARES PURCHASED       TOTAL CONSIDERATION      AVERAGE
                                            ---------------------   ----------------------     PRICE
                                              NUMBER     PERCENT      AMOUNT      PERCENT    PER SHARE
                                            ----------   --------   -----------   --------   ---------
<S>                                         <C>          <C>        <C>           <C>        <C>
Existing stockholders.....................  10,021,350     74.0%    $17,420,000     28.0%      $1.74
New investors.............................   3,500,000     26.0%    $44,500,000     72.0%
                                            ----------    -----     -----------    -----
  Total...................................  13,521,350    100.0%    $61,920,000    100.0%
                                            ==========    =====     ===========    =====
</TABLE>

    If the underwriters' over-allotment option is exercised in full, the number
of shares of common stock held by existing stockholders will be reduced to 71.3%
of the total number of shares of common stock to be outstanding after this
offering and the number of shares of common stock held by new investors will
increase to 4,025,000 shares, or 28.7% of the total number of shares of common
stock to be outstanding immediately after this offering.


    The foregoing discussions and tables assume no exercise of any stock options
or warrants outstanding. As of March 31, 2000, there were options outstanding to
purchase 1,065,014 shares of common stock at a weighted average exercise price
of $1.47 and 1,213,319 warrants and options outstanding to purchase shares of
common stock at a weighted average exercise price of $1.57 per share. If all of
these options and warrants were exercised on March 31, 2000, our pro forma net
tangible book value as of that date would have been $56,823,481, or $3.60 per
share of common stock, and this offering would represent an immediate dilution
of $10.40 per share to new investors.


                                       20
<PAGE>
                      SELECTED CONSOLIDATED FINANCIAL DATA

    The statement of operations data for each of the years in the three-year
period ended December 31, 1999 and the balance sheet data at December 31, 1998
and December 31, 1999 are derived from our audited financial statements included
elsewhere in this prospectus. The statement of operations data for each of the
three-month periods ended March 31, 1999 and 2000 and the balance sheet data at
March 31, 2000 are derived from our unaudited financial statements included
elsewhere in this prospectus. Such unaudited interim financial statements have
been prepared on the same basis as the audited financial statements and reflect
all adjustments (consisting only of normal recurring accruals) necessary for a
fair presentation of the financial information, in accordance with generally
accepted accounting principles. The statement of operations data for the year
ended December 31, 1996 and the balance sheet data at December 31, 1996 and 1997
are derived from our audited financial statements that are not included in this
prospectus. The statement of operations data for the year ended December 31,
1995 and the balance sheet data at December 31, 1995 are derived from our
unaudited financial statements that are not included in this prospectus. The
following selected consolidated financial data should be read in conjunction
with our consolidated financial statements and related notes and "Management's
Discussion and Analysis of Financial Condition and Results of Operations"
included elsewhere in this prospectus.


<TABLE>
<CAPTION>
                                                                                                            THREE MONTHS ENDED
                                                               YEAR ENDED DECEMBER 31,                           MARCH 31,
                                              ---------------------------------------------------------   -----------------------
                                                 1995         1996       1997       1998        1999         1999         2000
                                              -----------   --------   --------   --------   ----------   ----------   ----------
                                                                (IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)
<S>                                           <C>           <C>        <C>        <C>        <C>          <C>          <C>
STATEMENT OF OPERATIONS DATA:
Sales.......................................  $      931    $  2,630   $  2,551   $  3,205   $    8,856   $      870   $    2,945
Cost of sales...............................         777       1,855      1,699      2,038        5,111          518        1,661
                                              -----------   --------   --------   --------   ----------   ----------   ----------
Gross profit................................         154         775        852      1,167        3,745          352        1,284
Operating expenses:
  Research and development..................       1,314         997      1,266      1,451        2,283          588          685
  Sales and marketing.......................         491         898        695      1,020        1,689          383          290
  General and administrative................         258         473        321        609          880          195          204
                                              -----------   --------   --------   --------   ----------   ----------   ----------
Total operating expenses....................       2,063       2,368      2,282      3,080        4,852        1,166        1,179
                                              -----------   --------   --------   --------   ----------   ----------   ----------
Operating (loss) income.....................      (1,909)     (1,593)    (1,430)    (1,913)      (1,107)        (814)         105
Other income (expense), net.................        (288)        (21)       (32)        90           11           (3)         (12)
                                              -----------   --------   --------   --------   ----------   ----------   ----------
Net (loss) income...........................      (2,197)     (1,614)    (1,462)    (1,823)      (1,096)        (817)          93
Charge for beneficial conversion feature of
  Series B redeemable preferred stock.......           -           -          -          -            -            -       (4,570)
Accretion of redemption value of Series A
  redeemable convertible preferred stock....        (120)       (173)      (300)      (383)        (427)        (107)        (165)
                                              -----------   --------   --------   --------   ----------   ----------   ----------
Net loss applicable to common stock.........  $   (2,317)   $ (1,787)  $ (1,762)  $ (2,206)  $   (1,523)  $     (924)  $   (4,642)
                                              ===========   ========   ========   ========   ==========   ==========   ==========
Net loss per share of common stock, basic
  and diluted...............................  $    (8.08)   $  (6.23)  $  (5.86)  $  (7.13)  $    (4.50)  $    (2.97)  $    (8.14)
                                              ===========   ========   ========   ========   ==========   ==========   ==========
Weighted average number of shares of common
  stock outstanding.........................     286,625     286,625    300,709    309,536      338,295      310,995      570,557
                                              ===========   ========   ========   ========   ==========   ==========   ==========
Pro forma net income (loss) per share of
  common stock, basic and diluted...........                                                 $    (0.12)  $    (0.09)  $     0.01
                                                                                             ==========   ==========   ==========
Pro forma weighted average number of shares
  of common stock outstanding...............                                                  8,948,078    8,920,778    9,749,945
                                                                                             ==========   ==========   ==========
</TABLE>



<TABLE>
<CAPTION>
                                                                          AS OF DECEMBER 31,
                                                        -------------------------------------------------------   AS OF MARCH 31,
                                                           1995         1996       1997       1998       1999          2000
                                                        -----------   --------   --------   --------   --------   ---------------
                                                                                     (IN THOUSANDS)
<S>                                                     <C>           <C>        <C>        <C>        <C>        <C>
BALANCE SHEET DATA:
Cash and cash equivalents.............................  $    1,114    $     95   $    271   $  3,791   $  2,475      $  6,612
Working capital.......................................         915         (96)       223      4,171      3,111         8,627
Total assets..........................................       2,235       1,368      1,568      5,769      6,577        10,950
Series A redeemable convertible preferred stock.......       3,783       4,147      4,954      7,816      8,243         8,408
Series B redeemable convertible preferred stock.......           -           -          -          -          -         5,000
Stockholders' equity (capital deficiency).............      (2,519)     (4,047)    (4,524)    (3,517)    (4,886)       (4,555)
</TABLE>


                                       21
<PAGE>
                      MANAGEMENT'S DISCUSSION AND ANALYSIS
                OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

    YOU SHOULD READ THE FOLLOWING DISCUSSION AND ANALYSIS IN CONJUNCTION WITH
OUR CONSOLIDATED FINANCIAL STATEMENTS AND RELATED NOTES INCLUDED ELSEWHERE IN
THIS PROSPECTUS. EXCEPT FOR HISTORICAL INFORMATION, THE DISCUSSION IN THIS
PROSPECTUS CONTAINS CERTAIN FORWARD-LOOKING STATEMENTS THAT INVOLVE RISKS AND
UNCERTAINTIES. THE PRINCIPAL FACTORS THAT COULD CAUSE OR CONTRIBUTE TO
DIFFERENCES IN OUR ACTUAL RESULTS ARE DISCUSSED IN THE SECTION TITLED "RISK
FACTORS."

OVERVIEW

    We design and sell chips that establish connections between video devices
and computers, as well as connections between video devices across a variety of
networks. Our chips and related decompression software use proprietary
algorithms designed to provide high quality video, low power consumption and
advanced capabilities. These features enable cost-effective plug-and-play video
connections.

    In 1995 and 1996, we introduced our NT1001 video chip and NT1002 sound chip
for connecting video sources to laptop computers. We sold both of these chips
embedded in PCMCIA cards, which are connectors that allow accessory equipment,
such as modems, CD-ROM drives and video cameras, to be connected to personal
computers. In 1998, we introduced our NT1003 chip, which compresses video for
transfer through the Universal Serial Bus (USB) interface between computer
accessories and computers. The USB is an interface standard for connections
between a computer and its accessories using a standard cable. We sold the
NT1003 chip on a stand-alone basis to original equipment manufacturers for
integration into their video products and also incorporated into our own video
devices.

    With the introduction of our NT1003 chip, we began to reduce our sales of
NT1001 and NT1002 chips embedded in PCMCIA cards. In addition, we began to
increase our sales of NT1003 chips on a stand-alone basis. Our strategy is to
continue increasing our sales of chips on a stand-alone basis rather than
incorporated into our own video devices. We anticipate that these sales will
constitute the primary portion of our future sales.

    We primarily sell our chips to original equipment manufacturers that
incorporate our chips into their video applications and products. Purchasers of
our chips in 1999 were AME Group, Camtel Technology, Fujitsu General, Hauppauge
Computer Works, Ingram Micro, Interex, IO Data, Pinnacle Systems, Sharp
Electronics and X-10.com. In the first quarter of 2000, approximately 50% of our
sales were derived from customers in North America, 26% from customers in Asia
and 24% from customers in Europe and other regions. In 1999, approximately 61%
of our sales were derived from customers in North America, 31% from customers in
Asia, and 8% from customers in Europe and other regions.

    Our sales are concentrated among relatively few customers. In the first
quarter of 2000, sales to Hauppauge represented approximately 31% of sales,
sales to Camtel represented approximately 12% of sales, and sales to Pinnacle
represented approximately 11% of sales. In 1999, sales to Hauppauge represented
approximately 24% of sales, sales to Tomen Electronics, our Japanese
distributor, represented approximately 14% of sales, and sales to Interex
represented approximately 13% of sales. Tomen Electronics accounted for
approximately 41% of sales in 1998 and 17% of sales in 1997. Although our
principal customers are likely to vary on a quarterly basis, we anticipate that
our sales will remain concentrated among a few customers for the foreseeable
future.

    The sales prices of our chips decreased in 1999 and in the first quarter of
2000 primarily as a result of increased volume and competition, and we may need
to reduce prices further in order to remain competitive. We have offset
decreased chip prices by reducing the prices we pay our chip suppliers due to
increased volume. In addition, we design each generation of our chips to use
more advanced micron process technology, which determines the relative size of
our chips. For example, our NT1003 chip uses 0.60-micron process technology
while our NT1004 chip uses 0.35-micron process technology. Our use of smaller
micron process technology allows us to reduce the size of our chips and

                                       22
<PAGE>
results in lower costs per chip. We are designing our next generation of chips
to be manufactured using smaller micron process technology, which we believe
will enable us to reduce manufacturing costs further.


    We have incurred significant net losses since our inception, and we may
continue to do so for the foreseeable future. We incurred net losses of $1.8
million in 1998 and $1.1 million in 1999. Our accumulated deficit was
$10.6 million as of December 31, 1999 and $15.2 million as of March 31, 2000.


    Our results of results of operations include our subsidiaries, Nogatech
Ltd., an Israeli corporation, and Nogatech California, Inc., unless the context
requires otherwise.

RESULTS OF OPERATIONS

    The following table sets forth selected data from our consolidated statement
of operations as a percentage of sales for the periods indicated:

<TABLE>
<CAPTION>
                                                                                               THREE MONTHS ENDED
                                                         YEAR ENDED DECEMBER 31,                   MARCH 31,
                                                   ------------------------------------      ----------------------
                                                     1997          1998          1999          1999          2000
                                                   --------      --------      --------      --------      --------
                                                                      (AS A PERCENTAGE OF SALES)
<S>                                                <C>           <C>           <C>           <C>           <C>
STATEMENT OF OPERATIONS DATA:
Sales........................................        100.0%        100.0%        100.0%        100.0%        100.0%
Cost of sales................................         66.6          63.6          57.7          59.5          56.4
                                                    ------        ------        ------        ------        ------
Gross profit.................................         33.4          36.4          42.3          40.5          43.6
Operating expenses:
  Research and development...................         49.6          45.3          25.8          67.6          23.3
  Sales and marketing........................         27.2          31.8          19.1          44.0           9.9
  General and administrative.................         12.6          19.0           9.9          22.4           6.9
                                                    ------        ------        ------        ------        ------
Total operating expenses.....................         89.4          96.1          54.8         134.0          40.1
                                                    ------        ------        ------        ------        ------
Operating income (loss)......................        (56.0)        (59.7)        (12.5)        (93.5)          3.5
Other income (expense), net..................         (1.3)          2.8           0.1          (0.3)         (0.4)
                                                    ------        ------        ------        ------        ------
Net income (loss)............................        (57.3)%       (56.9)%       (12.4)%       (93.8)%         3.1%
                                                    ======        ======        ======        ======        ======
</TABLE>

    SALES.  Sales to original equipment manufacturers are recorded when we ship
our products. We recognize sales to distributors when they ship our products to
their customers. We accrue for estimated product warranty and liability costs
upon recognition of product sales.

    Sales increased approximately 26% from $2.6 million in 1997 to $3.2 million
in 1998 and 176% to $8.9 million in 1999, and approximately 239% from
$0.9 million in first quarter 1999 to $2.9 million in the first quarter of 2000.
These increases primarily reflect the increase in unit sales of our products.
Sales increased from 1998 to 1999 and from the first quarter of 1999 to the
first quarter of 2000 primarily as a result of increased sales of our NT1003
chip, on both a stand-alone basis and incorporated into our video devices. Our
sales in 1997 and 1998 were primarily derived from sales of PCMCIA cards, which
we are no longer selling.

    COST OF SALES.  Cost of sales consists of component costs, warranty costs,
royalties and overhead related to manufacturing our products. Cost of sales
increased from $1.7 million in 1997 to $2.0 million in 1998 and to $5.1 million
in 1999, and from $0.5 million in the first quarter of 1999 to $1.7 million in
the first quarter of 2000. These increases were primarily due to increased
shipments of our products. Gross margins were 33.4% in 1997, 36.4% in 1998 and
42.3% in 1999, and were 40.5% in the first quarter of 1999 and 43.6% in the
first quarter of 2000. The increase from 1997 to 1998 was primarily due to cost
reductions that we implemented in our PCMCIA cards, and the increases from 1998
to

                                       23
<PAGE>
1999 and from the first quarter of 1999 to the first quarter of 2000 were
primarily due to the transition to our higher margin video compression chip
business.

    RESEARCH AND DEVELOPMENT EXPENSES.  Research and development expenses
consist primarily of personnel, equipment, software tools and supplies for our
research and development activities. Substantially all of our research and
development activities occur in our facility in Israel. These expenses are
charged to operations as incurred. Our research and development expenses
increased from $1.3 million in 1997 to $1.5 million in 1998 and to $2.3 million
in 1999, and from $0.6 million in the first quarter of 1999 to $0.7 million in
the first quarter of 2000. These increases were primarily due to increased
levels of research and development activities and related costs of personnel.
Research and development expenses as a percentage of sales were 49.6% in 1997,
45.3% in 1998 and 25.8% in 1999, and were 67.6% in the first quarter of 1999 and
23.3% in the first quarter of 2000. The decreases as a percentage of sales from
1998 to 1999 and from the first quarter of 1999 to the first quarter of 2000
were due to our substantial increase in sales in 1999 and in the first quarter
of 2000. We believe significant investment in research and development is
essential to our future success. We plan to increase our research and
development activities, including recruiting and hiring additional personnel,
and to incur non-recurring engineering expenses associated with the manufacture
of our next generation chips, which will result in increased expenses in
absolute dollars.


    SALES AND MARKETING EXPENSES.  Sales and marketing expenses consist of
salaries and related costs of sales and marketing employees, consulting fees,
and expenses for travel, trade shows and promotional activities. Sales and
marketing expenses increased from $0.7 million in 1997 to $1.0 million in 1998
and to $1.7 million in 1999, and decreased from $0.4 million in the first
quarter of 1999 to $0.3 million in the first quarter of 2000. These changes were
primarily due to increases in the number of our sales and marketing personnel.
Sales and marketing expenses as a percentage of sales were 27.2% in 1997, 31.8%
in 1998 and 19.1% in 1999, and 44.0% in the first quarter of 1999 and 9.9% in
the first quarter of 2000. The decreases as a percentage of sales from 1998 to
1999 and in the first quarter of 1999 to the first quarter of 2000 were due to
our substantial increase in sales in 1999 and in the first quarter of 2000. We
plan to increase our sales and marketing activities, including recruiting and
hiring additional senior personnel, which will result in increased expenses in
absolute dollars.



    GENERAL AND ADMINISTRATIVE EXPENSES.  General and administrative expenses
consist primarily of personnel and related costs for general corporate
functions, including finance, accounting, strategic and business development,
human resources and legal. General and administrative expenses increased from
$321,000 in 1997 to $609,000 in 1998 and to $880,000 in 1999, and from $195,000
in the first quarter of 1999 to $204,000 in the first quarter of 2000. General
and administrative expenses as a percentage of sales were 12.6% in 1997, 19.0%
in 1998 and 9.9% in 1999, and 22.4% in the first quarter of 1999 and 6.9% in the
first quarter of 2000. In the fourth quarter of 1999, we recorded a $126,000
allowance for doubtful accounts to reflect a past due receivable from a single
customer. As of March 31, 2000, this receivable was $192,000. We believe that
the allowance is sufficient to reflect the potential loss related to this
receivable. We expect general and administrative expenses to increase in
absolute dollars as a result of our growing operational and corporate
activities, including activities related to our operations as a public company.


    OTHER INCOME (EXPENSE), NET.  Other income (expense) consists of interest
earned on cash and cash equivalents offset by interest expense related to bank
loans. Net interest income (expense) was an expense of $32,000 in 1997, income
of $90,000 in 1998 and income of $11,000 in 1999 and an expense of $3,000 in the
first quarter of 1999 and $12,000 in the first quarter of 2000.

    INCOME TAXES.  As of March 31, 2000, we had approximately $2.0 million of
Israeli net operating loss carryforwards, $5.2 million of U.S. federal net
operating loss carryforwards and $1.7 million of state net operating loss
carryforwards. The Israeli net operating loss carryforwards have no expiration
date. The U.S. net operating loss carryforwards expire in various amounts
between the years 2004 and 2019.

                                       24
<PAGE>
QUARTERLY RESULTS OF OPERATIONS

    The tables below set forth unaudited statement of operations data for each
of the eight consecutive quarters ended March 31, 2000. This information has
been prepared on the same basis as our audited consolidated financial
statements. The information should be read in conjunction with our consolidated
financial statements and notes thereto appearing elsewhere in this prospectus
and, in the opinion of management, includes all adjustments, consisting only of
normal recurring adjustments, that we believe are necessary to present fairly
the unaudited quarterly results. Our limited operating history with respect to
our current chips makes the prediction of future operating results difficult or
impossible. We believe that period-to-period comparisons of our financial
results are not necessarily meaningful and should not be relied upon as an
indication of future performance.

<TABLE>
<CAPTION>
                                                                        QUARTER ENDED
                                    -------------------------------------------------------------------------------------
                                    JUNE 30,   SEP. 30,   DEC. 31,   MAR. 31,   JUNE 30,   SEP. 30,   DEC. 31,   MAR. 31,
                                      1998       1998       1998       1999       1999       1999       1999       2000
                                    --------   --------   --------   --------   --------   --------   --------   --------
                                                                       (IN THOUSANDS)
<S>                                 <C>        <C>        <C>        <C>        <C>        <C>        <C>        <C>
Sales............................    $ 589      $ 873     $ 1,073    $   870    $ 1,953    $ 2,947    $ 3,086    $ 2,945
Cost of sales....................      361        529         648        518      1,167      1,678      1,748      1,661
                                     -----      -----     -------    -------    -------    -------    -------    -------
Gross profit.....................      228        344         425        352        786      1,269      1,338      1,284

Operating expenses:
  Research and development.......      352        369         370        588        520        622        554        685
  Sales and marketing............      239        244         329        383        511        413        382        290
  General and administrative.....      133        153         207        195        183        215        286        204
                                     -----      -----     -------    -------    -------    -------    -------    -------
Total operating expenses.........      724        766         906      1,166      1,214      1,250      1,222      1,179
                                     =====      =====     =======    =======    =======    =======    =======    =======
Operating income (loss)..........     (496)      (422)       (481)      (814)      (428)        19        116        105
Other income (expenses), net.....      (17)        64          55         (3)         9         59        (54)       (12)
                                     -----      -----     -------    -------    -------    -------    -------    -------
Net income (loss)................    $(513)     $(358)    $  (426)   $  (817)   $  (419)   $    78    $    62         93
                                     =====      =====     =======    =======    =======    =======    =======    =======
</TABLE>


<TABLE>
<CAPTION>
                                                                        QUARTER ENDED
                                    -------------------------------------------------------------------------------------
                                    JUNE 30,   SEP. 30,   DEC. 31,   MAR. 31,   JUNE 30,   SEP. 30,   DEC. 31,   MAR. 31,
                                      1998       1998       1998       1999       1999       1999       1999       2000
                                    --------   --------   --------   --------   --------   --------   --------   --------
                                                                 (AS A PERCENTAGE OF SALES)
<S>                                 <C>        <C>        <C>        <C>        <C>        <C>        <C>        <C>
Sales............................    100.0%     100.0%      100.0%     100.0%     100.0%     100.0%     100.0%     100.0%
Cost of sales....................     61.3       60.6        60.4       59.5       59.8       56.9       56.6       56.4
                                     -----      -----     -------    -------    -------    -------    -------    -------

Gross profit.....................     38.7       39.4        39.6       40.5       40.2       43.1       43.4       43.6
Operating expenses:
  Research and development.......     59.8       42.3        34.5       67.6       26.6       21.1       18.0       23.3
  Sales and marketing............     40.6       27.9        30.7       44.0       26.2       14.0       12.4        9.9
  General and administrative.....     22.6       17.5        19.3       22.4        9.4        7.3        9.2        6.9
                                     -----      -----     -------    -------    -------    -------    -------    -------
Total operating expenses:            123.0       87.7        84.5      134.0       62.2       42.4       39.6       40.1
                                     -----      -----     -------    -------    -------    -------    -------    -------
Operating income (loss)..........    (84.3)     (48.3)      (44.9)     (93.5)     (22.0)      0.70        3.8        3.5
Other income (expenses), net.....     (2.8)       7.3         5.1       (0.3)       0.5        2.0       (1.7)      (0.4)
                                     -----      -----     -------    -------    -------    -------    -------    -------
Net income (loss)................    (87.1)%    (41.0)%     (39.8)%    (93.8)%    (21.5)%      2.7%       2.1%       3.1%
                                     =====      =====     =======    =======    =======    =======    =======    =======
</TABLE>



    Our quarterly results tend to fluctuate significantly. Sales decreased from
the fourth quarter of 1998 to the first quarter of 1999 because of our shift in
product mix from selling chips embedded in PCMCIA cards to selling our chips and
video devices to original equipment manufacturers and the associated time
required to ramp-up sales of those products. Sales increased on a quarterly
basis in each year as a result of increased unit shipments of our NT1003 chip,
which was introduced in the


                                       25
<PAGE>

second quarter of 1998. Gross margins have generally increased due to the
transition to our higher margin video compression chip business.



    We have experienced seasonal sales patterns in the past and we expect to
continue to experience seasonal sales patterns in the future. Specifically, we
expect to experience stronger demand for our chips during the last two quarters
of each year and weaker demand in the first quarter of each year because the
purchasing cycles of many of our customers, particularly those in the consumer
electronics industry, generally result in their purchasing more chips in the
last quarter and less in the first quarter of the year.


LIQUIDITY AND CAPITAL RESOURCES

    Since our inception, we have funded operations primarily through the private
placement of our preferred stock and bank loans. We raised proceeds of
approximately $1.8 million in 1997, $5.6 million in 1998 and $4.7 million in
January 2000 from private placements of our securities, net of issuance costs.
Through January 2000, we issued an aggregate of 15,906,304 shares of Series A
preferred stock and 1,196,172 shares of Series B preferred stock. We estimate
that these shares will be converted into approximately 9,293,310 shares of our
common stock upon the closing of this offering. As of December 31, 1999, we had
cash and cash equivalents of $2.5 million, and as of March 31, 2000, we had cash
and cash equivalents of $6.6 million.


    Cash used in operations include expenditures associated with development
activities and marketing efforts related to commercialization and improvement of
our current products, as well as the development of our future products. Cash
used in operations was $1.1 million in 1997, $1.8 million in 1998, $1.1 million
in 1999 and $1.2 in the first quarter of 2000. We made investments in fixed
assets of approximately $510,000 between January 1, 1997 and March 31, 2000.


    We have a line of credit arrangement with a bank for an aggregate amount of
$2.0 million. The loans under this line of credit bear interest at a rate that
is a fixed percentage in excess of the interest rate set by the Bank of Israel.
The line of credit is secured by liens on our assets. Bank guarantees provided
under the line of credit amounted to approximately $0.5 million at March 31,
2000. As of that date, we had $1.5 million available under the line of credit.

    Our capital requirements depend on numerous factors, including market
acceptance of our products, the resources we devote to developing, marketing,
selling and supporting our products, the timing and extent of establishing
additional international operations and other factors. We expect to devote
substantial capital resources to expand our research and development and our
sales and marketing activities, and to other general corporate activities. We
expect that the net proceeds from this offering, our cash on hand and cash from
operations will be sufficient to meet our working capital and capital
expenditure needs for at least the next 12 months. After that, we may need to
raise additional funds which we may not be able to obtain on acceptable terms,
if at all.

BENEFICIAL CONVERSION CHARGE

    In January 2000, we issued 1,196,172 shares of our Series B preferred stock
to a financial investor, which will convert into shares of our common stock upon
the closing of this offering. In connection with this issuance, we have recorded
a beneficial conversion charge of $4.6 million in the three months ended
March 31, 2000. This charge is calculated as the difference between the
estimated fair value of one share of our common stock on the date of issuance
and the per share conversion price applicable to the Series B preferred stock,
multiplied by the number of shares of common stock into which the shares of
Series B preferred stock are convertible. This nonrecurring charge has been
reflected as a decrease of the net income that we recorded as applicable to
common stock during this period, against a corresponding credit to additional
paid-in capital.

                                       26
<PAGE>
EFFECTIVE CORPORATE TAX RATES

    Our tax rate will reflect a mix of the U.S. federal and state tax on our
U.S. income and Israeli tax on non-exempt income. The majority of our Israeli
subsidiary's income is derived from our capital investment program with
"Approved Enterprise" status under the Israeli Law for the Encouragement of
Capital Investments--1959, and therefore is eligible for tax benefits. Under
these benefits, we will enjoy a tax exemption on income derived during the first
four years in which this investment program produces taxable income, provided
that our Israeli subsidiary does not distribute this income to us as a dividend,
and a reduced tax rate of 10% to 15% for the remaining term of the program. All
of these tax benefits are subject to various conditions and restrictions. Since
we have incurred tax losses through March 31, 2000, we have not yet used the tax
benefits for which we are eligible.

YEAR 2000 ISSUES

    We currently are not aware of any Year 2000 problem in any of our critical
systems and products. However, the success to date of our Year 2000 efforts
cannot guarantee that a Year 2000 problem affecting third parties upon which we
rely will not become apparent in the future and interfere with our operations or
otherwise harm our business.

RECENT ACCOUNTING PRONOUNCEMENTS

    In June 1998, the Financial Accounting Standards Board issued SFAS No. 133,
Accounting for Derivative Instruments and Hedging Activities, which establishes
accounting and reporting standards for derivative instruments and hedging
activities. SFAS No. 133 requires recognition of all derivatives at fair value
in the financial statements. We believe that, upon implementation, the standard
will not have a significant effect on our financial statements.

    In December 1999, the U.S. Securities and Exchange Commission issued SAB
101, "Revenue Recognition in Financial Statements," which summarizes some of the
Commission's views in applying generally accepted accounting principles to
revenue recognition in financial statements. Our adoption of SAB 101 has not had
a material impact on our financial statements.

MARKET RISK

    We are exposed to financial market risks including changes in interest rates
and foreign currency exchange rates. Substantially all of our cash and cash
equivalents consisted of short-term deposits and therefore are not subject to
significant interest rate risk. Substantially all of our sales and capital
spending is transacted in U.S. dollars, although approximately 54.3% of the cost
our operations, relating mainly to our personnel and facilities in Israel, was
incurred in New Israeli Shekels or NIS in the three months ended March 31, 2000.
We have not engaged in hedging transactions to reduce our exposure to
fluctuations that may arise from changes in foreign exchange rates. In the event
of an increase in inflation rates in Israel, or if appreciation of the NIS
occurs without a corresponding adjustment in our dollar-denominated sales, our
results of operations could be materially harmed.

                                       27
<PAGE>
                                    BUSINESS

OVERVIEW

    We design and sell computer chips that establish connections between video
devices and computers, as well as connections between video devices across a
variety of networks. Our chips and related decompression software use
proprietary mathematical procedures known as algorithms and are designed to
provide high quality video, low power consumption and advanced capabilities.

    Our products simultaneously compress digital video signals and process audio
and data, enabling real-time transmission of signals from video sources into
personal computers and hand-held personal computing devices known as personal
digital assistants through the Universal Serial Bus (USB) interface standard.
The USB is a widely accepted interface standard for simplified plug-and-play
connections between a PC and its accessories. Our chips are integrated into PC
digital video cameras, video capture devices and PC-TVs.

    Our products are compatible with the Windows 95, Windows 98, Windows 2000,
Mac OS and Windows CE operating systems. In addition to our chips, we also sell
our own video devices that incorporate our chips.

    Demand for video over the Internet and over other communication networks,
for convenient connectivity solutions and for low-cost video-enabled consumer
products is currently undergoing substantial growth. In order to meet this
demand, the Moving Picture Experts Group, an industry committee commonly known
as MPEG, has developed a new standard for video compression known as MPEG-4.
MPEG-4 has been adopted by Microsoft in its new operating system, Windows
Millennium, which is expected to be released by the end of 2000. It has also
been adopted as the standard for the transmission of video in many new models of
mobile telephones. We expect that MPEG-4 will be the primary standard for
integrating and standardizing a wide range of video applications. We are
currently in the early stages of developing our next generation of chips to be
compatible with the MPEG-4 compression standard. We expect to release these
chips in the second half of 2001 and believe that compatibility with the MPEG-4
standard will enhance the market for our chips.

    In 1999, purchasers of our products included AME Group, Camtel Technology,
Fujitsu General, Hauppauge Computer Works, Interex, IO Data, Pinnacle Systems,
Sharp Electronics and X-10.com.

INDUSTRY BACKGROUND

    RECENT MARKET TRENDS

    The markets for products that incorporate our chips are growing rapidly. The
primary factors driving this growth include the following:


    - IMPLEMENTATION OF PLUG-AND-PLAY CONNECTIONS:  New PC systems today are
      generally being developed and shipped to the market with standard
      plug-and-play interface ports. The USB is a widely accepted standard
      interface between PCs and computer accessories. International Data
      Corporation (IDC) estimated that the USB would be available on 92.2% of
      all desktop PC shipments in the U.S. in 1999 and would reach 100% by the
      year 2001. As a result, we expect that the demand for plug-and-play
      computer accessories, especially in the video area, will increase.


    - CONVERGENCE OF TV AND PC:  In recent years, there has been substantial
      convergence of applications designed for television sets and PCs,
      including the capacity to watch television broadcasts on a PC. This
      development has resulted in the introduction of new services and products,
      such as targeted interactive Internet and TV advertising, video streaming
      and digital TV and set top boxes.

                                       28
<PAGE>

    - ESTABLISHMENT OF BROADBAND COMMUNICATION NETWORKS: Broadband communication
      networks based on cable and wide-band digital subscriber line (DSL) modems
      enable the use of digital video applications for high speed Internet
      access and voice, data and video communications. We believe that broadband
      communication networks will increase the popularity of applications such
      as video conferencing and video streaming, or the transmission of video
      data in real time. These networks may also lead to the development of
      future applications, such as video cellular phones, that will require
      advanced video compression and capture technology. According to a November
      1999 IDC study, the number of U.S. households using cable modems was
      expected to grow to 1.3 million in 1999 and to reach 9.0 million by 2003.



    - DRAMATIC GROWTH OF INTERNET COMMUNICATION:  According to IDC, there were
      an estimated 144 million users of the Internet in 1998 and the number of
      users is expected to grow to over 600 million by the end of 2003. The
      dramatic growth of the Internet has led to substantial increases in the
      amount of video, audio and other data that is transferred between
      computers. In addition, Internet communication increasingly involves video
      and audio streaming. As a result, there has been substantial growth in the
      use of digital cameras for video e-mail, webcams, video conferencing and
      website development, driving demand for products that can input video
      images into computers.


    - STANDARDIZATION OF DIGITAL VIDEO COMPRESSION:  The sharp increase in
      demand for video compression for the Internet, for convenient connections
      between computers and for video-enabled consumer products has fueled the
      computer industry's search for a compression standard. We expect that
      MPEG-4 will become the primary standard for integrating and standardizing
      a wide range of video compression applications, including video streaming,
      digital television broadcasting, home video archiving, interactive local
      multimedia and other modes of video communication across the Internet and
      third generation mobile phone and broadcast networks. We believe that the
      standardization of video compression through the growing acceptance of
      MPEG-4 will significantly expand the range of products and devices that
      use the next generation of our chips.

    THE CHALLENGES

    The technologies involved in video compression and its integration into
computer products pose unique challenges:

    - TIME TO MARKET:  In the computer industry, the average product life cycle
      is short, making time to market critical. As a result, manufacturers must
      continuously, effectively and rapidly offer new products.

    - CPU EFFICIENCY:  Video applications, such as video conferencing, video
      e-mail and other related video capture software programs, use significant
      power and memory of the CPU to compress and decompress video data.
      Typically, the more complex the video application, the greater the
      utilization of the CPU. The continued expansion of video applications
      requires improvements in CPU speed and efficiency and, in particular,
      requires an efficient balance between video compression and decompression
      in order to minimize CPU usage.

    - FLEXIBLE ADAPTATION TO CHANGING COMPUTER INTERFACES AND MULTIPLE OPERATING
      SYSTEMS:  The Universal Serial Bus is currently the most popular standard
      for connecting PCs and video-based computer accessories. In the future,
      however, manufacturers may introduce interfaces based on new standards. In
      addition, original equipment manufacturers offer their products for use on
      a wide range of operating systems. As a result, the chips used for video
      devices must operate with major operating systems for PCs and personal
      digital assistants, including Windows and Mac.

                                       29
<PAGE>
    - QUALITY OF VIDEO IMAGE:  Efficient video compression algorithms are
      essential for high quality video imaging. Without seamless migration of
      the video image from the camera to the ultimate display on the screen,
      poor quality video images will occur. As a result, the efficiency of
      algorithms must continue to develop in a manner consistent with the
      complexity of the video data that is being transmitted.

    - DEMAND FOR STANDARD VIDEO COMPRESSION:  The proliferation of video
      communication applications has fueled the demand for standard video
      compression for wide and narrow band video communication across the
      Internet and mobile and broadcast networks. Video compression chips and
      the algorithms on which those chips are based must enable video
      compression and archiving for a broad range of applications in the
      environment that we expect will be governed by the MPEG-4 video
      compression standard.

THE NOGATECH SOLUTION

    Our products are designed to address the substantial need for video
connections for computers. Our video compression chips, which are based upon our
algorithms, are incorporated into new video-to-PC solutions for consumer
electronics products, such as PC-TVs and PC digital video cameras. We expect to
develop new algorithms and chips that will respond to the growing demands for
connections between video devices across a variety of networks resulting from
increasing Internet video use and plug-and-play applications.

    We believe that we were the first company to introduce a single chip that
enabled the streaming of video, audio and data through the Universal Serial Bus
interface for a variety of PC video products and applications. Our chips operate
on all major operating systems for PCs and personal digital assistants and are
compatible with a wide variety of video applications.

    We believe that our technology and expertise will enable us to develop
future products that will comply with the evolving standardization of video
compression reflected in MPEG-4. We anticipate that our chips will have wide
applications for the broadband communication networks that are being established
and will ensure high video quality for the advanced video communication that
those networks will facilitate.

    We believe that our products have successfully addressed the market's
challenges as follows:

    - TIME TO MARKET:  We design our chips to be compatible with products of
      leading original equipment manufacturers and consumer electronics
      companies. We support our customers with reference designs that facilitate
      their ability to respond quickly and efficiently to market demands. In
      addition, we work closely with our customers to tailor our products to
      meet their specific needs. We assist our customers in integrating our
      chips into their products and to help them bring their new products to
      market on a cost-effective and timely basis.

    - CPU EFFICIENCY:  Our chips require low usage of CPU processing time,
      memory and power. This is achieved through the combination of advanced
      compression algorithms and efficient decompression software tailored
      specifically to transferring video into the computer through the USB
      interface.

    - FLEXIBLE ADAPTATION TO CHANGING COMPUTER INTERFACES AND MULTIPLE OPERATING
      SYSTEMS: We have developed compression algorithms that respond to the
      changing requirements of a wide variety of computer interfaces. As the
      interfaces have changed and advanced, we have adapted our technology to
      the new interfaces. In addition, our products are used on a variety of
      operating systems. We believe that we can rapidly adapt our software to
      other operating systems. Our design also offers our customers additional
      versatility in that our chips can be incorporated into different
      video-based accessories, which reduces the customers' time to market,
      support costs and overall chip costs.

                                       30
<PAGE>
    - QUALITY OF VIDEO IMAGE:  Our compression algorithms are designed to
      minimize noticeable degradation in video images.

    - DEMAND FOR STANDARD VIDEO COMPRESSION:  We have developed substantial
      knowledge and experience in developing video compression algorithms in
      order to develop algorithms and chips that can implement the broad range
      of video applications that will be possible in the standardized MPEG-4
      environment.

BUSINESS STRATEGY

    Our goal is to be the leading provider of video connection solutions using
enhanced video compression technology and plug-and-play interfaces.

    The following are the key elements of our strategy:

    - MAINTAIN EXPERTISE IN VIDEO COMPRESSION TECHNOLOGY:  We use our expertise
      in developing and implementing algorithms and software to develop chips
      that establish connections between video devices and computers, as well as
      connections between video devices across a variety of networks and media.
      We believe that our expertise in all aspects of video compression
      technology and our focus on emerging industry standards enable us to
      design chips that are attractive to a broad range of customers because
      they incorporate several different operating functions on a single chip.
      As a result, our products are referred to as "systems-on-chips." In
      addition, our engineering team of mathematicians and chip designers, of
      which a significant number hold Ph.D. and MSEE degrees, is experienced in
      all aspects of algorithm development. For over 15 years, our key
      development personnel have been developing video compression technology
      and video connectivity products. We are active committee members in the
      Video Class USB Implementers Forum, an industry organization founded by
      the companies that developed the Universal Serial Bus standard.

    - FOCUS ON HIGH VOLUME APPLICATIONS:  We focus on designing chips for
      manufacturers of video products for emerging high volume PC business and
      consumer applications, such as video streaming, interactive multimedia on
      mobile networks and digital multimedia broadcasting. We attempt to
      identify market segments that have the potential for substantial growth
      and to tailor our products for these markets. By focusing our marketing
      efforts on leading OEMs with large volume potential, we believe that we
      will reach a substantial segment of our potential customer base while
      minimizing the cost and complexity of our marketing efforts.

    - CREATE AND STRENGTHEN OUR RELATIONSHIPS WITH KEY CUSTOMERS:  Our goal is
      to sell our products to leading original equipment manufacturers in the
      consumer electronics market and to develop long-term working relationships
      with them. Our engineers work closely with our current and potential
      customers both before and after we introduce our chips to develop and
      modify our designs to meet their particular needs and to support their
      future products. Based upon our experience with our customers' projects,
      we typically are involved from the design stage to the product launch
      stage.

    - BUILD EXISTING TECHNOLOGIES TO PENETRATE NEW MARKETS:  We plan to use the
      algorithms that we developed in connection with the current video-based
      Universal Serial Bus market to develop new chips for future products. Our
      new products use many of the same design features that we have previously
      developed. We believe that these factors will enable us to quickly
      establish new reference designs for emerging new market opportunities for
      our existing and potential original equipment manufacturer customers.

                                       31
<PAGE>
PRODUCTS

    We design, develop and market chips for video connectivity that enable
video-to-PC connections and high quality video on PCs. Our chips are
"system-on-chip" products that process and compress video images and handle the
transfer of data through the USB interface. Our chips work in tandem with our
PC-based software, which decompresses and processes the video. We believe that
our chips, which are small, power-efficient and compatible with a variety of
operating systems, are effective PC interface solutions for manufacturers of
Universal Serial Bus-based digital video cameras, PC-TVs and video capture
devices. We also provide our customers with comprehensive reference designs for
our chips. These reference designs enable our customers to design and build new
products rapidly and to reduce significantly the amount of time that they need
to introduce new products.

    Each of our chips incorporates its own related software. Our software is the
interface between the chips and PCs and can be installed and used rapidly,
enabling plug-and-play connectivity. Our software enables video decompression,
Universal Serial Bus protocol implementation and video device control, such as
brightness, hue and zoom control. The key feature of our software is its ability
to maintain high video quality while using the CPU's resources efficiently.

    The role that our chips play in the transmission of digital video from a
video device to a PC is illustrated below:

<TABLE>
<CAPTION>
   <S>                     <C>                       <C>                       <C>                       <C>
                                VIDEO DEVICE
                                                                                                                     PC
   VIDEO SOURCE                                      NOGATECH CHIP
                               RAW VIDEO DATA                                   COMPRESSED VIDEO DATA
                                                                                                         NOGATECH SOFTWARE
   - PC DIGITAL VIDEO                                - VIDEO COMPRESSION                                 - VIDEO DECOMPRESSION
     CAMERAS, PC-TVS AND                             - AUDIO/DATA STREAMING                              - SOFTWARE CONTROL OF
     VIDEO CAPTURE                                   - INTERFACE PROTOCOL                                  VIDEO
     DEVICES                                         - PLUG-AND-PLAY                                      (BRIGHTNESS, HUE, ZOOM)
    - AUDIO/VIDEO DATA                                                                                   - PLUG-AND-PLAY
     STREAMING
</TABLE>


    [The words "Video source" and Nogatech chip are each within a rectangular
box with an arrow pointing from "Video source" to "Nogatech chip" above the
words "Raw video data." These words and the words "Video device" are within a
larger rectangular box with the words "Compressed video data" below an arrow
pointing from the rectangular box to a graphic depiction of a computer enclosing
the words "PC" and "Nogatech software."]


    In the future, we expect that more advanced versions of our chips will
support additional connections between PCs and video-based accessories, as well
as video network connections for the Internet and mobile and broadcast
communication networks. We anticipate that our next-generation chips will be
compatible with MPEG-4 standard applications. These applications include
advanced video streaming through the Internet, digital video archiving, personal
video recorders and high quality streaming using wireless networks.

    In 1995 and 1996, we introduced our NT1001 video chip and NT1002 sound chip
for connecting video sources to laptop computers. We sold both of these chips
embedded in PCMCIA cards. In 1998 we introduced our NT1003 chip which compresses
video for transfer through the Universal Serial Bus interface to computers. We
sold the NT1003 chip on both a stand-alone basis to original equipment
manufacturers for integration into their video products and also incorporated
into our own video devices.

                                       32
<PAGE>
    The following table describes our current and anticipated future chips and
the products in which they are or are expected to be used:

<TABLE>
<CAPTION>
- ---------------------------------------------------------------------------------------------------------------
  CHIP        DATE INTRODUCED                   DESCRIPTION                           OEM PRODUCTS
- ---------------------------------------------------------------------------------------------------------------
<S>        <C>                     <C>                                    <C>
NT1003     Second quarter 1998     - Video compression across USB         - PC-TVs
                                     interface                            - Video capture devices
                                   - Plug-and-play                        - PC digital video cameras
                                   - Low power consumption
- ---------------------------------------------------------------------------------------------------------------
NT1004     Fourth quarter 1999     - Video compression, audio and data    - PC-TVs
                                     streaming across USB interface       - PC digital video cameras
                                   - Plug-and-play                        - Video capture devices
                                   - Low power consumption
- ---------------------------------------------------------------------------------------------------------------
NT1005     Second quarter 2000     - Companion chip for NT1004 chip       - PC-TVs with Vertical Blank Interval
                                   - Data streaming enhancements:         (VBI)
                                     Vertical Blank Interval (VBI)
- ---------------------------------------------------------------------------------------------------------------
NT1006     Scheduled for third     - Chip that allows cameras to take     - PC digital video cameras, with
           quarter 2000              digital still pictures when            possible dual mode for digital
                                     detached from computer and live        still pictures
                                     video when connected to computer     - Webcams
                                   - For USB and wireless Bluetooth
                                     interfaces
- ---------------------------------------------------------------------------------------------------------------
</TABLE>

    NT1003.  The NT1003 is a video chip for video communication across the USB
channel to the PC. The NT1003 chip is incorporated into a variety of video
products, including PC-TVs, PC digital cameras and video capture devices. We
also sell our own video devices that incorporate the NT1003 chip. These devices
include our PC-TV device, which enables users to watch television on a PC, video
cable adapters and PC digital video cameras.

    NT1004.  The NT1004 chip incorporates video, audio and data streaming into a
single chip for video, audio and data transfer across the USB channel to the PC.
In addition to its use with PC cameras and PC-TVs, the NT1004 can be
incorporated into PC set-top boxes, cable modems and computer displays.

    NT1005.  The NT1005 is a companion chip to the NT1004. It enhances the
NT1004 chip by offering additional features such as data streaming for vertical
blank interval, which is a standard technique enabling transmission of digital
data simultaneously with standard analog video in connection with PC-TV
applications. We introduced this chip in April 2000 but have not yet made
substantial sales.

    NT1006.  The NT1006 chip is scheduled to be introduced in the third quarter
of 2000. It is being designed to enable larger video images than the NT1004 chip
and has additional features, such as permitting PC digital cameras to take both
still and video images. It also enables the transmission of live video through
the Bluetooth interface, a standard for short range wireless transmissions.

    NEXT GENERATION.  We are designing our next generation chips to be
compatible with the MPEG-4 standard. These chips will be designed to provide
video streaming through the Internet and video archiving for personal computers,
personal digital assistants, PC digital video cameras, video capture devices and
PC-TVs.

                                       33
<PAGE>
SALES AND MARKETING

    The majority of our customers are original equipment manufacturers that buy
our chips and design them into their products. We work closely with existing and
potential customers to assist them in integrating our chips into their products
by offering reference designs and close collaboration with our application
engineers. In some cases, we collaborate with manufacturers whose products work
together with our chips to create and market reference designs for original
equipment manufacturer customers. This approach encourages these manufacturers
to market our chips with their products, increasing our market reach and
visibility.

    We market our products worldwide from our direct sales offices in the U.S.
and Israel. We depend solely upon Tomen Electronics for distribution of our
products in Japan, which we view as a critical market for our success. We
provide marketing and customer support services from our U.S. office.

    The following table sets forth original equipment manufacturers that
purchased products in 1999 and their products incorporating our chips:
<TABLE>
<CAPTION>
- -------------------------------------------------------------------------------------------

<S>                             <C>
          PURCHASER                                      PRODUCTS

<CAPTION>
- -------------------------------------------------------------------------------------------
<S>                             <C>
          AME Group               Video capture devices, PC digital video cameras, PC-TVs
      Camtel Technology           Video capture devices, PC digital video cameras, PC-TVs
       Fujitsu General                           PC digital video cameras
   Hauppauge Computer Works                    Video capture devices, PC-TVs
           Interex                                 Video capture devices
           IO Data                                 Video capture devices
       Pinnacle Systems                                   PC-TVs
      Sharp Electronics                            Video capture devices
           X-10.com                                Video capture devices
- -------------------------------------------------------------------------------------------
</TABLE>

    We do not have long-term contracts with any of our customers. Sales of our
products are made under firm purchase orders. However, we do at times allow
customers to reschedule deliveries. Our business is characterized by short lead
times and quick delivery schedules. Our backlog fluctuates substantially from
period to period. As a result, we do not believe that backlog at any given time
is a meaningful indicator of future sales.

CORE TECHNOLOGY

    We believe that one of our key competitive advantages is our unique core
technologies. These range from advanced video compression and image processing
algorithms to the design of our system architecture, efficient software
implementation, cost-effective design of high-performance video processing chips
and the integration of these core technologies into our chips. We have developed
and continue to build on the following key technology areas:

    - standard and proprietary high quality video compression algorithms;

    - advanced image processing algorithms that enable our bit rate control of
      USB data, vertical blank interval detection, infrared remote control
      detection and scene analysis for computer control applications;

                                       34
<PAGE>
    - multiple-platform video streaming software for Windows 95, 98, 2000, CE
      and Mac operating systems; and

    - implementation of "system-on-chip" architecture for multiple video
      applications.

    Each of these technologies is described in further detail below:

    STANDARD AND PROPRIETARY HIGH QUALITY VIDEO COMPRESSION ALGORITHMS

    Video compression techniques exploit unchanged parts of a video image and
identical images in consecutive video frames. These redundancies are used to
reduce the data required for representing video on the computer while
maintaining acceptable video quality. In "closed loop systems," such as video
data transmitted through the Universal Serial Bus interface, no industry
standard is required. However, in open systems such as the Internet, standard
protocols must be used to facilitate communications between different systems.
As a result, our technology addresses standard as well as proprietary video
compression techniques.

    Our compression technology provides the following features:

    - high quality image with minimal and imperceptible degradation of the
      picture;

    - high frequency details of the image, including edges;

    - efficient use of CPU resources;

    - use of minimal silicon area on the chip;

    - ability to compress images and display them in real time; and

    - highly efficient cost and performance.

    We are developing advanced video processing technology for implementation
and enhancement of the MPEG-4 video compression standard for PC video
accessories and for communication across networks. MPEG-4 builds on the
experience of the MPEG-1 and MPEG-2 standards, which are currently used in
digital video applications. MPEG-4 is rich in features, and can be customized to
serve the needs of specific industries while preserving a high level of
interoperability across a variety of applications. It allows a new level of
interaction with visual content, providing the ability to view, access and
manipulate objects rather than pixels. MPEG-4's impact is especially significant
in video streaming, digital television, mobile multimedia and game applications.
We are adapting and enhancing our existing core technologies in order to develop
algorithms and chips that will be compatible with the variety of Internet video,
plug-and-play and other applications based upon MPEG-4.

    IMAGE PROCESSING ALGORITHMS

    We have developed a library of digital signal, image and video processing
algorithms that provide video image processing solutions for different video
applications. These algorithms enable the delivery of additional functionality,
such as segmentation of objects by motion, bit rate control, vertical blank
interval detection and camera-aided touch-screen, as described below. The
segmentation of objects by motion involves the separation of images into
distinct visual objects and is an important feature of the MPEG-4 standard. As a
result, the MPEG-4 standard supports higher quality video images, especially for
mobile applications. We use bit rate control, vertical blank interval detection,
multiple-platform video streaming software and system-on-chip architecture in
our products, and we expect to include camera-aided touch screen in our future
products. These additional functions are described as follows:

    - Bit rate control

       In the USB interface, the available channel bandwidth between the PC and
       its accessories varies. Consequently, when only a single accessory is
       connected to the PC, available bandwidth may be fairly broad, while in
       cases where multiple accessories are connected, the available bandwidth
       per accessory will be narrower. Our flexible image processing algorithms
       allow the PC to choose any bandwidth per accessory at variable rates.
       This technology, which is known

                                       35
<PAGE>
       as bit rate control, can be modified to comply with restrictions imposed
       by the MPEG-4 standard and for other computer interfaces.

    - Vertical blank interval detection

       Vertical blank interval (VBI) is a standard technique that enables
       transmission of digital data simultaneously with standard analog video.
       This technique is used by most cable, over the-air and satellite
       television companies and involves the insertion of information such as
       closed-captions into the blank vertical lines in the broadcast video data
       stream. We have developed an algorithm that allows detection of the VBI
       information. In addition, we have developed technology that allows our
       chips to use the VBI information to integrate television, VBI and
       Internet capabilities.

    - Multiple-operating system video streaming software

       We have developed software that can be implemented on various operating
       systems while maintaining an efficient decompression algorithm and bit
       rate control. Our software maintains system stability, plug-and-play and
       ease of use while achieving high performance on the target operating
       system. The software, when used together with our chips, provides a
       complete system solution. We work with Microsoft Corporation and Apple
       Corporation to ensure that our software works properly on their operating
       systems.

    - "System-on-chip" architecture

       Our chips are "system-on-chip" solutions, consisting of an image
       processing unit, image compression unit and an interface protocol unit.
       The image processing unit is designed to comply with as many available
       digital video sources as possible. Our chips can process images from most
       video sources without additional hardware changes. Using our chips,
       systems designers are able to develop many cost-effective applications
       for camera sensors, tuners or video decoders without any restrictions.
       The image compression unit compresses the video signal to the desired bit
       rate. The interface protocol unit handles the data transfer over the
       Universal Serial Bus interface while optimizing overall system
       performance, reliability, flexibility, image quality, size, cost and
       power consumption.

    - Camera-aided touch-screen

       We developed our camera-aided touch-screen technology to provide
       touch-screen pointing and selecting functionality using a conventional
       low cost video camera together with image processing software running on
       the PC. The video camera is used to obtain a video image of a finger or a
       pointing device, pointing at an icon on the screen. The image processing
       algorithm analyzes the video image and determines whether the icon is
       being touched. In response, the computer performs the required operation
       of the icon. We have applied for a patent relating to this technology,
       which we plan to incorporate into our software.

RESEARCH AND DEVELOPMENT

    In order to accommodate the rapidly changing needs of the markets that we
serve, we place a major emphasis on research projects designed to improve our
existing chips, software and reference designs. We are developing more advanced
video compression and video connectivity technology to meet the new standards
that are currently evolving. These new products will enable our customers to
operate their video-enhanced devices with the interfaces that will be used on
future PC platforms. From time to time, we engage in research and development
projects with our customers to develop special devices for their specific
product designs.

    We are designing the NT1006 chip to support multiple applications, including
digital still camera mode as well as live video camera mode and the transmission
of live video for wireless applications. In 2000, a significant part of our
development efforts will concentrate on technology that is compatible with the
MPEG-4 video compression standard.

                                       36
<PAGE>
    As of March 31, 2000, 18 of our employees were engaged in research and
development.

    Prior to 1995, we participated in two Israeli government research and
development incentive programs, under which we received research and development
participation of approximately $263,000. We are obligated to pay royalties to
the Office of the Chief Scientist of Israel's Ministry of Industry and Trade, at
rates that generally range from 100% to 150% of revenues resulting from the
funded projects up to maximum amounts of 100% to 150% of the funded amount.
Because we no longer intend to manufacture and sell products developed under the
projects funded by the Office of the Chief Scientist, we believe that we no
longer have these royalty liabilities.

MANUFACTURING

    Our manufacturing process consists primarily of the production of chips,
test engineering, assembly of chips and original equipment manufacturer products
and quality control. In 1998 and 1999, Fujitsu Microelectronics Europe and
Hyundai Electronics manufactured all of our chips, which we purchased from an
independent distributor. We may use additional manufacturing sources in the
future. Our manufacturers use a range of manufacturing technology, known as
process technology. Our NT1003 chip is based on 0.60-micron process technology.
Our NT1004 and NT1005 chips are based on the more advanced 0.35-micron process
technology, which enables us to produce a smaller and less expensive chip than
the 0.60 micron process technology used in the NT1003 chip. We believe that
other components are generic in nature and can be obtained from a variety of
suppliers. Our USB video devices are assembled by subcontractors in Israel.

COMPETITION

    Our industry is characterized by intense competition. The markets in which
we operate are characterized by rapid technological change, evolving industry
standards and declining average selling prices, and we expect them to become
increasingly competitive. We believe that the key competitive factors in our
markets are product design, performance, price, features, size, reliability,
time to market and customer support. In particular, we believe that our ability
to offer chips that have the flexibility to be used in a variety of products and
on a variety of operating systems will be critical to the competitiveness of our
products.

    Our principal competitors in the sale of USB-compliant chip solutions for
video applications include Divio, SunPlus Technology and Winbond Electronics,
each of which supplies these chips to original equipment manufacturers for use
in consumer electronics products. We expect that large manufacturers of generic
chips or manufacturers of chips in the video compression arena, such as Zoran
and C-Cube Microsystems, may begin marketing competing chips and become more
active in our target markets. Additionally, in the future, some of our customers
may internally develop products that we currently sell to them.

    Some of our competitors have greater financial, personnel and other
resources or offer a broader range of products and services than we do, and may
be able to respond more quickly to new or emerging technologies or changes in
customer requirements, benefit from greater purchasing economies, offer more
aggressive pricing or devote greater resources to the promotion of their
products. In addition, one or more of our competitors may develop products that
are superior to ours or that will achieve greater market acceptance than our
products.

    We believe that our success will depend primarily on our ability to provide
technologically advanced and cost-effective video connectivity solutions for
consumer electronics products. Additionally, we will have to provide our
customers with a short time to market for their products and responsive customer
support.

INTELLECTUAL PROPERTY AND PROPRIETARY RIGHTS

    Our success is largely dependent upon proprietary technology. We rely
primarily on a combination of copyright and trade secret laws, as well as
confidentiality procedures and contractual provisions, to

                                       37
<PAGE>
protect our proprietary rights. We also rely to a lesser extent on trademark
protection concerning various names and marks that serve to identify our
products.

    We have applied for three U.S. patents that relate to our video technology.
These patent applications do not cover our proprietary algorithms, for which we
have not applied for patents to date. While we do not currently intend to seek
patent protection for our algorithms, we may do so in the future. We also seek
to protect our proprietary rights through copyright protection and through
restrictions on access to our trade secrets and other proprietary information
contained in confidentiality agreements with our customers, suppliers, employees
and consultants. While our ability to compete may be affected by our ability to
protect our intellectual property, we believe that, because of the rapid pace of
technological change in our industry, maintaining our technological leadership
and our comprehensive familiarity with all aspects of the technology contained
in our chips and associated software is of great importance in addition to
patent protection.

EMPLOYEES

    As of March 31, 2000, we employed a total of 37 persons worldwide, including
18 in research and development, eight in technical service support and sales and
marketing, eight in management and administration and three in operations. 33 of
our employees are based in Israel and four of our employees are based in Santa
Clara, California. None of our employees is subject to a collective bargaining
agreement, and we consider our relations with our employees to be good.

    Israeli labor laws and regulations are applicable to our employees in
Israel. These laws principally concern matters such as paid annual vacation,
paid sick days, length of the workday, pay for overtime, insurance for
work-related accidents, severance pay and other conditions of employment.
Israeli law generally requires severance pay, which may be funded by Manager's
Insurance, described below, upon the retirement or death of an employee or
termination of employment without cause. This insurance policy provides a
combination of savings plans, insurance and severance pay, if the employee is
legally entitled upon termination of employment. Furthermore, Israeli employees
and employers are required to pay specified sums to the National Insurance
Institute. Since January 1, 1995, these amounts also include payments for
national health insurance. The payments to the National Insurance Institute are
approximately 14% of wages, up to a specified amount. The employee contributes
approximately 66% and the employer contributes approximately 34% of these
amounts. Although not legally required, we regularly contribute to a "Manager's
Insurance" fund or to a privately managed pension fund on behalf of our
employees located in Israel.

LEGAL PROCEEDINGS

    We are not a party to any legal proceedings.

FACILITIES


    We lease a 1,800 square foot facility in Santa Clara, California at an
annual rental of approximately $60,000. This lease expires in September 2002.
Our main office and research and development facilities, located in Kfar Saba,
Israel, occupy approximately 9,000 square feet, which we lease at an annual
rental of approximately $95,000. This lease expires in March 2003, with an
option to extend until February 2008, subject to an increase in our annual
rental payments to a range of $100,000 to $160,000. We believe that our
properties are adequate to meet our current needs and that any additional space
that we may need in the future will be available on commercially reasonable
terms.


                                       38
<PAGE>
                                   MANAGEMENT

DIRECTORS AND EXECUTIVE OFFICERS

    The following table sets forth information with respect to our directors and
executive officers:

<TABLE>
<CAPTION>
NAME                                       AGE                           POSITION
- ----                                     --------                        --------
<S>                                      <C>        <C>
Nathan Hod.............................     54      Chairman of the Board
Arie Heiman............................     53      President and Chief Executive Officer and Director
Yaron Garmazi..........................     35      Chief Financial Officer and Secretary
Arie Gavriely..........................     38      Vice President of Engineering
Liat Hod...............................     26      Vice President of Business Development
Gerald Dogon...........................     60      Director
Avraham Fischer........................     43      Director
Davidi Gilo............................     43      Director
Moshe Harel............................     59      Director
Yirmiyahu Kaplan.......................     64      Director
Andrew Schonzeit.......................     43      Director
Yossi Vinitski.........................     33      Director
</TABLE>


    NATHAN HOD co-founded Nogatech in 1993. Mr. Hod has served as our Chairman
since August 1995 and does not currently hold any other position with us. From
August 1995 though November 1995, Mr. Hod also served as our Chief Executive
Officer, Treasurer and Chief Financial Officer. From March 1994 until July 1998,
Mr. Hod also served as Chief Executive Officer and President of DSP
Communications, a manufacturer of digital wireless technology that was acquired
by Intel in 1999. From November 1997 until October 1998, Mr. Hod also served as
Chairman of the Board of DSP Communications. Mr. Hod also served as General
Manager of Scitex Japan, a subsidiary of Scitex Corporation, a developer of
imaging and publishing systems, from 1986 until 1992. Mr. Hod has a Masters
degree in Business Administration from the University of Massachusetts, Amherst.


    ARIE HEIMAN, PH.D., co-founded Nogatech in 1993. Dr. Heiman has served as a
director and as our Chief Executive Officer since November 1995 and served as
our Chief Financial Officer between November 1995 and February 1999. In
addition, from January 1993 to November 1995, Dr. Heiman served as our Vice
President of Engineering and Technology. From 1990 to 1993, Dr. Heiman served as
Vice President, Image Activity for DSP Group, a computer technology company.
From 1978 to 1990, Dr. Heiman was Head of Digital Signal Processing Activities
for Tadiran Communications Group, an electronics/communications manufacturing
company. Dr. Heiman has a Ph.D. degree in Electrical Engineering from Tel Aviv
University.

    YARON GARMAZI has served as our Chief Financial Officer since February 1999.
From 1995 until that time, he served as Controller for DSP Communications, where
he was responsible for the company's financial reporting system. Prior to that
time he was an auditor with Doron & Co., an Israeli accounting firm.
Mr. Garmazi has a Bachelors degree from Tel Aviv Management College.
Mr. Garmazi is an Israeli certified public accountant.

    ARIE GAVRIELY has served as our Vice President of Engineering since January
1998. From January 1997 to December 1997, Mr. Gavriely served as our Vice
President of Mobile Video Conference Products. From 1993 to December 1996 he
held various engineering positions with us. Mr. Gavriely was with the image
processing group at DSP Group from 1991 to 1993. He was with the Israeli Defense
Forces during from 1985 to 1991. Mr. Gavriely has a Masters of Science degree in
Electrical Engineering from the Technion Israel Institute of Technology.

    LIAT HOD has served as our Vice President of Business Development since
August 1996. Between January 1996 and July 1996, she was our U.S. Marketing
Manager. Ms. Hod received her Masters

                                       39
<PAGE>
degree in Business Administration from San Francisco State University in June
1996. Ms. Hod is the daughter of Nathan Hod, our Chairman of the Board.

    GERALD DOGON has served as a director since August 1999. Mr. Dogon served as
a director of DSP Communications from November 1997 through January 1999, as
Chief Financial Officer of DSP Communications from August 1994 through October
1998, as Executive Vice President of DSP Communications from July 1996 through
October 1998 and as Senior Vice President of DSP Communications from August 1994
through July 1996. Between April 1992 and August 1994, Mr. Dogon served as
Director of Finance of Nilit, an Israeli manufacturer of nylon fibers. From
March 1991 to March 1992, Mr. Dogon served as Vice President of Finance of
Mul-T-Lock, an Israeli manufacturer of security devices. Between March 1989 and
March 1991, he served as Manager of the International Division of the Israel
General Bank. From December 1987 to March 1989, he served as Chief Financial
Officer of Indigo, an Israeli developer of imaging systems. Prior to December
1987, he was employed for 17 years by Scitex, where he last served as Executive
Vice President and Chief Financial Officer. Mr. Dogon has a Bachelors degree in
Economics and Commerce from the University of Cape Town, South Africa.

    AVRAHAM FISCHER has served as a director since January 1995. Mr. Fischer is
a managing partner of the law firm Fischer, Behar, Chen & Co., of Tel Aviv,
Israel, where he has practiced since 1982. Mr. Fischer has also served as a
director of DSP Group from 1989 through 1997, of DSP Communications from 1996
through 1999, and of Vyyo, a developer of wireless broadband technologies, since
April 1996. Since January 1998, Mr. Fischer has served as co-Chairman of the
Board of Israir Aviation and Tourism and since January 1997, he has been
co-Chairman of the Board of Ganden Investment, which has holdings in a group of
Israeli tourism and aviation companies. Mr. Fischer has a law degree from the
Tel Aviv University Law School and was a lecturer at the school from 1982 to
1987.

    DAVIDI GILO has served as a director since August 1999. Mr. Gilo has served
as the Chairman of the Board of Vyyo since its inception in 1996. In March and
April 1996, and from April 1999 through the present, Mr. Gilo has served as the
Chief Executive Officer of Vyyo. Mr. Gilo served as the Chairman of the Board of
DSP Communications from October 1998 through November 1999, and as Chief
Executive Officer of DSP Communications from June 1999 through November 1999.
Mr. Gilo also served as the Chairman of the Board of DSP Communications from its
founding in 1987 through November 1997. Since 1996, Mr. Gilo has also been the
manager of the Gilo Group, an investment company he founded in 1996. Between
1987 and 1993, Mr. Gilo was the President and Chief Executive Officer of DSP
Group, and he served as Chairman of the board of DSP Group from 1987 until April
1995.

    MOSHE HAREL has served as a director since July 1998. Mr. Harel joined the
Van Leer Group Foundation in 1991 as the General Manager of Sor-Van Radiation.
He is currently responsible for the business activities of the Van Leer Group
Foundation in Israel. Since 1994, Mr. Harel has served as a director and member
of the executive board of Inventech, Mercator Management and several companies
in which Inventech has invested. From 1980 to 1991, Mr. Harel served in
management positions at several Israeli and U.S. companies. In 1964, Mr. Harel
joined the Israeli Air Force and served as a research and development engineer
and a fighter pilot. He retired in 1980 after commanding the air force flight
test center. Mr. Harel has a Bachelors of Science degree in Aeronautical
Engineering from the Technion in Israel and a Masters of Science degree in Data
Management and Automation from Princeton University.

    YIRMIYAHU KAPLAN has served as a director since July 1998. Since 1993,
Mr. Kaplan has been Managing Director of Ophir Holdings. From 1986 to 1993,
Mr. Kaplan managed various projects and activities for the Investment Company of
Bank Hapoalim. Mr. Kaplan is a director of a number of private companies in
which Ophir Holdings is a shareholder, including Memco Software. Mr. Kaplan

                                       40
<PAGE>
has a Bachelor of Arts degree in Economics and a Masters degree in Business
Administration from the Hebrew University.

    ANDREW SCHONZEIT has served as a director since January 1996. Since 1984
Mr. Schonzeit has served as the President of Idesco, a manufacturer and
distributor of identification, security and safety products, and as its Chairman
of the board since 1989. Mr. Schonzeit served as a director of DSP
Communications from 1992 to 1999. Mr. Schonzeit has a Bachelors degree in
Economics from New York University.

    YOSSI VINITSKI was appointed a director in December 1999. Mr. Vinitski is a
Vice President and investment committee member at Challenge Fund-Etgar, a
venture capital fund. From 1995 to 1999, Mr. Vinitski was a Senior Investment
Manager at Yozma Management and Investment Ltd., an Israeli venture capital
fund. From 1993 to 1995, Mr. Vinitski served as a development engineer for
several high-tech companies. Mr. Vinitski has a Bachelors of Science degree, cum
laude, in Mechanical Engineering and a Masters degree in Business Administration
from Tel Aviv University.

CLASSIFIED BOARD AND TERM OF OFFICES

    Our bylaws provide for a board of directors consisting of nine members.
There are currently nine directors on the board. Effective upon the closing of
this offering, our board will be divided into three classes of directors,
denominated Class I, Class II and Class III. Members of each class will hold
their office for three-year staggered terms. At the annual meeting of our
stockholders to be held in 2001, the term of office of the Class I directors
will expire, and Class I directors will be elected for a three-year term. At the
annual meeting of our stockholders to be held in 2002, the term of office of the
Class II directors will expire, and Class II directors will be elected for a
three-year term. At the annual meeting of our stockholders to be held in 2003,
the term of office of the Class III directors will expire, and Class III
directors will be elected for a three-year term. At each succeeding annual
meeting of stockholders, successors to the class of directors whose term expires
at that annual meeting will be elected to a three-year term. The initial Class I
directors will be Messrs. Fischer, Heiman and Hod. The initial Class II
directors will be Messrs. Harel, Kaplan and Vinitski. The initial Class III
directors will be Messrs. Dogon, Gilo and Schonzeit.

    Our certificate of incorporation does not provide for cumulative voting;
therefore, our stockholders representing a majority of the shares of common
stock outstanding will be able to elect all of the directors. The classification
of the board of directors and lack of cumulative voting will make it more
difficult for our existing stockholders to replace the board of directors or for
another party to obtain control of our company by replacing the board of
directors. Since the board of directors has the power to retain and discharge
our officers, these provisions could also make it more difficult for existing
stockholders or another party to effect a change in our management.

    Under a stockholders' agreement dated as of January 13, 2000, Holland
Ventures, Ophir Holdings, Docor International, Inventech and Ronchal Investments
(the "Holland Investors"), together with some of our other stockholders,
including Nomura International, Challenge Fund-Etgar and Corex Israeli
Industries, agreed to vote their shares in favor of the election of the
following members of our board:

    - Holland Investors Nominees:

       - two representatives nominated by the Holland Investors, one of whom is
         nominated by Holland Ventures, so long as the Holland Investors
         collectively hold at least 10% of our issued and outstanding capital
         stock; and

       - one representative nominated by the Holland Investors, who is selected
         by Holland Ventures, so long as the Holland Investors collectively own
         less than 10%, and at least 5% of our issued and outstanding capital
         stock.

                                       41
<PAGE>
    - Challenge Nominee:

       - one representative nominated by Challenge, so long as Challenge holds
         at least 89,928 shares of our common stock.

    Upon completion of the offering, the parties to this agreement will hold up
to approximately 8,262,698 shares of our common stock, or 56.1% of the total
outstanding number of shares. Mr. Vinitski currently serves as the designee of
Challenge and Messrs. Harel and Kaplan currently serve as the designees of the
Holland Investors. Unless otherwise terminated by the parties, this agreement
will continue in effect after the closing of the offering.

BOARD COMMITTEES

    We have established an audit committee and a compensation committee. The
audit committee reviews our internal accounting procedures and considers and
reports to the board of directors with respect to other auditing and accounting
matters, including the selection of our independent auditors, the scope of
annual audits, the fees to be paid to our independent auditors and the
performance of our independent auditors. The audit committee consists of
Messrs. Dogon, Harel and Kaplan. The compensation committee reviews and
recommends to the board of directors the salaries, benefits and stock option
grants for all employees, consultants, directors and other individuals
compensated by us. The compensation committee also administers our stock option
and benefit plans. The compensation committee consists of Messrs. Fischer, Hod
and Schonzeit.

DIRECTOR COMPENSATION

    Directors who are also our officers or employees do not receive any
compensation for their services as directors. Each nonemployee director receives
an annual retainer of $20,000, payable in quarterly installments of $5,000 each
at the end of each fiscal quarter. The retainer contemplates attendance at four
board meetings per year. Additional board meetings attended in person are
compensated at the rate of $1,000 per meeting. Additional board meetings
attended by telephone are compensated at the rate of $250 per meeting. In
addition, each committee member receives $500 for attending in person, and $250
for attending by telephone, each committee meeting held on a day other than a
day on which a board meeting is held. Directors are reimbursed for expenses
incurred in connection with attending board and committee meetings. Under our
2000 Equity Incentive Plan, each of our non-employee directors elected to the
board for the first time after the effective date of this offering will
automatically receive options to purchase 20,000 shares of our common stock at
fair market value on the date of grant. These options will have a 10-year term
and will vest over a four-year period. In addition, under the 2000 Plan, each of
our non-employee directors will annually receive options to purchase
5,000 shares of our common stock. These options will have a 10-year term and
will vest immediately upon the date of grant. In 1999, some of our directors
received options to purchase shares of our common stock as compensation for
their services. See "Stock Option Plans" and "Certain Relationships and Related
Transactions."

                                       42
<PAGE>
EXECUTIVE COMPENSATION

    SUMMARY OF COMPENSATION.  The following table sets forth all compensation
earned or paid for services rendered to us in all capacities for the year ended
December 31, 1999 by our Chief Executive Officer and by our only other executive
officer who earned more than $100,000 in salary and bonus for the year ended
December 31, 1999.

                           SUMMARY COMPENSATION TABLE

<TABLE>
<CAPTION>
                                              ANNUAL COMPENSATION                        LONG-TERM COMPENSATION
                                   -----------------------------------------   ------------------------------------------
                                                            ALL OTHER ANNUAL   SECURITIES UNDERLYING       ALL OTHER
NAME AND PRINCIPAL POSITION        SALARY($)    BONUS($)    COMPENSATION($)         OPTIONS(#)         COMPENSATION($)(1)
- ---------------------------        ---------   ----------   ----------------   ---------------------   ------------------
<S>                                <C>         <C>          <C>                <C>                     <C>
Arie Heiman......................  $168,500           --               --              37,500                $34,621
  President and Chief
  Executive Officer

Arie Gavriely....................  $129,640           --               --              15,000                $12,020
  Vice President of
  Engineering
</TABLE>

- --------------------------

(1) On behalf of each of these officers, we make monthly payments to a severance
    fund, a pension fund and a risk/disability fund. The amounts held in such
    funds on their behalf are payable to them upon termination of their
    employment.


    OPTION GRANTS.  The following table sets forth information with respect to
stock options granted during 1999 to the executive officers named in the summary
compensation table. The exercise price of all of these stock options was equal
to or greater than the then fair market value of our common stock on the date of
grant. In determining "fair market value," our Board of Directors considered our
then current financial condition, recent arm's length sales of our equity, our
historical and then current chip sales and net losses and future market
prospects for our chips. In accordance with the rules of the Securities and
Exchange Commission, also shown below is the potential realizable value over the
term of the option based on assumed rates of stock appreciation of 5% and 10%,
compounded annually. We assume that:


    - the fair market value of our common stock on the date of grant appreciates
      at the indicated annual rate compounded annually for the entire term of
      the option; and

    - the option is exercised and sold on the last day of its term for the
      appreciated stock price.

    These amounts are based on assumed rates of appreciation and do not
represent an estimate of our future stock price. Actual gains, if any, on stock
option exercises will be dependent on the future performance of our common
stock.

                             OPTION GRANTS IN 1999

<TABLE>
<CAPTION>
                                                                                        POTENTIAL REALIZABLE
                                                  INDIVIDUAL GRANTS                           VALUE AT
                                -----------------------------------------------------     ASSUMED RATES OF
                                  NUMBER OF      % OF TOTAL                                  STOCK PRICE
                                 SECURITIES       OPTIONS                                 APPRECIATION FOR
                                 UNDERLYING      GRANTED TO                                OPTION TERM($)
                                   OPTIONS      EMPLOYEES IN   EXERCISE    EXPIRATION   ---------------------
NAME                            GRANTED(#)(1)    1999(%)(2)    PRICE($)     DATE(3)        5%          10%
- ----                            -------------   ------------   ---------   ----------   ---------   ---------
<S>                             <C>             <C>            <C>         <C>          <C>         <C>
Arie Heiman...................      37,500          13.8%        $3.00        08/06     $181,198    $272,596
Arie Gavriely.................      15,000           5.5%        $3.00        08/06     $ 72,479    $109,038
</TABLE>

- --------------------------

(1) All options were granted under the 1999 Stock Option Plan.

(2) Based on an aggregate of 271,000 options granted to employees.

(3) These options will vest immediately if a change of control of our company
    occurs or if we are merged into another company, unless these options are
    assumed by our successor.

                                       43
<PAGE>
            OPTION EXERCISES IN 1999 AND 1999 YEAR-END OPTION VALUES

    The following table sets forth information concerning option exercises and
the aggregate value of unexercised options for the year ended December 31, 1999,
held by each executive officer named in the summary compensation table above.
Neither of these officers exercised any stock options in 1999.

<TABLE>
<CAPTION>
                                                          NUMBER OF SECURITIES UNDERLYING       VALUE OF UNEXERCISED IN-THE
                                                             UNEXERCISED OPTIONS AS OF              MONEY OPTIONS AS OF
                               SHARES                            DECEMBER 31, 1999                 DECEMBER 31, 1999(1)
                             ACQUIRED ON      VALUE      ---------------------------------   ---------------------------------
NAME                         EXERCISE(#)   REALIZED($)   EXERCISABLE(#)   UNEXERCISABLE(#)   EXERCISABLE($)   UNEXERCISABLE($)
- ----                         -----------   -----------   --------------   ----------------   --------------   ----------------
<S>                          <C>           <C>           <C>              <C>                <C>              <C>
Arie Heiman................          --           --        364,473           134,791          $5,040,000        $1,761,700
Arie Gavriely..............          --           --         20,000            32,500          $  274,525        $  397,400
</TABLE>

- ------------------------

(1) Value is based on the difference between the option exercise price and
    $14.00, the estimated initial public offering price of our common stock,
    multiplied by the number of shares of common stock underlying the option. No
    market existed for our common stock prior to this offering.

STOCK OPTION PLANS

    1999 STOCK OPTION PLAN.  Our 1999 Stock Option Plan provides for the grant
of incentive stock options and non-qualified stock options to our directors,
officers, employees and consultants, including some of our employees and
consultants that are based in Israel. A total of 3,041,537 shares of common
stock have been reserved for issuance under the 1999 Plan. As of March 31, 2000,
options to purchase 1,446,514 shares of common stock were outstanding under the
1999 Plan at a weighted average exercise price of $1.09 per share. We do not
currently anticipate granting options pursuant to the 1999 Plan following the
offering. The 1999 Plan will automatically terminate in October 2009.

    The 1999 Plan is administered by our compensation committee. The
compensation committee has the authority to construe, apply and interpret the
terms of the 1999 Plan. In the event that we merge with or into another
corporation or sell substantially all of our assets, the 1999 Plan provides for
the full acceleration of the exercisability of all outstanding options, unless
an outstanding option is assumed or an equivalent option is substituted by the
successor corporation or the option is replaced by a cash incentive program of
the successor corporation that preserves the compensation element of the option
at the time of the transaction and provides for subsequent payout in accordance
with the vesting schedule applicable to the option.

    2000 EQUITY INCENTIVE PLAN.  Our 2000 Equity Incentive Plan was adopted in
March 2000 and will serve as the successor to our 1999 Plan. We do not intend to
issue any shares under the 2000 Plan until this offering is completed. The 2000
Plan is for the benefit of our officers, directors, employees, advisors and
consultants and provides for the issuance of stock-based incentive awards,
including stock options, stock appreciation rights, limited stock appreciation
rights, restricted stock, deferred stock and performance shares. An award may
consist of one arrangement or benefit or two or more of them. Under the 2000
Plan, awards covering no more than 80% of the shares reserved for issuance under
the 2000 Plan may be granted to any participant in any one year. We have
reserved 3,500,000 shares of common stock for issuance under the 2000 Plan. The
2000 Plan provides for an annual increase of the shares of common stock reserved
for issuance to be added automatically on the first day of each fiscal year,
commencing in 2001, equal to the lesser of 500,000 shares or 5% of the number of
outstanding shares of our common stock on the last day of the immediately
preceding fiscal year.

    Each of our non-employee directors elected to the board for the first time
after the effective date of this offering will receive, upon election, options
to purchase 20,000 shares of our common stock at fair market value on the date
of grant. These options will have a 10-year term and will vest over a four-year
period. In addition, under the 2000 Plan, each of our non-employee directors
will annually receive options to purchase 5,000 shares of our common stock.
These options will have a 10-year term and will vest immediately upon the date
of grant.

                                       44
<PAGE>
    The compensation committee of our board of directors initially will be the
plan administrator of the 2000 Plan. The plan administrator may interpret the
2000 Plan and may prescribe, amend and rescind rules and make all other
determinations necessary or desirable for the administration of the 2000 Plan.
The 2000 Plan permits the plan administrator to select the officers, directors,
employees, advisors and consultants, including directors who are also employees,
who will receive awards and generally to determine the terms and conditions of
those awards.

    We may issue two types of stock options under the 2000 Plan: incentive stock
options which are intended to qualify under the Internal Revenue Code and
non-qualified stock options. The option price of each incentive stock option
granted under the 2000 Plan must be at least equal to the fair market value of a
share of common stock on the date the incentive stock option is granted.

    Stock appreciation rights and limited stock appreciation rights may be
granted under the 2000 Plan either alone or in conjunction with all or part of
any stock option granted under the 2000 Plan. A stock appreciation right granted
under the 2000 Plan entitles its holder to receive, at the time of exercise, an
amount per share equal to the excess of the fair market value at the date of
exercise of a share of common stock over a specified price fixed by the plan
administrator. A limited stock appreciation right granted under the 2000 Plan
entitles its holder to receive, at the time of exercise, an amount per share
equal to the excess of the price of a share of common stock upon a change in
control of our company over a specified price fixed by the plan administrator. A
limited stock appreciation right may only be exercised within the 30-day period
following a change in control.

    Restricted stock, deferred stock and performance shares may be granted under
the 2000 Plan. The plan administrator will determine the purchase price,
performance period and performance goals, if any, with respect to the grant of
restricted stock, deferred stock and performance shares. Participants holding
restricted stock and performance shares generally have all of the rights of a
stockholder. With respect to deferred stock, during the deferral period, subject
to the terms and conditions imposed by the plan administrator, the deferred
stock units may be credited with dividend equivalent rights. If the performance
goals and other restrictions are not attained, the participant will forfeit his
or her shares of restricted stock, deferred stock and/or performance shares.

    In the event we merge or consolidate with another entity in which we are not
the surviving corporation, dissolve or liquidate or sell substantially all of
our assets, outstanding awards under the 2000 Plan may be assumed or replaced by
the successor corporation, if any, or its parent. If the successor corporation
or its parent does not assume outstanding awards or substitute equivalent
awards, these awards will automatically become fully vested and exercisable and
be released from any restrictions on transfer or any repurchase or forfeiture
right.

    The terms of the 2000 Plan provide that the plan administrator may amend,
suspend or terminate the 2000 Plan at any time, provided, however, that some
amendments require approval of our stockholders. Further, no action may be taken
that adversely affects any rights under outstanding awards without the holder's
consent. The 2000 Plan will terminate in 2010.

    SPECIAL PROVISIONS FOR OPTION GRANTS TO ISRAELI EMPLOYEES AND
CONSULTANTS.  The 2000 Plan and the 1999 Plan set forth special provisions to
ensure that awards to Israeli employees and consultants of Nogatech Ltd. conform
to the Israeli Income Tax Ordinance [New Version]--1961. All awards to Israeli
employees and consultants of Nogatech Ltd. will be subject to a trust agreement
among us, Nogatech Ltd., and a trustee who will hold the awards on behalf of
these employees and consultants in accordance with applicable law. All issuances
of common stock upon exercise of the options will be issued in the name of the
trustee until the shares may be released to the employee or consultant
beneficiary in accordance with applicable law. No shares of common stock will be
released to a beneficiary of the trust unless the beneficiary deposits
sufficient funds to discharge his or her tax obligations under Israeli law, or
otherwise establishes that those obligations have been satisfied. Once the
shares have been issued to the trustee, the employee or consultant beneficiary
will have the right to vote his or her shares and receive cash dividends on
those shares.

                                       45
<PAGE>
2000 EMPLOYEE STOCK PURCHASE PLAN

    Our 2000 Employee Stock Purchase Plan, or Purchase Plan, was adopted in
March 2000. We do not intend to issue any shares under the Purchase Plan until
this offering is completed. The Purchase Plan allows eligible employees to
purchase our common stock at a discount from fair market value. The Purchase
Plan initially will be administered by the compensation committee of our board
of directors A total of 350,000 shares of our common stock have initially been
reserved for issuance under the Purchase Plan. The number of shares reserved for
issuance will be increased automatically on the first day of our fiscal year,
commencing in 2001, by an amount equal to the lesser of 100,000 shares or 1% of
the number of outstanding shares on the last trading day of the immediately
preceding fiscal year. The plan administrator may interpret the Purchase Plan
and, subject to its provisions, may prescribe, amend and rescind rules and make
other determinations necessary or desirable for the administration of the
Purchase Plan.

    Employees generally will be eligible to participate in our Purchase Plan if
they are employed by us, or any subsidiaries that we designate, for more than 20
hours per week and more than five months in a calendar year. Employees are not
eligible to participate in our Purchase Plan if they are 5% stockholders, or
would become 5% stockholders as a result of their participation in this plan.
Under our Purchase Plan, eligible employees may acquire shares of our common
stock through payroll deductions. Eligible employees select a rate of payroll
deduction between 1% and 15% of their cash compensation and are subject to a
maximum purchase limitations. An employee's participation in the Purchase Plan
ends automatically upon termination of employment for any reason. A participant
will not be able to purchase shares having a fair market value of more than
$25,000, determined as of the first day of the applicable offering period, for
each calendar year in which the employee participates. Each offering period
under the Purchase Plan will be for two years and will consist of four six-month
purchase periods. The first offering period is expected to begin on the first
business day after the date of this prospectus. Offering periods thereafter will
begin on February 15 and August 15. The purchase price for common stock
purchased under this plan will be 85% of the lesser of the fair market value of
our common stock on the first day of the applicable offering period or the last
day of each purchase period. The plan administrator will have the power to
change the duration of offering periods. Our Purchase Plan is intended to
qualify as an "employee stock purchase plan" under Section 423 of the Internal
Revenue Code. This plan will terminate in 2010, unless it is terminated earlier
under its terms.

EMPLOYMENT AGREEMENTS

    We have entered into an employment agreement with Arie Heiman, our President
and Chief Executive Officer. The agreement with Dr. Heiman became effective on
March 1, 2000 and is for an initial term of 12 months and will automatically
renew for successive 12 month periods unless sooner terminated by us immediately
for cause or on 12 months notice without cause, or by Dr. Heiman on 30 days
notice. Under his agreement, Dr. Heiman is entitled to receive a monthly salary
equal to NIS 51,000, or approximately $12,700, adjusted periodically to reflect
changes to the Israeli consumer price index. We also contribute to a "Manager's
Insurance" policy on behalf of Dr. Heiman in an amount equal to 15.83% of his
salary and to a continuing education fund in an amount equal to 7.5% of his
salary. If Dr. Heiman's employment is terminated by us without cause, he is
entitled to the amounts accumulated in his Manager's Insurance policy and
education fund. We are also required on such a termination to extend to Dr.
Heiman a loan, repayable in five years, in an amount equal to the aggregate
price of his vested and unexercised stock options.

    We have entered into an employment agreement with Arie Gavriely, our Vice
President of Engineering. The agreement with Mr. Gavriely became effective on
January 1, 1993 and is for an indefinite term. Mr. Gavriely's employment may be
terminated by Mr. Gavriely or by us with 30 days advance notice. Under this
agreement, Mr. Gavriely currently receives a monthly salary equal to
approximately NIS 25,000, or approximately $6,250 per month, adjusted
periodically to reflect changes to the Israeli consumer price index. Mr.
Gavriely is entitled to receive overtime payments at a rate of 175% of his
salary calculated on an hourly basis. We also contribute to a "Manager's
Insurance" policy

                                       46
<PAGE>
on behalf of Mr. Gavriely in an amount equal to 13.33% of his salary and to a
continuing education fund in an amount equal to 7.5% of his salary. If
Mr. Gavriely's employment is terminated by us without cause, he is entitled to
the amounts accumulated in his Manager's Insurance policy and continuing
education fund.

COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION

    The compensation committee was formed in March 2000 and currently consists
of Messrs. Fischer, Hod and Schonzeit. Prior to that time, compensation
decisions were made by our board of directors. In 1999, Nathan Hod, our Chairman
of the Board, and Arie Heiman, our President and Chief Executive Officer,
participated in deliberations of our board of directors concerning executive
compensation. None of our executive officers serve as members of the board of
directors or compensation committee of any entity that has one or more executive
officers who serve on our board or compensation committee.

LIMITATION ON LIABILITIES AND INDEMNIFICATION MATTERS

    Our certificate of incorporation limits the personal liability of our
directors to our stockholders to the maximum extent permitted by Delaware law.
Delaware law provides that directors of a corporation will not be personally
liable for monetary damages for breach of their fiduciary duties as directors,
except with respect to liability for:

    - any breach of their duty of loyalty to the corporation or its
      stockholders;

    - acts or omissions not in good faith or which involve intentional
      misconduct or a knowing violation of law;

    - unlawful payments of dividends or unlawful stock repurchases or
      redemptions; or

    - any transaction from which the director derived an improper personal
      benefit.

This provision will have no effect on any non-monetary remedies that may be
available to us or our stockholders, nor will it relieve us or other officers or
directors from compliance with federal or state securities laws.

    Our certificate of incorporation and bylaws also generally provide that we
will indemnify, to the fullest extent permitted by Section 145 of the Delaware
General Corporation Law, any person who was or is a party or is threatened to be
made a party to any threatened, pending or completed action, suit,
investigation, administrative hearing or any other proceeding by reason of the
fact that he or she is or was a director or officer of ours, or is or was
serving at our request as a director, officer, employee or agent of another
entity, against expenses incurred by him or her in connection that proceeding.
An officer or director will not be entitled to indemnification by us if:

    - the officer or director did not act in good faith and in a manner
      reasonably believed to be in, or not opposed to, our best interests; or

    - with respect to any criminal action or proceeding, the officer or director
      had reasonable cause to believe his or her conduct was unlawful.

    In addition, we have entered into indemnification agreements with our
directors and executive officers containing provisions that may require us,
among other things, to indemnify them against various liabilities that may arise
by virtue of their status or service as directors or executive officers and to
advance their expenses incurred as a result of any proceeding against them as to
which they could be indemnified.

    At the present time there is no pending litigation or proceeding involving
any of our directors, officers, employees or agents for which indemnification
will be required or permitted. We are not aware of any threatened litigation or
proceeding which may result in a claim for indemnification.

                                       47
<PAGE>
                 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

    Since January 1, 1997, there has not been, nor is there currently proposed,
any transaction or series of similar transactions to which we were or are to be
a party in which the amount involved exceeds $60,000 and in which any director,
executive officer or holder of more than 5% of our common stock, or an immediate
family member of any of the foregoing, had or will have a direct or indirect
interest other than:

    - compensation arrangements described where required under "Management"; and

    - the transactions described below.

    SALES OF STOCK AND WARRANTS

    On February 1, 2000, we sold 79,617 shares of common stock at $3.14 per
share to Les Fils Dreyfus & Cie., one of our principal shareholders, upon
exercise of a warrant.

    On January 13, 2000, we sold 1,196,172 shares of Series B preferred stock at
$4.18 per share to Nomura International.

    On July 15, 1998, we sold Series A preferred stock at $1.04 per share and
warrants to purchase shares of our common stock at an exercise price of $2.08
per share to the following investors, among others:

<TABLE>
<CAPTION>
NAME                                                          NUMBER OF SHARES   NUMBER OF WARRANTS
- ----                                                          ----------------   ------------------
<S>                                                           <C>                <C>
Holland Ventures............................................     1,921,667             144,125
Ophir Holdings..............................................     1,441,251             108,094
Docor International.........................................       960,834              72,062
Inventech...................................................       960,834              72,062
</TABLE>

    On February 4, 1997, we sold 159,235 shares of Series A preferred stock at
$1.57 per share and warrants to purchase 79,617 shares of our common stock at an
exercise price of $3.14 per share to Les Fils Dreyfus & Cie.

    STOCK OPTION GRANTS

    We have granted the following options to purchase shares of our common stock
to our directors and executive officers as set forth below:

<TABLE>
<CAPTION>
NAME                             NUMBER OF OPTIONS   EXERCISE PRICE   GRANT DATE      RELATIONSHIP TO NOGATECH
- ----                             -----------------   --------------   ----------   -------------------------------
<S>                              <C>                 <C>              <C>          <C>
Nathan Hod.....................       259,000             $0.02          07/98     Director, Chairman of the Board

Arie Heiman....................        12,500             $0.72          01/98     Director, Chief Executive
                                                                                   Officer
                                      122,500             $0.02          07/98
                                       37,500             $3.00          08/99

Yaron Garmazi..................        22,500             $0.72          03/99     Chief Financial Officer,
                                                                                   Secretary
                                        2,500             $3.00          08/99

Arie Gavriely..................        10,000             $0.72          03/97     Vice President of Engineering
                                       12,500             $0.72          08/98
                                       15,000             $3.00          08/99

Liat Hod.......................        20,000             $0.72          01/98     Vice President of Business
                                        2,500             $0.72          08/98     Development
                                       35,000             $3.00          08/99

Gerald Dogon...................        40,000             $3.00          08/99     Director
</TABLE>

                                       48
<PAGE>

<TABLE>
<CAPTION>
NAME                             NUMBER OF OPTIONS   EXERCISE PRICE   GRANT DATE      RELATIONSHIP TO NOGATECH
- ----                             -----------------   --------------   ----------   -------------------------------
<S>                              <C>                 <C>              <C>          <C>
Avraham Fischer................        12,500             $0.72          01/98     Director
                                       12,500             $3.00          08/99

Davidi Gilo....................        75,000             $3.00          08/99     Director

Moshe Harel....................        12,500             $3.00          08/99     Director

Andrew Schonzeit...............        12,500             $0.72          01/98     Director
                                       12,500             $3.00          08/99
</TABLE>

    In January 2000, Andrew Schonzeit, a member of our board, exercised options
to purchase 25,000 shares of our common stock at an exercise price of $0.14 per
share.

    In January 2000, Nathan Hod, our Chairman of the Board, exercised options to
purchase 77,205 shares of our common stock at an exercise price of $0.14 per
share.

    In February 2000, Davidi Gilo, a member of our board, exercised options to
purchase 75,000 shares of our common stock at an exercise price of $3.00 per
share.

    OTHER

    Tomen Electronics Corporation is our distributor in Japan and one of our
principal stockholders. Tomen purchases products from us and resells them to
OEMs. Our sales to Tomen were approximately $439,000 in 1997, approximately $1.3
million in each of 1998 and 1999, and approximately $242,000 in the first three
months of 2000. We purchased from Tomen components of our video devices having
an aggregate purchase price of approximately $194,000 in 1998 and $151,000 in
1999. We did not purchase any components from Tomen in the three months ended
March 31, 2000. In 1997, we entered into an engineering agreement with Tomen. In
1997, we received $100,000 under this agreement, which was terminated in 1998.
We believe that these transactions were on terms comparable to the terms that
would have applied to similar transactions with unrelated parties. Upon
completion of this offering, Tomen will own approximately 8.5% of the shares of
our common stock.

    In 1997, Kenwood Corporation, one of our principal stockholders, subleased
property from us. Kenwood's rental payments to us amounted to approximately
$75,000.

    In 1999, Fischer, Behar, Chen & Co., our Israeli counsel, provided us with
legal services with respect to a variety of matters. Mr. Avraham Fischer, one of
our directors, is a managing partner of the firm.

    On July 8, 1997, Mr. Nathan Hod, our Chairman of the Board, issued to us an
amended and restated secured promissory note in the principal amount of $56,500
with accrued interest at an annual rate of 5.5%. This amended note extended the
term of a secured promissory note that Mr. Hod issued to us in July 1994 in
connection with his purchase of shares of our common stock. All principal and
accrued interest on this amended note was paid in full on March 8, 2000.

                                       49
<PAGE>
                             PRINCIPAL STOCKHOLDERS

    The following table indicates information as of March 31, 2000 regarding the
beneficial ownership of our common stock by:

    - each person known to the board of directors to own beneficially 5% or more
      of our common stock;

    - each of our directors;

    - the executive officers identified in the Summary Compensation table under
      "Management"; and

    - all of our directors and executive officers as a group.

    Information with respect to beneficial ownership has been furnished by each
director, officer or 5% or more stockholder, as the case may be. Except as
otherwise noted below, the address for each person listed on the table is c/o
Nogatech, Inc., 5201 Great America Parkway, Santa Clara, California 95054.

    Beneficial ownership is determined in accordance with the rules of the
Securities and Exchange Commission which generally attribute beneficial
ownership of securities to persons who possess sole or shared voting power or
investment power with respect to those securities and includes shares of common
stock issuable pursuant to the exercise of stock options or warrants that are
immediately exercisable or exercisable within 60 days of March 31, 2000. These
shares are deemed to be outstanding and to be beneficially owned by the person
holding those options or warrants for the purpose of computing the percentage
ownership of that person, but are not treated as outstanding for the purpose of
computing the percentage ownership of any other person. Unless otherwise
indicated, the persons or entities identified in this table have sole voting and
investment power with respect to all shares shown as beneficially owned by them,
subject to applicable community property laws.


<TABLE>
<CAPTION>
                                                                                     PERCENT OF SHARES
                                                         NUMBER OF                      OUTSTANDING
                                                    SHARES BENEFICIALLY   ----------------------------------------
NAME AND ADDRESS OF BENEFICIAL OWNER                       OWNED          BEFORE THE OFFERING   AFTER THE OFFERING
- ------------------------------------                -------------------   -------------------   ------------------
<S>                                                 <C>                   <C>                   <C>
NAMED EXECUTIVE OFFICERS AND DIRECTORS
Nathan Hod(1).....................................       1,119,205                10.5%                 7.3%

Arie Heiman(2)....................................         491,097                 4.7                  3.2

Arie Gavriely.....................................          22,500                   *                    *

Gerald Dogon(3)...................................          40,000                   *                    *

Avraham Fischer(4)................................          85,000                   *                    *

Davidi Gilo.......................................          75,000                   *                    *

Moshe Harel(5)....................................          12,500                   *                    *

Yirmiyahu Kaplan(6)...............................         828,719                 8.2                  5.3

Andrew Schonzeit(7)...............................         145,489                 1.5                    *

Yossi Vinitski....................................              --                   *                    *

All directors and executive officers as a group          2,890,760                28.0%                17.2
  (12 persons)....................................
</TABLE>


- ------------------------

* represents less than 1%

                                       50
<PAGE>


<TABLE>
<CAPTION>
                                                                                    PERCENT OF SHARES
                                                        NUMBER OF                      OUTSTANDING
                                                   SHARES BENEFICIALLY   ----------------------------------------
NAME AND ADDRESS OF BENEFICIAL OWNER                      OWNED          BEFORE THE OFFERING   AFTER THE OFFERING
- ------------------------------------               -------------------   -------------------   ------------------
<S>                                                <C>                   <C>                   <C>
5% STOCKHOLDERS
Kenwood Corporation .............................       1,255,496                12.6%                 8.5%
  Alive Mitake
  2-5, Shibuya 1-chome
  Shibuya-ku
  Tokyo, 150 Japan
Tomen Electronics Corporation ...................       1,255,496                12.6                  8.5
  1-1, Uchisaiwai-cho
  2-Chome, Chiyoda-ku
  Tokyo 100, Japan
Holland Ventures B.V.(8) ........................       1,104,958                11.0                  7.4
  Dreeftoren-Etagel 14
  Haaksbergweg 55
  1101 BR Amsterdam Z.O.
  Netherlands
Les Fils Dreyfus & Cie S.A. .....................         838,876                 8.4                  5.7
  c/o Ajax Trading Co.
  2525 Davie Rd. Extension, Suite 320
  Davie, FL 33317
Ophir Holdings Ltd.(9) ..........................         828,719                 8.2                  5.6
  Amot Mishpat Bldg, 10(th) Floor
  8 Shaul Hamelech Boulevard
  Tel Aviv 64733, Israel
Nomura International plc ........................         683,297                 6.9                  4.6
  Nomura House
  1 St. Martins-le-Grand
  London EC1A 4NP, United Kingdom
Docor International B.V.(10) ....................         552,479                 5.5                  3.7
  P.O. Box 448
  Kiryat Weizman
  Rehovot, 76100 Israel
Inventech Ltd.(11) ..............................         552,479                 5.5                  3.7
  Shalom Tower
  Echad Ha'am 9
  P.O. Box 29076
  Tel Aviv 65251, Israel
</TABLE>


- ------------------------

 (1) Includes outstanding options and warrants to purchase 374,999 shares of
     common stock that are exercisable on or prior to May 30, 2000. Also
     includes an option to purchase 259,000 shares of common stock exercisable
     with respect to 86,334 shares on or prior to May 30, 2000, and exercisable
     with respect to the remaining 172,666 shares on the date of this
     prospectus. We have assumed that the option to purchase 172,666 shares will
     be exercised in full prior to its termination on the closing of this
     offering.

 (2) Includes outstanding options to purchase 326,765 shares of common stock
     that are exercisable on or prior to May 30, 2000. Also includes an option
     to purchase 122,500 shares of common stock exercisable with respect to
     40,833 shares on or before May 30, 2000, and exercisable with respect to
     the remaining 81,667 shares of common stock on the date of this prospectus.
     We have assumed

                                       51
<PAGE>
     that the option to purchase 81,667 shares will be exercised in full prior
     to its termination on the closing of this offering.

 (3) Consists of outstanding options to purchase 40,000 shares of common stock
     that are exercisable on or prior to May 30, 2000.


 (4) Includes outstanding options to purchase 60,000 shares of common stock that
     are exercisable on or prior to May 30, 2000.



 (5) Includes outstanding options to purchase 12,500 shares of common stock that
     are exercisable on or prior to May 30, 2000.



 (6) Consists of 720,626 shares of common stock issuable upon conversion of
     1,441,251 shares of our Series A preferred stock and a warrant to purchase
     108,094 shares of common stock held by Ophir Holdings Ltd. Mr. Kaplan is
     the Managing Director of Ophir Holdings Ltd. and may be deemed to share
     voting and investment power with respect to the shares held by Ophir
     Holdings Ltd. Mr. Kaplan disclaims beneficial ownership of these shares.



 (7) Includes outstanding options to purchase 50,000 shares of common stock that
     are exercisable on or prior to May 30, 2000. Excludes 13,176 shares of
     common stock issuable upon conversion of 23,322 shares of our Series A
     preferred stock held in four trusts for the benefit of Mr. Schonzeit's
     children, as to which Mr. Schonzeit has no voting or investment power.
     Mr. Schonzeit disclaims beneficial ownership of these shares.



 (8) Includes 144,125 shares of common stock issuable upon exercise of warrants
     that will terminate on the closing of this offering and which we have
     assumed will be exercised.



 (9) Includes 108,094 shares of common stock issuable upon exercise of warrants
     that will terminate on the closing of this offering and which we have
     assumed will be exercised.



 (10) Includes 72,062 shares of common stock issuable upon exercise of warrants
      that will terminate on the closing of this offering and which we have
      assumed will be exercised.



 (11) Includes 72,062 shares of common stock issuable upon exercise of warrants
      that will terminate on the closing of this offering and which we have
      assumed will be exercised.


                                       52
<PAGE>
                          DESCRIPTION OF CAPITAL STOCK


    Our authorized capital stock consists of 40,000,000 shares of common stock,
$0.001 par value per share, and 32,000,000 shares of preferred stock, $0.001 par
value per share, all of which will be available for issuance upon completion of
this offering.


    As of March 31, 2000, 728,040 shares of our common stock were outstanding.
As of March 31, 2000, 15,906,304 shares of Series A preferred stock were
outstanding, which will convert into 8,609,783 shares of common stock upon
completion of this offering. We also currently have 1,196,172 shares of
Series B preferred stock outstanding. Until May 31, 2000, the Series B preferred
stock will be convertible into 683,527 shares of common stock. From June 1, 2000
until June 30, 2000, the Series B preferred stock will be convertible into
724,952 shares of common stock. Thereafter, the number of shares of our common
stock into which our Series B preferred stock is convertible increases each day
based upon a formula set forth in our certificate of incorporation until
August 1, 2000 at which time the Series B preferred stock will be convertible
into 796,178 shares of common stock. For purposes of this prospectus, we have
assumed that the closing of this offering will take place prior to May 30, 2000,
and that the Series B preferred stock will convert into 683,527 shares of common
stock. Upon the consummation of this offering, no shares of preferred stock will
be outstanding, and we have no present plans to issue any shares of preferred
stock.

    We have issued warrants to purchase up to 831,819 shares of our common stock
which will terminate upon the closing of this offering. A portion of these
warrants may be exercised on a cashless basis, in which case a smaller number of
shares of our common stock will be issued. We will not be certain as to the
exact number of shares that will be issued upon exercise of these warrants until
the closing of this offering. In addition, if all of the shares issuable upon
exercise of these warrants are exercised in cash for the maximum number of
shares that may be purchased, we will receive proceeds of approximately $1.9
million.

    As of March 31, 2000, there were 21 holders of our common stock, 41 holders
of our Series A preferred stock and one holder of our Series B preferred stock.

COMMON STOCK

    VOTING RIGHTS.  Each outstanding share of common stock is entitled to one
vote on all matters submitted to a vote of our stockholders, including the
election of directors. There are no cumulative voting rights, and therefore the
holders of a plurality of the shares of common stock voting for the election of
directors may elect all of our directors standing for election. However, our
certificate of incorporation provides that actions may only be taken by our
stockholders at a duly called meeting, and may not be taken by written consent.

    DIVIDENDS.  Holders of common stock are entitled to receive dividends at the
same rate if and when dividends are declared by our board of directors out of
assets legally available for the payment of dividends, subject to preferential
rights of any outstanding shares of preferred stock.

    LIQUIDATION.  In the event of a liquidation, dissolution or winding up our
affairs, whether voluntary or involuntary, after payment of our debts or other
liabilities and making provisions for the holders of any outstanding shares of
preferred stock, our remaining assets will be distributed ratably among the
holders of shares of common stock.

    RIGHTS AND PREFERENCES.  Our common stock has no preemptive, redemption,
conversion or subscription rights. The rights, powers, references and privileges
of holders of common stock are subject to, and may be adversely affected by, the
rights of the holders of shares of any series of preferred stock that we may
designate and issue in the future.

                                       53
<PAGE>
    FULLY PAID AND NONASSESSABLE.  All of our outstanding shares of common stock
are, and the shares of common stock to be issued pursuant to this offering will
be, fully paid and nonassessable.

PREFERRED STOCK

    Our board of directors has the authority, without action by our
stockholders, to provide for the issuance of preferred stock in one or more
classes or series and to designate the rights, preferences and privileges of
each class or series, which may be greater than the rights of the holders of
common stock. We cannot predict the effect of the issuance of any shares of
preferred stock upon the rights of holders of the common stock until the board
of directors determines the specific rights of the holders of the preferred
stock. However, the effects could include one or more of the following:

    - restricting dividends on the common stock;

    - diluting the voting power of the common stock;

    - impairing the liquidation rights of the common stock; or

    - delaying or preventing a change in control of us without further action by
      the stockholders.

DELAWARE ANTI-TAKEOVER LAW

    We are subject to Section 203 of the Delaware General Corporation Law, an
anti-takeover law. Generally, Section 203 of the Delaware General Corporation
Law prohibits a publicly held Delaware corporation from engaging in a "business
combination" with an "interested stockholder" for a period of three years after
the date of the transaction in which the person became an interested
stockholder, unless:

    - prior to the date of the business combination, the transaction is approved
      by the board of directors of the corporation;

    - upon consummation of the transaction which resulted in the stockholder
      becoming an interested stockholder, the interested stockholder owns at
      least 85% of the outstanding voting stock of the corporation; or

    - on or after the date the business combination is approved by the board of
      directors of the corporation and by the affirmative vote of at least 2/3
      of the outstanding voting stock which is not owned by the interested
      stockholder.

    A "business combination" includes mergers, asset sales and other
transactions that may result in a financial benefit to the stockholder. An
"interested stockholder" is a person who, together with affiliates and
associates, owns, or within the three-year period immediately prior to the
relevant date, did own, 15% or more of the corporation's outstanding voting
stock. The existence of this provision would be expected to have an
anti-takeover effect with respect to transactions not approved in advance by our
board of directors, including discouraging attempts that might result in a
premium over the market price for the shares of common stock held by
stockholders.

TRANSFER AGENT AND REGISTRAR

    EquiServe Trust Company will serve as transfer agent and registrar for our
common stock.

LISTING

    We have applied to have our common stock approved for quotation on the
Nasdaq National Market under the trading symbol "NGTC."

                                       54
<PAGE>
                        SHARES ELIGIBLE FOR FUTURE SALE


    Future sales of our common stock, and the availability of our common stock
for sale, may depress the market price for our common stock. After this
offering, 14,734,669 shares of common stock will be outstanding. All of the
shares sold in this offering will be freely tradable except for the shares
purchased by our affiliates. Except as set forth below, the remaining shares of
common stock outstanding after this offering will be restricted as a result of
securities laws or lock-up agreements. These remaining shares will be available
for sale in the public market as follows:



<TABLE>
<CAPTION>
                                                                APPROXIMATE
DATE OF AVAILABILITY FOR SALE                                 NUMBER OF SHARES
- -----------------------------                                 ----------------
<S>                                                           <C>
As of the date of this prospectus...........................     1,226,328
180 days after the date of this prospectus..................     8,381,531
At various times afterwards upon expiration of applicable
  lock up agreements and holding periods....................     1,626,810
</TABLE>


    Each of our directors, executive officers and holders of 1% or more of our
outstanding common stock has agreed to certain restrictions on his ability to
sell, offer, contract or grant any option to sell, pledge, transfer or otherwise
dispose of shares of our common stock for a period of 180 days after the date of
this prospectus, without the prior written consent of WR Hambrecht + Co. WR
Hambrecht + Co may release all or a portion of the shares subject to this lockup
agreement at any time without notice.

    In general, under Rule 144 under the Securities Act of 1933, as currently in
effect, a person who has beneficially owned shares of our common stock for at
least one year would be entitled to sell within any three-month period a number
of shares that does not exceed the greater of:

    - 1% of the number of shares of our common stock then outstanding, which
      will equal approximately 147,347 shares immediately after this offering;
      or

    - the average weekly trading volume of our common stock on the Nasdaq
      National Market during the four calendar weeks preceding the filing of a
      notice on Form 144 with respect to the sale.

    Sales under Rule 144 are also subject to manner of sale provisions and
notice requirements and to the availability of current public information about
us.

    Under Rule 144(k), a person who is not deemed to have been one of our
affiliates at any time during the 90 days preceding a sale, and who has
beneficially owned the shares proposed to be sold for at least two years,
including the holding period of any prior owner other than an affiliate, is
entitled to sell the shares without complying with the manner of sale, public
information, volume limitation or notice provisions of Rule 144.

    Rule 701, as currently in effect, permits resales of shares in reliance upon
Rule 144 but without compliance with certain restrictions, including the holding
period requirement, of Rule 144. Any of our employees, officers, directors or
consultants who purchased shares under a written compensatory plan or contract
may be entitled to rely on the resale provisions of Rule 701. Rule 701 permits
affiliates to sell their Rule 701 shares under Rule 144 without complying with
the holding period requirements of Rule 144. Rule 701 further provides that
non-affiliates may sell their shares in reliance on Rule 144 without having to
comply with the holding period, public information, volume limitation or notice
provisions of Rule 144. All holders of Rule 701 shares are required to wait
until 90 days after the date of this prospectus before selling their shares.
However, substantially all Rule 701 shares are subject to lock-up agreements and
will only become eligible for sale at the earlier of the expiration of the
180-day lock-up agreements or no sooner than 90 days after the offering upon
obtaining the prior written consent of WR Hambrecht + Co.

                                       55
<PAGE>
    We intend to file a Registration Statement on Form S-8 registering shares of
common stock subject to outstanding options or reserved for future issuance
under our stock plans. As of March 31, 2000, options to purchase a total of
1,446,514 shares were outstanding under our 1999 Stock Option Plan. Common stock
issued upon exercise of outstanding vested options after the filing of this
Registration Statement on Form S-8, other than common stock issued to our
affiliates, will be available for immediate resale in the open market.


    In addition, we have outstanding a warrant to purchase 350,000 shares of
common stock. Under Rule 144, these shares will not be eligible for resale until
one year after they are issued on the exercise of the warrant.


REGISTRATION RIGHTS

    Upon completion of this offering, the holders of an aggregate of up to an
estimated 10,236,593 shares of our common stock and warrants to purchase shares
of our common stock will be entitled to rights with respect to the registration
of these shares under the Securities Act of 1933. Under the terms of the
registration rights agreements, if we propose to register any of our securities
under the Securities Act, either for our own account or for the account of other
security holders exercising registration rights, these holders are entitled to
notice of this registration and are entitled to include shares of common stock
in the registration. The rights are subject to conditions and limitations,
including the right of the underwriters of an offering subject to the
registration to limit the number of shares included in the registration. These
registration rights have been waived with respect to this offering. Holders of
these rights may also require us to file a registration statement under the
Securities Act at our expense with respect to their shares of common stock, and
we are required to use our best efforts to effect this registration.
Furthermore, beginning one year after the date of this prospectus, stockholders
with registration rights may require us to file additional registration
statements on Form S-3, if we qualify for the use of this form.

                                       56
<PAGE>
                              PLAN OF DISTRIBUTION

    In accordance with the terms of an underwriting agreement among us, W.R.
Hambrecht + Co., LLC, ING Barings LLC, and DLJDIRECT Inc. as representatives of
the underwriters, the underwriters will purchase from us the following
respective number of shares of common stock at the public offering price less
the underwriting discounts and commissions described on the cover page of this
prospectus.

<TABLE>
<CAPTION>
                                                                         NUMBER OF
                    UNDERWRITER                                           SHARES
                    -----------                                          ---------
<S>                                                                      <C>
W.R. Hambrecht + Co., LLC..........................
ING Barings LLC....................................
DLJDIRECT Inc......................................
                                                                         ---------
        Total......................................                      3,500,000
                                                                         =========
</TABLE>

    The underwriting agreement provides that the obligations of the underwriters
are subject to conditions, including the absence of any material adverse change
in our business, and the receipt of certificates, opinions and letters from us
and our counsel and independent accountants. Subject to those conditions, the
underwriters are committed to purchase all shares of our common stock offered if
any of the shares are purchased.

    The underwriters propose to offer the shares of our common stock directly to
the public at the offering price set forth on the cover page of this prospectus,
as this price is determined by the OpenIPO process described below, and to
certain dealers at this price less a concession not in excess of $      per
share. Any dealers that participate in the distribution of our common stock may
be deemed to be underwriters within the meaning of the Securities Act, and any
discounts, commissions or concessions received by them and any provided by the
sale of the shares by them might be deemed to be underwriting discounts and
commissions under the Securities Act. After completion of the initial public
offering of the shares, the public offering price and other selling terms may be
changed by the underwriters. The underwriters have informed us that they do not
intend discretionary sales to exceed 5% of the shares of the common stock
offered by this prospectus.

    The following table shows the per share and total underwriting discount to
be paid to the underwriters by us in connection with this offering. The
underwriting discount will be determined through negotiations between us and the
representatives of the underwriters, and will be calculated as a percentage of
the offering price. These amounts are shown assuming both no exercise and full
exercise of the over-allotment option.

<TABLE>
<CAPTION>
                                              PER SHARE   NO EXERCISE   FULL EXERCISE
                                              ---------   -----------   -------------
<S>                                           <C>         <C>           <C>
Public Offering Price.......................
Underwriting Discounts......................
Proceeds, before expenses, to us............
</TABLE>

    The expenses of the offering, exclusive of the underwriting discounts, will
be approximately $         . These fees and expenses are payable entirely by us.
These fees include, among other things, our legal and accounting fees, our
printing expenses, our expenses incurred in connection with meetings with
potential investors, the filing fees of the Securities and Exchange Commission,
and the listing fees of the Nasdaq National Market.

    An electronic prospectus is available on the websites maintained by WR
Hambrecht + Co and DLJDIRECT Inc., an affiliate of Donaldson, Lufkin & Jenrette
Securities Corporation, each of which is a representative of the underwriters.
Other than the prospectus in electronic format, the information on these
websites relating to the offering is not part of this prospectus and has not
been approved or endorsed by us and should not be relied on by prospective
investors.

                                       57
<PAGE>
THE AUCTION PROCESS

    The method of distribution being used by the underwriters in this offering
is known as the OpenIPO process. It differs from that traditionally employed in
underwritten public offerings. In particular, the public offering price will be
based primarily on an auction conducted by the underwriters. The allocation of
shares of our common stock will be determined entirely by the auction process.
The following describes how WR Hambrecht + Co, other underwriters and selected
dealers will conduct the auction process and confirm bids from prospective
investors:

    - Before the registration statement relating to this offering becomes
      effective, the underwriters and participating dealers will solicit bids
      from prospective investors through the Internet, telephone and facsimile.
      The bids will specify the number of shares of our common stock the
      potential investor proposes to purchase and the price the potential
      investor is willing to pay for the shares. These bids may be above or
      below the range set forth on the cover page of this prospectus. The
      minimum size of any bid is 100 shares.

    - The shares offered by this prospectus may not be sold nor may offers to
      buy be accepted prior to the time that the registration statement filed
      with the Securities and Exchange Commission becomes effective. A bid
      received by WR Hambrecht + Co involves no obligation or commitment of any
      kind prior to the closing of the auction. Bids can be modified or revoked
      at any time prior to the closing of the auction.


    - Approximately two business days prior to the registration statement being
      declared effective, prospective investors will receive, by e-mail, phone
      or facsimile, a notice indicating the proposed effective date.


    - After the registration statement relating to this offering becomes
      effective, potential investors who have submitted bids to WR Hambrecht +
      Co will be contacted by e-mail, telephone or facsimile. Potential
      investors will be advised that the registration statement has been
      declared effective and will be requested to confirm their bids.

    - The auction will close after the registration statement becomes effective
      at a time agreed to by us and WR Hambrecht + Co. The actual time at which
      the auction closes will be determined by us and WR Hambrecht + Co based on
      general market conditions during the period after the registration
      statement becomes effective. After the registration statement has been
      declared effective, the public offering price of our common stock may be
      set at a price that is outside of the range set forth on the cover of this
      prospectus.

    - All bids that are not confirmed before the time specified by the
      underwriters, or if the time is not specified, by the close of the
      auction, will be deemed withdrawn.

    - Once a potential investor affirmatively confirms its previous bid, the
      confirmation will remain valid unless subsequently withdrawn by the
      potential investor. Potential investors will be able to withdraw their
      bids at any time before the close of the auction by notifying
      WR Hambrecht + Co or a participating dealer.

    - If the public offering price range is changed before or after a potential
      investor affirmatively confirms a bid, or if the public offering price is
      outside the public offering range previously provided to the potential
      investor in the prospectus, the underwriters and participating dealers
      will notify potential investors of the change and that offers will not be
      accepted until the potential investor has again reconfirmed its bid
      regardless of whether the potential investor's initial bid was above,
      below or at the public offering price.

    - Following the closing of the auction, WR Hambrecht + Co will determine the
      highest price at which all of the shares offered, including shares that
      may be purchased by the underwriters to cover any overallotments, may be
      sold to potential investors. This price, which is called the

                                       58
<PAGE>
      "clearing price," will be determined based on the results of all valid
      bids at the time the auction is closed. The clearing price will not
      necessarily be the public offering price, which will be set as described
      in "Determination of Public Offering Price" below. The public offering
      price will determine the allocation of shares to potential investors, with
      all bids submitted at or above the public offering price receiving a pro
      rata portion of the shares bid for.

    - Once the auction closes and a clearing price is set as described below, WR
      Hambrecht + Co will accept the bids from those bidders whose bid is at or
      above the public offering price but may allocate to a prospective investor
      fewer shares than the number included in the investor's bid.

    - WR Hambrecht + Co or a participating dealer will notify successful bidders
      by e-mail, phone or fax that the auction has closed and that their
      confirmed bids have been accepted. Other bidders will be notified that
      their bids have not been accepted.

    - Potential investors may at any time expressly request that all, or any
      specific, communications between them and the underwriters and
      participating dealers be made by specific means of communication,
      including telephone and facsimile.


    Some underwriters and selected dealers that participate in this offering may
request prospective investors to confirm their bids prior to the effective date
of the registration statement, if that practice is used by these institutions in
connection with initial public offerings that are not conducted using the
OpenIPO process. Because the auction practices may differ among underwriters and
dealers, bidders should carefully review the procedures of, and communications
from, the institution through which they bid to purchase our shares. In general,
approximately two business days before the registration statement is declared
effective, underwriters and dealers will request potential investors to
reconfirm the bids that they have submitted. If a bid is not reconfirmed prior
to the close of the auction, it will be rejected. If a bid is reconfirmed, if
may still be modified or revoked prior to the auction closing; however, if the
reconfirmed bid is not revoked prior to the effectiveness of the registration
statement and the closing of the auction, it will be considered a firm bid and
may be accepted at the closing of the auction. These underwriters and dealers
will also seek reconfirmation of bids in the event that the price range of the
offering is changed, or if the initial public offering price is set at a price
that is outside the range that has previously been provided to potential
investors.


DETERMINATION OF PUBLIC OFFERING PRICE

    The public offering price for this offering will ultimately be determined by
negotiation between the underwriters and us after the auction closes and will
not necessarily bear any direct relationship to our assets, current earnings or
book value or to any other established criteria of value, although these factors
were considered in establishing the initial public offering price range. Prior
to the offering, there has been no public market for our common stock. The
principal factor in establishing the public offering price will be the clearing
price resulting from the auction.


    The clearing price is the highest price at which all of the shares offered,
including the shares that may be purchased by the underwriters to cover any
overallotments, may be sold to potential investors, based on the valid bids at
the time the auction is run. The shares subject to the underwriters'
overallotment option will be used to calculate the clearing price whether or not
the option is actually exercised.


    Factors considered in determining the initial public offering price range
included an assessment of our management, operating results, capital structure
and business potential and the demand for similar securities of comparable
companies. Changes, if any, in the public offering price range will be based
primarily on the bids received.

    The public offering price may be lower, but will not be higher, than the
clearing price based on negotiations between the underwriters and us. The public
offering price will always determine the

                                       59
<PAGE>
allocation of shares to potential investors. Therefore, if the public offering
price is below the clearing price, all bids that are at or above the public
offering price will receive a pro rata portion of the shares bid for. If
sufficient bids are not received, or if we do not consider the clearing price to
be adequate, or if we and the underwriters are not able to reach agreement on
the public offering price, then we and the underwriters will either postpone or
cancel this offering. Alternatively, we may file a post-effective amendment to
the registration statement in order to conduct a new auction.

    The following simplified example illustrates how the public offering price
will be determined through the auction process:

    Company X offers to sell 100 shares in its public offering through the
auction process. WR Ham-
brecht + Co, on behalf of Company X, receives five bids to purchase, all of
which are kept confidential until the auction closes.

    The first bid is to pay $10 per share for 20 shares. The second bid is to
pay $9 per share for 30 shares. The third bid is to pay $8 per share for 60
shares. The fourth bid is to pay $7 per share for 40 shares. The fifth bid is to
pay $6 per share for 80 shares.

    Assuming that all of these bids are confirmed and not withdrawn or modified
before the auction closes, and assuming that no additional bids are received,
the clearing price used to determine the public offering price would be $8 per
share, which is the highest price at which all 100 shares offered may be sold to
potential investors who have submitted valid bids. However, the shares may be
sold at a price below $8 per share based on negotiations between the
underwriters and Company X.

    If the public offering price is the same as the $8 per share clearing price,
the underwriters will confirm bids at or above $8 per share. Because 110 shares
were bid for at or above the clearing price, each of the three potential
investors who bid $8 per share or more would receive approximately 90% of the
shares for which bids were made. The two potential investors whose bids were
below $8 per share would not receive any shares in this example.

    If the public offering price is $7 per share, the underwriters will confirm
bids that were made at or above $7 per share. No bids made at a price of less
than $7 per share will be accepted. The four potential investors with the
highest bids would receive a pro rata portion of the 100 shares offered, based
on the 150 shares they requested, or two-thirds of the shares for which bids
were made. The potential investor with the lowest bid would not receive any
shares in this example.

    The following table illustrates the example described above, assuming that
the initial public offering price is set at $8.00 per share. The table also
assumes that these bids are the final bids, and that they reflect any
modifications that have been made to reflect any prior changes to the offering
range, and to avoid the issuance of fractional shares.

                      INITIAL PUBLIC OFFERING OF COMPANY X

<TABLE>
<CAPTION>
                                     BID INFORMATION                            AUCTION RESULTS
                            ----------------------------------   ---------------------------------------------
                                                                             APPROXIMATE
                                        CUMULATIVE                            ALLOCATED
                             SHARES       SHARES                  SHARES      REQUESTED    CLEARING    AMOUNT
                            REQUESTED   REQUESTED    BID PRICE   ALLOCATED     SHARES       PRICE      RAISED
                            ---------   ----------   ---------   ---------   -----------   --------   --------
<S>                         <C>         <C>          <C>         <C>         <C>           <C>        <C>
                               20            20       $10.00         18           90%       $8.00       $144
                               30            50       $ 9.00         27           90%       $8.00       $216
Clearing Price -->             60           110       $ 8.00         55           90%       $8.00       $440
                               40           150       $ 7.00          0            0%
                               80           230       $ 6.00          0            0%
                                                                    ---                                 ----
                                                      Total:        100                                 $800
                                                                    ===                                 ====
</TABLE>

                                       60
<PAGE>
REQUIREMENTS FOR VALID BIDS

    Valid bids are those that meet the requirements, including eligibility,
account status and size, established by the underwriters or participating
dealers. In order to open a brokerage account with WR Hambrecht + Co, potential
investors must deposit $2,000 in their account. This brokerage account will be a
general account subject to WR Hambrecht + Co's customary rules, and will not be
limited to this offering. In addition, once the registration statement becomes
effective and the auction closes, a prospective investor submitting a bid
through a WR Hambrecht + Co brokerage account must have an account balance equal
to or in excess of the amount of its bid or its bid will not be accepted by WR
Hambrecht + Co. However, other than the $2,000 described above, prospective
investors will not be required to deposit any money into their accounts until
after the registration statement becomes effective. No funds will be transferred
to the underwriters, and any amounts in excess of $2,000 may be withdrawn, at
any time until the acceptance of the bid and the subsequent closing of this
offering. Conditions for valid bids, including eligibility standards and account
funding requirements of other underwriters or participating dealers other than
WR Hambrecht + Co, may vary.


SALE OF SHARES TO PERSONS WE DESIGNATE



    The underwriters have reserved up to 100,000 shares of the common stock to
be sold in this offering for sale to some of our employees, directors and their
associates, and to other individuals or companies who have commercial
arrangements or personal relationships with us. Offers to purchase shares
received from persons we designate will not be subject to pro rata reduction.
The number of shares used to determine the clearing price will be reduced by any
shares sold to persons we designate. The description of the auction process
assumes that no shares will be sold to persons we designate.


THE CLOSING OF THE AUCTION AND ALLOCATION OF SHARES

    The auction will close on a date estimated and publicly disclosed in advance
by the underwriters on the web site of WR Hambrecht + Co at www.wrhambrecht.com
or www.openipo.com. The 3,500,000 shares offered hereby, or 4,025,000 shares if
the underwriters' overallotment option is exercised in full, will be purchased
from us by the underwriters and sold through the underwriters and participating
dealers to investors who have submitted bids at or higher than the public
offering price. These investors will be notified by e-mail, telephone, voice
mail, facsimile or mail as soon as practicable following the closing of the
auction that their bids have been accepted.

    Each participating dealer has agreed with the underwriters to sell the
shares it purchases from the underwriters in accordance with the auction process
described above, unless the underwriters otherwise consent. The underwriters
reserve the right to reject bids that they deem manipulative or disruptive in
order to facilitate the orderly completion of this offering, and they reserve
the right, in exceptional circumstances, to alter this method of allocation as
they deem necessary to ensure a fair and orderly distribution of the shares of
our common stock. For example, large orders may be reduced to ensure a public
distribution and bids may be rejected or reduced by the underwriters or
participating dealers based on eligibility or creditworthiness criteria. In
addition, the underwriters or the participating dealers may reject or reduce a
bid by a prospective investor who has engaged in practices that could have a
manipulative, disruptive or otherwise adverse effect upon the offering.

    Price and volume volatility in the market for our common stock may result
from the somewhat unique nature of the proposed plan of distribution. Price and
volume volatility in the market for our common stock after the completion of
this offering may adversely affect the market price of our common stock.

    We have granted to the underwriters an option, exercisable no later than 30
days after the date of this prospectus, to purchase up to an aggregate of
525,000 additional shares of our common stock at the offering price, less the
underwriting discount, set forth on the cover page of this prospectus. To the
extent that the underwriters exercise this option, the underwriters will have a
firm commitment to purchase the additional shares, and we will be obligated to
sell the additional shares to the

                                       61
<PAGE>
underwriters. The underwriters may exercise the option only to cover
over-allotments made in connection with the sale of shares offered. The
underwriting agreement provides that we will indemnify the underwriters against
specified liabilities, including liabilities under the Securities Act, or
contribute to payments that the underwriters may be required to make.

    We have agreed not to offer, sell, contract to sell, or otherwise dispose of
any shares of common stock, or any options or warrants to purchase common stock
other than the shares of common stock or options to acquire common stock issued
under our stock option plans and stock purchase plan, for a period of 180 days
after the date of this prospectus, except with the prior written consent of WR
Hambrecht + Co. Each of our directors, executive officers and additional holders
of approximately 8,700,000 shares of our outstanding capital stock has agreed to
restrictions on his or her ability to sell, offer, contract or grant any option
to sell, pledge, transfer or otherwise dispose of shares of our common stock for
a period of 180 days after the date of this prospectus, without the prior
written consent of WR Hambrecht + Co.

    In connection with the offering, persons participating in the offering may
purchase and sell shares of common stock on the open market. These transactions
may include short sales, stabilizing transactions in accordance with Rule 104 of
Regulation M under the Securities Exchange Act of 1934, as amended, and
purchases to cover positions created by short sales. Short sales involve the
sale by the underwriters of a greater number of shares than they are required to
purchase in the offering which creates a syndicate short position. Stabilizing
transactions consist of certain bids or purchases made for the purpose of
preventing or retarding a decline in the market price of the common stock. The
underwriters also may impose a penalty bid. This occurs when a particular
underwriter repays to the underwriters a portion of the underwriting discount
received by it because the representative has repurchased shares sold by or for
the account of that underwriter in stabilizing or short covering transactions.
These activities by the underwriters may stabilize, maintain or otherwise affect
the market price of our common stock. As a result, the price of our common stock
may be higher than the price that otherwise might exist in the open market. If
these activities are commenced, they may be discontinued by the underwriters at
any time. These transactions may be effected on the Nasdaq National Market, in
the over-the-counter market or otherwise.

    Persons participating in this offering may also engage in passive market
making transactions in our common stock on the Nasdaq National Market. Passive
market making consists of displaying bids on the Nasdaq National Market limited
by the prices of independent market makers and affecting purchases limited by
such prices and in response to order flow. Rule 103 of Regulation M promulgated
by the SEC limits the amount of net purchases that each passive market may make
and the displayed size of each bid.

    Passive market making may stabilize the market price of our common stock at
a level above that which might otherwise prevail in the open market and, if
commenced, may be discontinued at any time.

    WR Hambrecht + Co currently intends to act as a market maker for our common
stock following this offering. However, WR Hambrecht + Co is not obligated to do
so and may discontinue any market making at any time.

    WR Hambrecht + Co is an investment banking firm formed in February 1998. In
addition to this offering, WR Hambrecht + Co has engaged in the business of
public and private equity investing and financial advisory services since its
inception. The manager of WR Hambrecht + Co, William R. Hambrecht, has 40 years
of experience in the securities industry.

                                       62
<PAGE>
                                 LEGAL MATTERS

    The validity of our shares of common stock being offered will be passed upon
for us by Bay Venture Counsel, LLP, Oakland, California. Fischer, Behar, Chen &
Co. will render opinions for us as to matters of Israeli law. Mr. Avraham
Fischer, senior partner of Fischer, Behar, Chen & Co., is a member of our board
of directors and owns 25,000 shares of our common stock and options to purchase
60,000 shares of our common stock. Legal matters in connection with this
offering will be passed upon for the underwriters by Morrison & Foerster LLP,
San Francisco, California.

                                    EXPERTS

    Our consolidated balance sheets at December 31, 1998 and 1999 and our
consolidated statements of operations, changes in stockholders' equity and cash
flows for each of the three years in the period ended December 31, 1999 included
in this prospectus have been included herein in reliance on the report of
Kesselman & Kesselman, a member firm of PricewaterhouseCoopers International
Limited, independent certified public accountants in Israel, given upon the
authority of that firm as experts in accounting and auditing.

                       WHERE YOU CAN GET MORE INFORMATION

    We have filed with the Securities and Exchange Commission a registration
statement on Form S-1 under the Securities Act with respect to the shares of
common stock being offered. This prospectus does not contain all of the
information described in the registration statement and the related exhibits and
schedules. For further information with respect to Nogatech and the common stock
being offered, reference is made to the registration statement and the related
exhibits and schedule. Statements contained in this prospectus regarding the
contents of any contract or any other document to which reference is made are
not necessarily complete, and, in each instance, reference is made to the copy
of the contract or other document filed as an exhibit to the registration
statement, each statement being qualified in all respects by the reference. A
copy of the registration statement and the related exhibits and schedule may be
inspected without charge at the public reference facilities maintained by the
Commission in Room 1024, 450 Fifth Street, N.W., Washington, D.C. 20549, and at
the Commission's regional offices located at the Northwestern Atrium Center, 500
West Madison Street, Suite 1400, Chicago, Illinois 60661 and Seven World Trade
Center, 13th Floor, New York, New York 10048, and copies of all or any part of
the registration statement may be obtained from these offices upon the payment
of the fees prescribed by the Commission. Information on the operation of the
Public Reference Room may be obtained by calling the Commission at
1-800-SEC-0330. The Commission maintains a World Wide Web site that contains
reports, proxy and information statements and other information regarding
registrants that file electronically with the Commission. The address of the
site is http://www.sec.gov. Upon approval of our common stock for quotation on
the Nasdaq National Market, our reports, proxy statements and other information
may be inspected at the offices of Nasdaq Operations, 1735 K Street, N.W.,
Washington, D.C. 20006.

    We intend to provide our stockholders with annual reports containing
combined financial statements audited by an independent accounting firm and to
file with the Commission quarterly reports containing unaudited combined
financial data for the first three quarters of each year.

                                       63
<PAGE>
                                 NOGATECH, INC.
                   INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

<TABLE>
<CAPTION>
                                                                 PAGE
                                                                 ----
<S>                                                           <C>
Report of Independent Accountants...........................     F-2
Consolidated Balance Sheets as of December 31, 1998 and 1999
  and (unaudited) March 31, 2000............................     F-3
Consolidated Statements of Operations for the Years Ended
  December 31, 1997, 1998 and 1999 and for the (unaudited)
  Three Months Ended March 31, 1999 and 2000................     F-4
Consolidated Statements of Changes in Stockholders' Equity
  (Capital Deficiency) for the Years Ended December 31,
  1997, 1998 and 1999 and for the (unaudited) Three Months
  Ended March 31, 1999 and 2000.............................     F-5
Consolidated Statements of Cash Flows for the Years Ended
  December 31, 1997, 1998 and 1999 and for the (unaudited)
  Three Months Ended March 31, 1999 and 2000................     F-8
Notes to Consolidated Financial Statements..................     F-9
</TABLE>

                                      F-1
<PAGE>
                       REPORT OF INDEPENDENT ACCOUNTANTS

To the Stockholders of
NOGATECH, INC.

    We have audited the consolidated balance sheets of Nogatech, Inc. and its
subsidiaries (collectively, the "Company") as of December 31, 1998 and 1999 and
the related consolidated statements of operations, changes in stockholders'
equity (capital deficiency) and cash flows for each of the three years in the
period ended December 31, 1999. These financial statements are the
responsibility of the Company's Board of Directors and management. Our
responsibility is to express an opinion on these financial statements based on
our audits.

    We conducted our audits in accordance with generally accepted auditing
standards in Israel and in the United States, including those prescribed by the
Israeli Auditors (Mode of Performance) Regulations, 1973. Those standards
require that we plan and perform the audit to obtain reasonable assurance about
whether the financial statements are free of material misstatement. An audit
includes examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements. An audit also includes assessing the
accounting principles used and significant estimates made by the Company's Board
of Directors and management, as well as evaluating the overall financial
statement presentation. We believe that our audits provide a fair basis for our
opinion.

    In our opinion, the consolidated financial statements referred to above,
present fairly, in all material respects, the consolidated financial position of
the Company as of December 31, 1998 and 1999 and the consolidated results of
their operations, changes in stockholders' equity (capital deficiency) and their
cash flows for each of the three years in the period ended December 31, 1999, in
conformity with accounting principles generally accepted in the United States.

<TABLE>
<S>                                            <C>
Tel Aviv, Israel                                           Kesselman & Kesselman
February 25, 2000                                  Certified Public Accountants (Israel)
(except for Note 6,
the date of which is
March 8, 2000)
</TABLE>

                                      F-2
<PAGE>
                                 NOGATECH, INC.

                          CONSOLIDATED BALANCE SHEETS

                         (IN THOUSANDS OF U.S. DOLLARS)


<TABLE>
<CAPTION>
                                                                                                   PRO FORMA
                                                                                                   (NOTE 1O)
                                                                 DECEMBER 31,                     -----------
                                                              -------------------    MARCH 31,     MARCH 31,
                                                                1998       1999        2000          2000
                                                              --------   --------   -----------   -----------
                                                                                    (UNAUDITED)   (UNAUDITED)
<S>                                                           <C>        <C>        <C>           <C>
                           ASSETS
CURRENT ASSETS:
  Cash and cash equivalents.................................  $ 3,791    $ 2,475     $  6,612      $  6,612
  Accounts receivable: (note 9a)
    Trade...................................................      848      1,019        1,484         1,484
    Other...................................................      140        197          213           213
  Inventories (note 9b).....................................      581      2,109        1,747         1,747
  Other current assets......................................       26        169          277           277
                                                              -------    -------     --------      --------
      Total current assets..................................    5,386      5,969       10,333        10,333
                                                              -------    -------     --------      --------
FIXED ASSETS (note 2):
  Cost......................................................      535        835          873           873
  Less--accumulated depreciation and amortization...........     (355)      (483)        (523)         (523)
                                                              -------    -------     --------      --------
      Total fixed assets....................................      180        352          350           350
                                                              -------    -------     --------      --------
OTHER ASSETS................................................      203        256          267           267
                                                              -------    -------     --------      --------
                                                              $ 5,769    $ 6,577     $ 10,950      $ 10,950
                                                              =======    =======     ========      ========
  LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND
                    STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
  Accounts payable and accruals: (note 9c)
    Trade...................................................  $   508    $ 1,967     $    830      $    830
    Other...................................................      707        891          876           876
                                                              -------    -------     --------      --------
      Total current liabilities.............................    1,215      2,858        1,706         1,706
EMPLOYEE RIGHTS UPON RETIREMENT (note 3)....................      255        362          391           391
                                                              -------    -------     --------      --------

COMMITMENTS AND CONTINGENT LIABILITIES (note 4)
    Total liabilities.......................................    1,470      3,220        2,097         2,097
                                                              -------    -------     --------      --------

SERIES A AND B REDEEMABLE CONVERTIBLE PREFERRED
  STOCK, at redemption value (note 5).......................    7,816      8,243       13,408            --
                                                              -------    -------     --------
STOCKHOLDERS' EQUITY (CAPITAL DEFICIENCY) (note 6):
    Common stock*, $0.001 par value:
      authorized--40,000,000 shares at December 31, 1998,
      1999 and March 31, 2000;
      issued and outstanding: 310,995, 419,370 and 728,040
      shares at December 31, 1998, 1999 and March 31, 2000,
      respectively; March 31, 2000 pro forma 10,021,350
      shares................................................        1          1            1            10
    Additional paid-in capital..............................    5,882      6,157       11,024        24,423
    Note receivable from a stockholder......................      (57)       (57)
    Deferred compensation...................................     (271)      (392)        (343)         (343)
    Accumulated deficit.....................................   (9,072)   (10,595)     (15,237)      (15,237)
                                                              -------    -------     --------      --------
  Total stockholders' equity (capital deficiency)...........   (3,517)    (4,886)      (4,555)        8,853
                                                              -------    -------     --------      --------
                                                              $ 5,769    $ 6,577     $ 10,950      $ 10,950
                                                              =======    =======     ========      ========
</TABLE>


- --------------------------
*After giving retroactive effect to the reverse stock split, see note 6a.

    THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THE FINANCIAL STATEMENTS.

                                      F-3
<PAGE>
                                 NOGATECH, INC.

                     CONSOLIDATED STATEMENTS OF OPERATIONS

        (IN THOUSANDS OF U.S. DOLLARS, EXCEPT SHARE AND PER SHARE DATA)


<TABLE>
<CAPTION>
                                                                                              THREE MONTHS ENDED
                                                         YEAR ENDED DECEMBER 31,                   MARCH 31,
                                                 ---------------------------------------   -------------------------
                                                    1997          1998          1999          1999          2000
                                                 -----------   -----------   -----------   -----------   -----------
                                                                                                  (UNAUDITED)
<S>                                              <C>           <C>           <C>           <C>           <C>
SALES (notes 8 and 11).........................  $     2,551   $     3,205   $     8,856   $       870   $     2,945
COST OF SALES (notes 8 and 11).................        1,699         2,038         5,111           518         1,661
                                                 -----------   -----------   -----------   -----------   -----------
GROSS PROFIT...................................          852         1,167         3,745           352         1,284
                                                 -----------   -----------   -----------   -----------   -----------
OPERATING EXPENSES:
  Research and development.....................        1,266         1,451         2,283           588           685
  Sales and marketing..........................          695         1,020         1,689           383           290
  General and administrative...................          321           609           880           195           204
                                                 -----------   -----------   -----------   -----------   -----------
TOTAL OPERATING EXPENSES.......................        2,282         3,080         4,852         1,166         1,179
                                                 -----------   -----------   -----------   -----------   -----------
OPERATING INCOME (LOSS)........................       (1,430)       (1,913)       (1,107)         (814)          105
OTHER INCOME (EXPENSE), NET....................          (32)           90            11            (3)          (12)
                                                 -----------   -----------   -----------   -----------   -----------
NET INCOME (LOSS)..............................       (1,462)       (1,823)       (1,096)         (817)           93
CHARGE FOR BENEFICIAL CONVERSION FEATURE OF
  SERIES B PREFERRED STOCK.....................           --            --            --            --        (4,570)
ACCRETION OF REDEMPTION VALUE OF SERIES A
  REDEEMABLE CONVERTIBLE PEREFERRED STOCK......         (300)         (383)         (427)         (107)         (165)
                                                 -----------   -----------   -----------   -----------   -----------
NET LOSS APPLICABLE TO COMMON STOCK............  $    (1,762)  $    (2,206)  $    (1,523)  $      (924)  $    (4,642)
                                                 -----------   -----------   -----------   -----------   -----------

NET LOSS PER SHARE OF COMMON STOCK,
  basic and diluted (note 1k)..................  $     (5.86)  $     (7.13)  $     (4.50)  $     (2.97)  $     (8.14)
                                                 ===========   ===========   ===========   ===========   ===========

WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON
  STOCK OUTSTANDING (note 1k)..................      300,709       309,536       338,295       310,995       570,557
                                                 ===========   ===========   ===========   ===========   ===========
PRO FORMA NET INCOME (LOSS) PER SHARE OF COMMON
  STOCK, basic and diluted (note 1k)...........                              $     (0.12)  $     (0.09)  $      0.01
                                                                             ===========   ===========   ===========
PRO FORMA WEIGHTED AVERAGE
  NUMBER OF SHARES OF COMMON STOCK
  OUTSTANDING (note 1k)........................                                8,948,078     8,920,778     9,749,945
                                                                             ===========   ===========   ===========
</TABLE>


    THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THE FINANCIAL STATEMENTS.

                                      F-4
<PAGE>
                                 NOGATECH, INC.
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (CAPITAL DEFICIENCY)
              (IN THOUSANDS OF U.S. DOLLARS, EXCEPT SHARE AMOUNTS)


<TABLE>
<CAPTION>
                                                                          NOTE                                         TOTAL
                                   COMMON STOCK          ADDITIONAL    RECEIVABLE                                  STOCKHOLDERS'
                             -------------------------     PAID-IN       FROM A        DEFERRED     ACCUMULATED   EQUITY (CAPITAL
                               NUMBER*       AMOUNT        CAPITAL     STOCKHOLDER   COMPENSATION     DEFICIT       DEFICIENCY)
                             -----------   -----------   -----------   -----------   ------------   -----------   ---------------
<S>                          <C>           <C>           <C>           <C>           <C>            <C>           <C>
BALANCE AT JANUARY 1,
  1997.....................      286,625    $        1    $    1,113    $     (57)                   $  (5,104)        $  (4,047)
  Issuance of common stock
    in connection with
    stock options
    exercised..............       18,120            **             2                                                            2
  Excess of consideration
    received, net of
    issuance costs of $60,
    over the redemption
    value of series A
    redeemable convertible
    preferred stock issued
    (note 5b(1))...........                                    1,283                                                        1,283
  Accretion of redemption
    value of series A
    redeemable convertible
    preferred stock........                                                                               (300)             (300)
  Net loss.................                                                                             (1,462)           (1,462)
                              ----------    ----------    ----------    ----------     ----------    ----------        ----------

BALANCE AT DECEMBER 31,
  1997.....................      304,745             1         2,398          (57)                      (6,866)           (4,524)
  Issuance of common stock
    in connection with
    stock options
    exercised..............        6,250            **             1                                                            1
  Deferred compensation
    related to employee
    stock option grants....                                      268                        (268)
  Deferred compensation
    related to nonemployee
    stock option grants....                                       53                         (53)
  Amortization of deferred
    compensation related to
    stock option grants....                                                                    50                              50
  Excess of consideration
    received, net of
    issuance costs of $355,
    over the redemption
    value of series A
    redeemable convertible
    preferred stock issued
    (note 5b(1))...........                                    3,162                                                        3,162
  Accretion of redemption
    value of series A
    redeemable convertible
    preferred stock........                                                                               (383)             (383)
  Net loss.................                                                                             (1,823)           (1,823)
                              ----------    ----------    ----------    ----------     ----------    ----------        ----------
BALANCE AT DECEMBER 31,
  1998--FORWARD............      310,995    $        1    $    5,882    $     (57)     $    (271)    $  (9,072)        $  (3,517)
</TABLE>


                                      F-5
<PAGE>
                                 NOGATECH, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (CAPITAL DEFICIENCY)
              (IN THOUSANDS OF U.S. DOLLARS, EXCEPT SHARE AMOUNTS)

<TABLE>
<CAPTION>

                                                    COMMON STOCK         ADDITIONAL   NOTE RECEIVABLE
                                               -----------------------    PAID-IN         FROM A          DEFERRED     ACCUMULATED
                                                NUMBER*       AMOUNT      CAPITAL       STOCKHOLDER     COMPENSATION     DEFICIT
                                               ----------   ----------   ----------   ---------------   ------------   -----------
<S>                                            <C>          <C>          <C>          <C>               <C>            <C>
BALANCE AT DECEMBER 31, 1998--BROUGHT
  FORWARD....................................     310,995   $        1   $    5,882     $      (57)      $     (271)   $   (9,072)
  Issuance of common stock in connection with
    stock options exercised..................     108,375           **           39
  Deferred compensation related to employee
    stock option grants......................                                   214                            (214)
  Deferred compensation related to
    nonemployee stock option grants..........                                    22                             (22)
  Amortization of deferred compensation
    related to stock option grants...........                                                                   115
  Accretion of redemption value of series A
    redeemable convertible preferred stock...                                                                                (427)
  Net loss...................................                                                                              (1,096)
                                               ----------   ----------   ----------     ----------       ----------    ----------
BALANCE AT DECEMBER 31, 1999.................     419,370            1        6,157            (57)            (392)      (10,595)
  Issuance of common stock in connection with
    stock options and warrants exercised.....     308,670           **          604
  Deferred compensation related to employee
    stock option grants......................                                    35                             (35)
  Deferred compensation related to employee
    stock option forfeited...................                                   (40)                             40
  Repayment of note receivable from a
    stockholder..............................                                                   57
  Amortization of deferred compensation
    related to stock option grants...........                                                                    44
  Accretion of redemption value of Series A
    redeemable convertible preferred stock...                                                                                (165)
  Beneficial conversion feature - relating to
    Series B convertible preferred stock
    (note 5c)................................                                 4,570                                        (4,570)
  Excess of redemption value of Series B
    redeemable convertible preferred stock
    issued, over the consideration received,
    net of issuance costs of $302
    (note 5d)................................                                  (302)
  Net income.................................                                                                                  93
                                               ----------   ----------   ----------     ----------       ----------    ----------
BALANCE AT MARCH 31, 2000 (UNAUDITED)........     728,040   $        1   $   11,024                      $     (343)   $  (15,237)

<CAPTION>
                                                     TOTAL
                                                 STOCKHOLDERS'
                                                EQUITY (CAPITAL
                                                  DEFICIENCY)
                                               -----------------
<S>                                            <C>
BALANCE AT DECEMBER 31, 1998--BROUGHT
  FORWARD....................................     $   (3,517)
  Issuance of common stock in connection with
    stock options exercised..................             39
  Deferred compensation related to employee
    stock option grants......................
  Deferred compensation related to
    nonemployee stock option grants..........
  Amortization of deferred compensation
    related to stock option grants...........            115
  Accretion of redemption value of series A
    redeemable convertible preferred stock...           (427)
  Net loss...................................         (1,096)
                                                  ----------
BALANCE AT DECEMBER 31, 1999.................         (4,886)
  Issuance of common stock in connection with
    stock options and warrants exercised.....            604
  Deferred compensation related to employee
    stock option grants......................
  Deferred compensation related to employee
    stock option forfeited...................
  Repayment of note receivable from a
    stockholder..............................             57
  Amortization of deferred compensation
    related to stock option grants...........             44
  Accretion of redemption value of Series A
    redeemable convertible preferred stock...           (165)
  Beneficial conversion feature - relating to
    Series B convertible preferred stock
    (note 5c)................................
  Excess of redemption value of Series B
    redeemable convertible preferred stock
    issued, over the consideration received,
    net of issuance costs of $302
    (note 5d)................................           (302)
  Net income.................................             93
                                                  ----------
BALANCE AT MARCH 31, 2000 (UNAUDITED)........     $   (4,555)
</TABLE>


                                      F-6
<PAGE>
                                 NOGATECH, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (CAPITAL DEFICIENCY)
              (IN THOUSANDS OF U.S. DOLLARS, EXCEPT SHARE AMOUNTS)

<TABLE>
<CAPTION>

                                                  COMMON STOCK         ADDITIONAL   NOTE RECEIVABLE
                                             -----------------------    PAID-IN         FROM A          DEFERRED     ACCUMULATED
                                              NUMBER*       AMOUNT      CAPITAL       STOCKHOLDER     COMPENSATION     DEFICIT
                                             ----------   ----------   ----------   ---------------   ------------   -----------
<S>                                          <C>          <C>          <C>          <C>               <C>            <C>
BALANCE AT MARCH 31, 2000 (UNAUDITED)--
  BROUGHT FORWARD..........................     728,040   $        1   $   11,024                      $     (343)   $  (15,237)
  Pro forma conversion of series A and B
    redeemable convertible preferred stock
    into common stock (note 1p)............   9,293,310            9       13,399
                                             ----------   ----------   ----------     ----------       ----------    ----------
PRO FORMA STOCKHOLDERS' EQUITY AT MARCH 31,
  2000 (NOTE 1P) (UNAUDITED)...............  10,021,350           10       24,423                            (343)      (15,237)
                                             ==========   ==========   ==========     ==========       ==========    ==========

BALANCE AT JANUARY 1, 1999.................     310,995   $        1   $    5,882     $      (57)      $     (271)   $   (9,072)
  Amortization of deferred compensation
    related to stock option grants.........                                                                    28
  Accretion of redemption value of Series A
    redeemable convertible preferred
    stock..................................                                                                                (107)
  Net loss.................................                                                                                (817)
                                             ----------   ----------   ----------     ----------       ----------    ----------
BALANCE AT MARCH 31, 1999 (UNAUDITED)......     310,995   $        1   $    5,882     $      (57)      $     (243)   $   (9,996)
                                             ==========   ==========   ==========     ==========       ==========    ==========

<CAPTION>
                                                   TOTAL
                                               STOCKHOLDERS'
                                              EQUITY (CAPITAL
                                                DEFICIENCY)
                                             -----------------
<S>                                          <C>
BALANCE AT MARCH 31, 2000 (UNAUDITED)--
  BROUGHT FORWARD..........................     $   (4,555)
  Pro forma conversion of series A and B
    redeemable convertible preferred stock
    into common stock (note 1p)............         13,408
                                                ----------
PRO FORMA STOCKHOLDERS' EQUITY AT MARCH 31,
  2000 (NOTE 1P) (UNAUDITED)...............          8,853
                                                ==========
BALANCE AT JANUARY 1, 1999.................     $   (3,517)
  Amortization of deferred compensation
    related to stock option grants.........             28
  Accretion of redemption value of Series A
    redeemable convertible preferred
    stock..................................           (107)
  Net loss.................................           (817)
                                                ----------
BALANCE AT MARCH 31, 1999 (UNAUDITED)......     $   (4,413)
                                                ==========
</TABLE>


- ------------------------

 *  After giving retroactive effect to the reverse stock-split, see note 6a.

**  Representing an amount less than $1,000.

    THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THE FINANCIAL STATEMENTS.

                                      F-7
<PAGE>
                                 NOGATECH, INC.
                     CONSOLIDATED STATEMENTS OF CASH FLOWS
                         (IN THOUSANDS OF U.S. DOLLARS)

<TABLE>
<CAPTION>
                                                                                                  THREE MONTHS
                                                                 YEAR ENDED DECEMBER 31,         ENDED MARCH 31,
                                                              ------------------------------   -------------------
                                                                1997       1998       1999       1999       2000
                                                              --------   --------   --------   --------   --------
                                                                                                   (UNAUDITED)
<S>                                                           <C>        <C>        <C>        <C>        <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
  Net income (loss)........................................   $(1,462)   $(1,823)   $(1,096)   $  (817)   $    93
                                                              -------    -------    -------    -------    -------
  Adjustments to reconcile net income (loss) to net cash
    used in operating activities:
    Employee rights upon retirement........................         7         19         54         48         18
    Depreciation and amortization..........................        97         91        128         23         40
    Compensation relating to stock options.................                   50        115         28         44
    Changes in operating asset and liability items:
      Decrease (increase) in accounts receivable:
        Trade..............................................         1       (547)      (171)      (324)      (465)
        Other..............................................       (75)       (65)       (57)       (69)       (16)
      Decrease (increase) in inventories...................        94         50     (1,528)      (147)       362
      Decrease (increase) in other current assets..........       (33)        57       (143)         7       (108)
      Increase (decrease) in accounts payable and accruals:
        Trade..............................................       151          2      1,459        358     (1,152)
        Other..............................................        87        344        184        116        (15)
                                                              -------    -------    -------    -------    -------
                                                                  329          1         41         40     (1,292)
                                                              -------    -------    -------    -------    -------
  Net cash used in operating activities....................    (1,133)    (1,822)    (1,055)      (777)    (1,199)
                                                              -------    -------    -------    -------    -------
CASH FLOWS USED IN INVESTING ACTIVITIES--purchases of fixed
 assets....................................................      (108)       (64)      (300)       (63)       (23)
                                                              -------    -------    -------    -------    -------
CASH FLOWS FROM FINANCING ACTIVITIES:
  Issuance of series A redeemable convertible preferred
    stock, net of issuance costs of $60 and $355 in 1997
    and 1998, respectively.................................     1,790      5,641         --         --         --
  Issuance of series B redeemable convertible preferred
    stock, net of issuance costs of $302...................        --         --         --         --      4,698
  Issuance of common stock in connection with stock options
    and warrants exercised.................................         2          1         39                   604
  Receipt (repayment) of short-term credit, net............      (375)      (236)                  294
  Repayment of note receivable from a stockholder..........        --         --         --         --         57
                                                              -------    -------    -------    -------    -------
  Net cash provided by financing activities................     1,417      5,406         39        294      5,359
                                                              -------    -------    -------    -------    -------
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS...........       176      3,520     (1,316)      (546)     4,137
BALANCE OF CASH AND CASH EQUIVALENTS AT BEGINNING OF
 PERIOD....................................................        95        271      3,791      3,791      2,475
                                                              -------    -------    -------    -------    -------
BALANCE OF CASH AND CASH EQUIVALENTS AT END OF PERIOD......   $   271    $ 3,791    $ 2,475    $ 3,245    $ 6,612
                                                              =======    =======    =======    =======    =======

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION--CASH PAID
 DURING THE PERIOD FOR:
  Interest.................................................   $    27    $    57    $    41    $     5    $    24
                                                              =======    =======    =======    =======    =======
  Taxes....................................................   $     2    $     9    $     4    $     1    $     1
                                                              =======    =======    =======    =======    =======
</TABLE>

    THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THE FINANCIAL STATEMENTS.

                                      F-8
<PAGE>
                                 NOGATECH, INC.

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1--SIGNIFICANT ACCOUNTING POLICIES:

 a. GENERAL

     1) NATURE OF OPERATIONS:

        (a) Nogatech, Inc. ("Nogatech Delaware") was incorporated in Delaware on
            September 22, 1999.

           On December 28, 1999, Nogatech, Inc. ("Nogatech California"), which
           was incorporated in California in 1993, merged into Nogatech
           Delaware. In the merger, the stockholders of Nogatech California
           exchanged their shares for all of the issued and outstanding stock of
           Nogatech Delaware. At the time of the merger, the wholly owned
           subsidiary of Nogatech California was Nogatech Ltd., an Israeli
           company ("Nogatech Israel"). The ownership interest of each of the
           two companies' stockholders before and after the merger was
           identical.

        (b) Nogatech Delaware and its two wholly owned subsidiaries, Nogatech
            Israel and Nogatech California, Inc. (collectively, the "Company"),
            are engaged in research, development, production, sales and
            marketing of the Company's products to customers.

           The Company provides video compression chips which establish
           connections between video devices and computers, as well as
           connections between video devices across a variety of networks. As to
           information regarding the Company's major customers and supplier, see
           note 11.

        (c) The merger described in (a) above has been recorded as a
            reorganization of entities under common control, and has been
            accounted for at the recorded amount in Nogatech California's
            (predecessor) financial statements. Accordingly, the Company's
            consolidated financial statements reflect the predecessor's
            financial position, results of operations and cash flows, from its
            inception to December 28, 1999 (date of merger), in a manner similar
            to a pooling-of-interests accounting. Such presentation reflects the
            combined financial statements as if the merger occurred at the
            beginning of the earliest period presented herein.

     2) ACCOUNTING PRINCIPLES

       The consolidated financial statements have been prepared in accordance
       with generally accepted accounting principles ("GAAP") in the United
       States ("U.S. GAAP").

     3) USE OF ESTIMATES IN THE PREPARATION OF CONSOLIDATED FINANCIAL STATEMENTS

       The preparation of financial statements in conformity with U.S. GAAP
       requires management to make estimates and assumptions that affect the
       reported amounts of assets and liabilities and disclosure of contingent
       assets, liabilities at the date of the financial statements and the
       reported amounts of sales and expenses during the reporting periods.
       Actual results could differ from those estimates.

 b. FUNCTIONAL CURRENCY

    The currency of the primary economic environment in which the operations of
    Nogatech Delaware and Nogatech California are conducted is the U.S. dollar
    ("$" or "dollar").

                                      F-9
<PAGE>
                                 NOGATECH, INC.

             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 1--SIGNIFICANT ACCOUNTING POLICIES: (CONTINUED)
    Most of Nogatech Israel's sales are made in dollars. Substantially all of
    the subsidiary's production costs are comprised of cost of materials, which
    are purchased in dollars. Most of the research and development expenses and
    general and administrative expenses are incurred in Israeli currency. Most
    of the sales and marketing expenses are incurred in dollars. Thus, the
    functional currency of Nogatech Israel is the dollar, and accordingly, the
    functional currency of the Company is the dollar.

    Transactions and balances originally denominated in dollars are presented at
    their original amounts. Balances in non-dollar (Israeli) currency are
    translated into dollars using historical and current exchange rates for
    non-monetary and monetary balances, respectively. For non-dollar
    transactions and other items (stated below) reflected in the statements of
    operations, the following exchange rates are used: (i) for transactions --
    exchange rates at transaction dates; and (ii) for other items (derived from
    non-monetary balance sheet items, such as depreciation and amortization,
    changes in inventories, etc.) -- historical exchange rates. The resulting
    currency transaction gains or losses are included in other income or
    expenses, as appropriate.

 c. PRINCIPLES OF CONSOLIDATION

    The consolidated financial statements include the accounts of Nogatech
    Delaware and its two wholly owned subsidiaries. Intercompany balances and
    transactions have been eliminated. Profits from intercompany sales, not yet
    realized, have also been eliminated.

 d. INVENTORIES

    Inventories are recorded at the lower of cost or market. Cost is determined
    on a "first-in, first-out" basis.

 e. FIXED ASSETS

    Fixed assets are stated at cost.

    Depreciation in calculated using the straight-line method over the estimated
    useful life of the assets, at the following annual rates:

<TABLE>
<CAPTION>
                                                                 %
                                                              --------
<S>                                                           <C>
Computers and software......................................  20-33
Office furniture and equipment..............................   6-15
Laboratory equipment........................................    20
Motor vehicles..............................................    15
</TABLE>

    Leasehold improvements are amortized by the straight-line method over the
    term of the lease, which is shorter than the estimated useful life of the
    improvements.

 f. IMPAIRMENT IN VALUE OF FIXED ASSETS

    The Company adopted Statement of Financial Accounting Standards FAS
    No. 121, "Accounting for the Impairment of Long-Lived Assets and for
    Long-Lived Assets to be Disposed of". This Statement refers to fixed assets
    and identifiable intangible assets (hereafter -- long-lived assets). Under
    the provisions of FAS 121, the Company reviews its long-lived assets for
    impairment on an exception basis whenever events or changes in circumstances
    indicate that the carrying amount of

                                      F-10
<PAGE>
                                 NOGATECH, INC.

             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 1--SIGNIFICANT ACCOUNTING POLICIES: (CONTINUED)
    the assets may not be recoverable through future undiscounted cash flows. If
    it is determined that an impairment has occurred, a loss will be recognized
    in the statements of operations based on fair values determined using
    discounted cash flows compared to carrying amounts.

 g. REVENUE RECOGNITION

    Revenue from product sales to customers, other than sales to distributors,
    is recognized when products are shipped to the customers. Sales to
    distributors, where the Company allows right of return on products unsold by
    the distributors, are not recognized until the products are sold by the
    distributors to their customers.

    The provision for warranty is recorded at the time of the sale of the
    related product for probable costs in connection with warranties, based on
    the Company's experience.

 h. RESEARCH AND DEVELOPMENT EXPENSES

    Research and development expenses are charged to the statements of
    operations as incurred.

 i. CONCENTRATION OF CREDIT RISKS AND ALLOWANCE FOR DOUBTFUL ACCOUNTS

    Financial instruments that subject the Company to credit risks consist
    primarily of uninsured cash and cash equivalents, which are deposited in
    major financial institutions in the United States and in Israel, and of
    trade receivables. The Company performs ongoing credit evaluations of its
    customers and generally does not require collateral. The Company provides
    for estimated credit losses.

    The provision for doubtful accounts is principally determined for specific
    debts when their collection is doubtful.

 j. CASH EQUIVALENTS

    The Company considers all highly liquid investments, with an original
    maturity of three months or less when issued, that are not restricted as to
    withdrawal or use, to be cash equivalents.

 k. NET LOSS PER SHARE OF COMMON STOCK ("EPS")

     1) Historical EPS

         a) Basic EPS is computed by dividing net loss applicable to common
            stock by the weighted average number of shares of common stock
            outstanding during each period.

         b) Since the basic EPS for the years ended December 31, 1997, 1998 and
            1999 and for the periods of three months ended March 31, 1999 and
            2000, represents a loss per share of common stock, the effect of
            including the incremental shares of common stock from assumed
            exercise of options and from assumed conversion of redeemable
            convertible preferred stock in EPS computation is anti-dilutive, and
            accordingly the basic and diluted EPS are the same (see also note
            9d).

     2) Pro forma EPS

       Pro forma basic and diluted EPS have been calculated assuming the
       conversion of all outstanding shares of preferred stock that are
       convertible upon the Company's initial public offering into common stock,
       as if the shares had been converted immediately upon their

                                      F-11
<PAGE>
                                 NOGATECH, INC.

             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 1--SIGNIFICANT ACCOUNTING POLICIES: (CONTINUED)
       issuance. Accretion of redemption value of redeemable convertible
       preferred stock and the deemed dividend relating to the beneficial
       conversion feature of the Series B preferred stock have been excluded
       from the calculation of pro forma basic and diluted EPS as the related
       shares are assumed to have converted to common stock upon issuance.

     3) Weighted average number of common shares outstanding used in the
        computation of the basic and diluted historical EPS and pro forma EPS
        has been calculated after giving retroactive effect in all the reported
        periods, to a one-for-two reverse stock split, as approved by the
        Company's Board of Directors on March 5, 2000 (note 6a).

 l. STOCK-BASED COMPENSATION

    The Company applies Accounting Principles Board Opinion No. 25, "Accounting
    for Stock Issued to Employees" (APB 25), and related interpretations in
    accounting for its stock option plan grants to employees and directors, with
    the disclosure provisions of Statement of Financial Accounting Standards FAS
    No. 123, "Accounting for Stock-Based Compensation" (FAS 123). Under APB 25,
    compensation expense is computed under the intrinsic value method of
    accounting to the extent that the fair value of the underlying stock on the
    date of grant exceeds the exercise price of the stock option. Compensation
    so computed is deferred and then recognized over the vesting period of the
    stock option.

    The Company applies FAS 123 in accounting for stock options granted to
    nonemployees in exchange for services received using the fair value method
    of accounting. Under FAS 123, these equity transactions are accounted for
    based on the fair value of the consideration received or the fair value of
    the equity instruments issued, whichever is more reliably measurable. The
    value of the equity instruments is calculated using a Black-Scholes pricing
    model.


 m. REDEEMABLE CONVERTIBLE PREFERRED STOCK



    The preferred stock, which entitles its holders to redeem their shares in
    certain events (see note 5b), is initially measured at fair value
    (consideration received) and reported in stockholders' equity and the amount
    equal to its cash redemption value is transferred apart from the
    stockholders' equity and classified as redeemable convertible preferred
    stock. The annual accretion of the redemption value computed using the
    interest method is charged to accumulated deficit (see note 5d).


 n. COMPREHENSIVE INCOME (LOSS)

    The Company adopted FAS 130, "Reporting Comprehensive Income" (FAS 130). FAS
    130 requires reporting and display of comprehensive income (loss) and its
    components, in a full set of general-purpose financial statements. The
    Company has no other comprehensive income (loss) components other than the
    net income (loss) for the reported periods.

 o. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS:

    1) In June 1998, the FASB issued FAS 133, "Accounting for Derivative
       Instruments and Hedging Activities" (FAS 133). FAS 133 established a new
       model for accounting for derivatives and hedging activities. FAS 133
       requires companies to record derivatives on the balance sheet as assets
       or liabilities, measured at fair value. Gains or losses resulting from
       changes in the values of those derivatives would be accounted for,
       depending on the use of the derivative and

                                      F-12
<PAGE>
                                 NOGATECH, INC.

             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 1--SIGNIFICANT ACCOUNTING POLICIES: (CONTINUED)
     whether it qualifies for hedge accounting. FAS 133 is effective for
       calendar year companies beginning January 1, 2001. The Company does not
       currently use derivative instruments, accordingly, it does not anticipate
       that the new standard will have any impact on its financial statements.

    2) In December 1999, the U.S. Securities and Exchange Commission (SEC)
       issued SAB 101, "Revenue Recognition in Financial Statement", which
       summarizes certain of the SEC staff views in applying generally accepted
       accounting principles to revenue recognition in financial statements. The
       company adopted SAB 101 in these financial statements. Such adoption has
       no impact on the company's financial statement.

 p. UNAUDITED PRO FORMA BALANCE SHEET

    Upon the planned closing of the Company's anticipated initial public
    offering in May 2000, the outstanding shares of redeemable convertible
    preferred stock will automatically convert into common stock. The unaudited
    pro forma balance sheet reflects these transactions as if they occurred on
    March 31, 2000.

 q. DEFERRED INCOME TAXES

    Deferred income taxes are created for temporary differences between the
    assets and liabilities as measured in the financial statements and for tax
    purposes. Deferred taxes are computed using the tax rates expected to be in
    effect when these differences reverse. Valuation allowances in respect of
    deferred tax assets are provided when it is more likely than not that all or
    part of the deferred tax assets will not be realized.

 r. UNAUDITED INFORMATION

    The financial statements include the unaudited consolidated balance sheets
    and the related consolidated statements of operations, changes in
    stockholders' equity (capital deficiency) and cash flows for the three
    months ended March 31, 1999 and 2000. This unaudited information has been
    prepared by the Company on the same basis as the audited consolidated
    financial statements and, in management's opinion, reflects all adjustments
    (consisting only of normal recurring accruals) necessary for a fair
    presentation of the financial information, in accordance with generally
    accepted accounting principles, for the period presented. Results for
    interim periods are not necessarily indicative of the results to be excepted
    for the entire year.

                                      F-13
<PAGE>
                                 NOGATECH, INC.

             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 2--FIXED ASSETS:

    A.  Grouped by major classifications, fixed assets are composed as follows:

<TABLE>
<CAPTION>
                                                       DECEMBER 31,
                                                  -----------------------     MARCH 31,
                                                    1998           1999          2000
                                                  --------       --------   --------------
                                                      (IN THOUSANDS)        (IN THOUSANDS)
                                                                             (UNAUDITED)
<S>                                               <C>            <C>        <C>
Cost:
  Computers and software........................    $404           $647          $679
  Office furniture and equipment................      51             78            84
  Laboratory equipment..........................      40             45            45
  Leasehold improvements........................      40             41            41
  Motor vehicles................................      --             24            24
                                                    ----           ----          ----
                                                     535            835           873
                                                    ----           ----          ----
Less--accumulated depreciation and amortization:
  Computers and software........................     279            386           423
  Office furniture and equipment................      11             16            17
  Laboratory equipment..........................      36             38            39
  Leasehold improvements........................      29             40            40
  Motor vehicles................................      --              3             4
                                                    ----           ----          ----
                                                     355            483           523
                                                    ----           ----          ----
                                                    $180           $352          $350
                                                    ====           ====          ====
</TABLE>

    B.  Depreciation and amortization expenses related to fixed assets totaled
       $97,000, $91,000 and $128,000 for the years ended December 31, 1997, 1998
       and 1999, respectively and (unaudited) $ 23,000 and (unaudited) $ 40,000
       for the periods of three months ended March 31, 1999 and 2000,
       respectively.

NOTE 3--EMPLOYEE RIGHTS UPON RETIREMENT:

    A.  Israeli labor laws and agreements require payment of severance pay upon
       dismissal of an employee or upon termination of employment in certain
       other circumstances. Nogatech Israel's severance pay liability for its
       employees, which reflects the undiscounted amount of the liability, is
       calculated based upon length of service and the latest monthly salary
       (one month's salary for each year worked). This liability is mainly
       covered by the Company's insurance policies.

    B.  The balance sheet liability for Israeli employee rights upon retirement,
       and the amount funded with insurance companies, are composed as follows:

<TABLE>
<CAPTION>
                                                           DECEMBER 31,
                                                      -----------------------     MARCH 31,
                                                        1998           1999          2000
                                                      --------       --------   --------------
                                                          (IN THOUSANDS)        (IN THOUSANDS)
                                                                                 (UNAUDITED)
<S>                                                   <C>            <C>        <C>
  Severance pay liability...........................    $255           $362          $391
  Less--amount funded (presented in other assets)...     203            256           267
                                                        ----           ----          ----
  Unfunded balance..................................    $ 52           $106          $124
                                                        ====           ====          ====
</TABLE>

                                      F-14
<PAGE>
                                 NOGATECH, INC.

             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 4--COMMITMENTS AND CONTINGENT LIABILITIES:

    a.  LEASE COMMITMENTS

    1)  Rent:

       a)  The Company leases its U.S. facility under an operating lease
           agreement which expires in September 2002. The Israeli subsidiary's
           facility is leased under an operating lease which expires on February
           22, 2003, with an option to be extended until February 2008. Up to
           $67,000 of the Israeli facility rent is guaranteed by a financial
           institution. The guarantees expires on March 9, 2001 and March 10,
           2001.

       b)  Future minimum lease commitments under non-cancelable operating lease
           agreements are as follows (in thousands):

<TABLE>
<CAPTION>

<S>                                                           <C>
Nine months ending December 31, 2000 (unaudited)............     $117
Year ending December 31:
2001........................................................      158
2002........................................................      141
2003........................................................       24
                                                                 ----
                                                                 $440
                                                                 ====
</TABLE>

    2)  Car lease:

       a)  The Company has four vehicles which have been leased since 1999 and
           2000 under operating lease agreements for the periods ending in 2002
           and 2003.

       b)  Future minimum lease commitment under these agreements are as follows
           (in thousands):

<TABLE>
<CAPTION>

<S>                                                           <C>
Nine months ending December 31, 2000 (unaudited)............      $25
Year ending December 31:
2001........................................................       33
2002........................................................       31
2003........................................................        5
                                                                  ---
                                                                  $94
                                                                  ===
</TABLE>

    3)  Lease expenses totaled $91,000, $86,000 and $135,000 in the years ended
       December 31, 1997, 1998 and 1999, respectively, and (unaudited) $22,000
       and (unaudited) $39,000 in the periods of three months ended March 31,
       1999 and 2000, respectively.

    b.  ROYALTY COMMITMENTS

       The Company licensed technologies from three companies that are subject
       to a per unit royalty ranging from $0.50 to $3.00. The royalties are
       included in the cost of sales and amounted to $61,000, $40,000 and
       $43,000 in the years ended December 31, 1997, 1998 and 1999,
       respectively, and (unaudited) $10,000 and (unaudited) $5,000 in the
       periods of three months ended March 31, 1999 and 2000, respectively.

    c.  COMMISSION COMMITMENTS

       Nogatech Israel is committed to pay a consulting company a commission
       equal to 3.0% of the initial order of the net sales initiated by that
       consulting company and a commission of 1.5% to 2.5% for all subsequent
       orders.

       Nogatech Israel is also committed to pay a commission equal to 3.0% of
       orders of the net sales initiated by two other companies in sales to the
       Far East.

                                      F-15
<PAGE>
                                 NOGATECH, INC.

             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 4--COMMITMENTS AND CONTINGENT LIABILITIES: (CONTINUED)
       Commissions paid by the Company amounted to $81,000 in the year ended
       December 31, 1999 and amounted to (unaudited) $2,500 and (unaudited)
       $25,000 in the periods of three months ended March 31, 1999 and 2000,
       respectively.

    d.  LINE OF CREDIT

       The Company has obtained a line of credit from an Israeli financial
       institution for working capital purposes, in the amount of $2,000,000.
       Repayment terms and interest rates are determined at the time of each
       request for credit. The Company has pledged all of its assets as
       collateral for this credit line. As of March 31, 2000, the financial
       institution has provided the Company guarantees in a total amount of
       (unaudited) $456,000 in favor of rent facility, a supplier and customs
       authorities in Israel, which reduce the available amount of line of
       credit to zero.

NOTE 5--REDEEMABLE CONVERTIBLE PREFERRED STOCK:

    a.  Redeemable convertible preferred stock consists of the following:

<TABLE>
<CAPTION>
                                                                    DECEMBER 31,
                                                               -----------------------     MARCH 31,
                                                                 1998           1999          2000
                                                               --------       --------   --------------
                                                                   (IN THOUSANDS)        (IN THOUSANDS)
                                                                                          (UNAUDITED)
<S>                                                            <C>            <C>        <C>
Series A redeemable convertible preferred stock--$0.43
  redemption value plus an accrued amount (see note b(1)
  below): authorized 30,000,000 shares; issued and
  outstanding--15,906,304 shares at December 31, 1998 and
  1999 and at March 31, 2000 (at redemption value)..........    $7,816         $8,243       $ 8,408
Series B redeemable convertible preferred stock--$4.18
  redemption value: authorized at December 31, 1999 and
  March 31, 2000--1,196,172 shares; no shares issued and
  outstanding at December 31, 1999, 1,196,172 shares issued
  and outstanding at March 31, 2000.........................        --             --         5,000
                                                                ------         ------       -------
                                                                $7,816         $8,243       $13,408
                                                                ======         ======       =======
</TABLE>

       In addition, the Company has authorized 803,828 shares of undesignated
       convertible preferred stock.

    b.  Following are the main terms of the Company's redeemable convertible
       preferred stock:

       1)  Liquidation preference

           Holders of preferred stock are entitled to a liquidation preference
           of $0.43 and $4.18 for series A and B, respectively, per share plus
           an amount equal to 8% of such liquidation price, compounded annually,
           for each year (or fraction thereof) after the first two years from
           issuance of the stock, plus any declared but unpaid dividends. The
           terms of the preferred stock stipulate that certain events (such as a
           change in control) shall be considered as a deemed liquidation of the
           Company which entitle the holders to redeem the outstanding shares
           based on their liquidation amounts.


           The excess of the consideration received, net of issuance costs, from
           the issuance of the series A convertible preferred stock over its
           redemption value, is recorded as additional paid-in capital at the
           date of issuance. The annual accretion of the redemption value,
           computed using the interest method, is charged to accumulated
           deficit.


                                      F-16
<PAGE>
                                 NOGATECH, INC.

             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 5--REDEEMABLE CONVERTIBLE PREFERRED STOCK: (CONTINUED)
       2)  Voting rights

           As long as an aggregate amount of at least 4,000,000 shares of
           series A and series B preferred stock are outstanding, preferred
           stockholders are entitled to vote on all matters submitted or
           required to be submitted to a vote of the stockholders of the Company
           and shall be entitled to the number of votes equal to the number of
           full shares of common stock into which such shares of series A and
           series B preferred stock could be converted.

       3)  Election of Directors

           So long as at least 4,000,000 shares of series A preferred stock are
           outstanding, the authorized number of directors shall be nine and any
           change in the number shall be with the consent of the holders of a
           majority of the outstanding series A preferred stock. The holders of
           the outstanding shares of series A preferred stock, voting as a
           single class, are entitled to elect seven directors to the board of
           directors. The holders of the outstanding shares of common stock,
           voting as a single class, shall be entitled to elect two directors to
           the board of directors.

       4)  Right to convert

           At the option of the holder, each share of series A preferred stock
           is convertible, at any time after issuance, into common stock based
           on the determined conversion price subject to certain antidilution
           provisions. According to the determined conversion price, as of
           March 31, 2000, 5,765,003 shares of series A preferred stock are
           convertible on a basis of two shares of preferred stock for one share
           of common stock and 10,141,301 shares are convertible according to a
           ratio of 1.7707 share of preferred stock for one share of common
           stock.

           At the option of the holder, each share of series B preferred stock
           is convertible, at any time after issuance, into common stock, based
           on the determined conversion price subject to certain antidilution
           provisions. The determined conversion price of series B preferred
           stock will be equal to the quotient obtained by dividing $4.18 by the
           Series B conversion price in effect immediately prior to the time of
           such conversion. The "Series B Conversion Price" shall be equal to
           $8.36 through February 28, 2000. Thereafter, commencing on
           February 29, 2000 though May 31, 2000, the "Series B Conversion
           Price" shall be equal to $7.315. Thereafter, commencing on June 1,
           2000 through June 30, 2000, the Series B Conversion Price shall be
           equal to $6.897. Thereafter, commencing on July 1, 2000 through
           July 31, 2000, the "Series B Conversion Price" on any given date
           shall be equal to the result obtained by dividing (i) 100,000,000
           less the result of multiplying 163,398.69 by the number of days after
           February 29, 2000 on which such measurement date occurs, by
           (ii) 23,915,417, subject to certain antidilution adjustments.
           Commencing on August 1, 2000, the "Series B Conversion Price" shall
           be $6.28.

           The series A and B preferred stock will be automatically converted
           into common stock concurrently with the closing of an underwritten
           public offering of common stock resulting in aggregate gross cash
           proceeds from the issuance in excess of $10,000,000.

                                      F-17
<PAGE>
                                 NOGATECH, INC.

             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 5--REDEEMABLE CONVERTIBLE PREFERRED STOCK: (CONTINUED)
       5)  Dividends

           When and if declared by the board of directors, noncumulative
           dividends at the annual rate of $0.0258 per share of series A
           preferred stock and $0.1039 per share of series B preferred stock are
           payable in cash to the preferred stockholders, in preference to any
           declaration or payment on the common stock.


    c.  On January 13, 2000, the Company issued 1,196,172 shares of series B
       redeemable convertible preferred stock to a financial investor for a
       total consideration of (unaudited) $5,000,000. These shares of preferred
       stock are convertible into common stock as described in note b(4) above.
       In connection with this issuance, the Company recorded a beneficial
       conversion charge of (unaudited) $4,570,000 in the three months ended
       March 31, 2000. This charge is calculated as the difference between the
       per share conversion price of $7.315 and the deemed fair value of a share
       of common stock at commitment date (the mid-range of the expected initial
       public offering price of $14.00 per share of common stock) multiplied by
       the applicable number of equivalent shares of common stock (683,527
       shares). This nonrecurring amount has been entirely reflected as a
       decrease of the net income applicable to common stock, against a
       corresponding credit to additional paid-in capital.


                                      F-18
<PAGE>
                                 NOGATECH, INC.

             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 5--REDEEMABLE CONVERTIBLE PREFERRED STOCK: (CONTINUED)

    D.  Details regarding issuances of Series A and Series B redeemable
convertible preferred stock:



<TABLE>
<CAPTION>
                                           NUMBER                           AMOUNT
                                         ----------   ---------------------------------------------------
                                                      CLASSIFIED AS
                                                       REDEEMABLE
                                                        PREFERRED
                                                        STOCK--AT     CLASSIFIED   CHARGED TO
                                                       REDEMPTION     AS PAID-IN   ACCUMULATED
                                                          VALUE        CAPITAL       DEFICIT      TOTAL
                                                      -------------   ----------   -----------   --------
                                                                        (IN THOUSANDS)
<S>                                      <C>          <C>             <C>          <C>           <C>
1. SERIES A REDEEMABLE CONVERTIBLE
  PREFERRED STOCK:
  Balance at January 1, 1997...........   8,962,959       $4,147            634         (293)    $ 4,488
  Preferred shares issued on February
    4, 1997............................     859,871          370           *936                    1,306
  Preferred shares issued on August 17,
    1997...............................     318,471          137           *347                      484
  Accretion of redemption value for
    1997...............................                      300                        (300)         --
                                         ----------       ------        -------      -------     -------
  Balance as of December 31, 1997......  10,141,301        4,954          1,917         (593)      6,278
  Preferred shares issued on July 15,
    1998...............................   5,765,003        2,479         *3,162                    5,641
  Accretion of redemption value for
    1998...............................                      383                        (383)         --
                                         ----------       ------        -------      -------     -------
  Balance as of December 31, 1998......  15,906,304        7,816          5,079         (976)     11,919
  Accretion of redemption value for
    1999...............................                      427                        (427)         --
                                         ----------       ------        -------      -------     -------
  Balance as of December 31, 1999......  15,906,304        8,243          5,079       (1,403)     11,919
  Accretion of redemption value for the
    three months ended March 31, 2000
    (unaudited)........................                      165                        (165)         --
                                         ----------       ------        -------      -------     -------
  Balance of Series A redeemable
    convertible preferred stock as of
    March 31, 2000 (unaudited).........  15,906,304        8,408          5,079       (1,568)     11,919
                                         ==========       ======        =======      =======     =======
2. SERIES B REDEEMABLE CONVERTIBLE
  PREFERRED STOCK--
  Preferred shares issued on
    January 13, 2000...................   1,196,172        5,000         **(302)          --       4,698
  Charge for beneficial conversion
    feature............................          --           --          4,570       (4,570)         --
                                         ----------       ------        -------      -------     -------
  Balance of Series B redeemable
    convertible preferred stock as of
    March 31, 2000 (unaudited).........   1,196,172        5,000          4,268       (4,570)      4,698
                                         ==========       ======        =======      =======     =======
  TOTAL BALANCE OF REDEEMABLE
    CONVERTIBLE PREFERRED STOCK AS OF
    MARCH 31, 2000 (unaudited).........                   13,408          9,347       (6,138)     16,617
                                                          ======        =======      =======     =======
</TABLE>


- ------------------------


*   Net of issuance costs of $60,000 in 1997 and $355,000 in 1998.



**  Reflects issuance costs.


                                      F-19
<PAGE>
                                 NOGATECH, INC.

             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 6--STOCKHOLDERS' EQUITY

    a.  REVERSE STOCK SPLIT

       On March 5, 2000, the Company's Board of Directors approved a
       reorganization of the Company's share capital, whereby each two shares of
       common stock of $0.001 par value will be reverse stock split into one
       share of common stock of $0.001 par value. All share and per share data
       included in these financial statements have been retroactively adjusted
       to reflect the abovementioned reverse stock split. In addition, the
       conversion ratio of the convertible preferred stock, the number of
       options and their exercise price have been adjusted accordingly.

    b.  INITIAL PUBLIC OFFERING

       On March 5, 2000, the Company's Board of Directors authorized the Company
       to file a registration statement with the U.S. Securities and Exchange
       Commission for an initial public offering of its common shares.

    c.  EMPLOYEE STOCK OPTION PLANS

       1)  Previous stock option plans:

           a)  U.S. 1993 Stock Option Plan

               In February 1993, the Company's Board of Directors approved a
               U.S. stock option plan (the U.S. plan), under which options are
               to be granted to the Company's employees including officers,
               directors and consultants, without consideration. Each option can
               be exercised to purchase one common share of the Company. Any
               option not exercised within 4 or 5 years, as applicable, from
               allotment date will expire, unless extended by the Board of
               Directors.

                                      F-20
<PAGE>
                                 NOGATECH, INC.

             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 6--STOCKHOLDERS' EQUITY (CONTINUED)

               Options granted under the plan may be either incentive stock
               options or nonstatutory stock options and may become exercisable
               as specified in each option agreement.

               Options granted to a holder of more that 10% of the voting stock
               of the Company may be granted at not less than 110% of fair value
               of the common share on the date of grant. Incentive stock options
               granted to employees under the U.S. plan must have exercise
               prices not less than 100% of fair value of the common share on
               the date of the grant, as determined by the Board of Directors.

           b)  Israeli 1993 Stock Option Plan

               In July 1993, the Company's Board of Directors approved an
               Israeli employee option plan (the Israeli plan), under which
               options are to be granted to the Company's employees including
               officers, directors and consultants without consideration. Each
               option can be exercised to purchase one common share of the
               Company. Any option not exercised within 7 years from allotment
               date will expire, unless extended by the Board of Directors.

           c)  Options granted to consultants under these plans were excluded
               from the summary presented in the tables 4 and 5 below and were
               treated as options granted to nonemployees, see note 6(d) below.

       2)  Existing stock option plan--1999 stock option plan

           On December 8, 1999, in connection with the merger (note 1a(1)), the
           Company adopted the 1999 stock option plan. All issued and
           outstanding options under the 1993 plans were assumed under the 1999
           stock option plan. In addition, the Company has the right to issue
           new options pursuant to the 1999 plan. The terms of the new options
           issued under the 1999 plan are identical to the terms of the options
           granted under the 1993 plans.

       3)  The 2000 Equity Incentive Plan

           On March 5, 2000, the Board of Directors adopted the 2000 Equity
           Incentive Plan, under which the Company's employees, directors and
           consultants are eligible to receive grants of options to purchase
           common stock, stock appreciation rights and restricted shares of
           common stock. It was further resolved to reserve for issuance under
           the plan a maximum amount of 3,500,000 shares plus automatic annual
           increases equal to the lesser of 500,000 shares or 5% of the
           Company's outstanding shares on the last day of the preceding year.
           This plan will become effective after the consummation of the
           Company's initial public offering.

           The rights of the common stock obtained upon exercise of the options
           will be identical to those of the other shares of common stock of the
           Company.

                                      F-21
<PAGE>
                                 NOGATECH, INC.

             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 6--STOCKHOLDERS' EQUITY (CONTINUED)
       4)  A summary of the status of the 1999 stock option plan as of
           December 31, 1997, 1998, 1999, and as of (unaudited) March 31, 2000
           and changes during the periods of three months ended on those dates,
           is presented below:

<TABLE>
<CAPTION>
                                                   YEAR ENDED DECEMBER 31,
                              -----------------------------------------------------------------    THREE MONTHS ENDED
                                     1997                   1998                   1999              MARCH 31, 2000
                              -------------------   --------------------   --------------------   --------------------
                                         WEIGHTED               WEIGHTED               WEIGHTED               WEIGHTED
                                         AVERAGE                AVERAGE                AVERAGE                AVERAGE
                                         EXERCISE               EXERCISE               EXERCISE               EXERCISE
                               NUMBER     PRICE      NUMBER      PRICE      NUMBER      PRICE      NUMBER      PRICE
                              --------   --------   ---------   --------   ---------   --------   ---------   --------
                                                                                                      (UNAUDITED)
<S>                           <C>        <C>        <C>         <C>        <C>         <C>        <C>         <C>
Options outstanding at
  beginning of period......   772,720     $0.24       734,470    $0.28     1,248,470    $0.26     1,531,220    $ 0.94
Changes during the period:
  Granted..................    51,750     $0.72       549,000    $0.24       431,000    $2.78        21,000    $11.33
  Exercised................   (18,120)    $0.14        (6,250)   $0.12      (100,875)   $0.34      (187,206)   $ 1.35
  Forfeited................   (71,880)    $0.30       (28,750)   $0.64       (47,375)   $0.72       (13,500)   $ 5.22
                              -------               ---------              ---------              ---------

Options outstanding at
  period end...............   734,470     $0.28     1,248,470    $0.26     1,531,220    $0.94     1,351,514    $ 1.08
                              =======               =========              =========              =========

Options exercisable at
  period end...............   556,014     $0.26       791,146    $0.28       948,261    $0.72       775,994    $ 0.56
                              =======               =========              =========              =========

Options available for grant
  under the stock option
  plan.....................   473,823                 953,572              3,011,787              3,004,287
                              =======               =========              =========              =========

Weighted average fair value
  of options granted during
  the period*..............               $0.27                  $0.58                  $1.34                  $ 7.33
</TABLE>

- --------------------------

*   The fair value of each option granted is estimated on the date of grant
    using the Black-Scholes option-pricing model, based on the following
    weighted average assumptions: dividend yield of 0% for all periods; expected
    volatility of 55% for all periods; risk-free interest rates (in dollar
    terms): 1997 - 6.1%; 1998 - 5.4%; 1999 - 5.7% and 2000 - 6%; and expected
    lives of 4 years in all periods.

                                      F-22
<PAGE>
                                 NOGATECH, INC.

             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 6--STOCKHOLDERS' EQUITY (CONTINUED)
       5)  The following table summarizes information about options outstanding
           at March 31. 2000 (unaudited):

<TABLE>
<CAPTION>
                  OPTIONS OUTSTANDING                         OPTIONS EXERCISABLE
- -------------------------------------------------------   ----------------------------
                               WEIGHTED
                                AVERAGE
                               REMAINING     WEIGHTED
                              CONTRACTUAL     AVERAGE                      WEIGHTED
   RANGE OF       NUMBER         LIFE        EXERCISE       NUMBER         AVERAGE
EXERCISE PRICE  OF OPTIONS     IN YEARS        PRICE      OF OPTIONS    EXERCISE PRICE
- --------------  -----------   -----------   -----------   -----------   --------------
<S>             <C>           <C>           <C>           <C>           <C>
 $0.02-$0.20        759,765           2.6   $      0.08       502,931    $      0.12
    $0.72           297,250           3.4   $      0.72       195,563    $      0.72
    $3.00           279,500           5.3   $      3.00        77,500    $      3.00
    $8.00             5,000           6.8   $      8.00
    $15.00           10,000           2.0   $     15.00
                -----------                               -----------
                  1,351,515                 $      1.08       775,994    $      0.56
                ===========                               ===========
</TABLE>

       6)  Options to employees were granted at exercise prices which were equal
           to the fair value of the common stock at dates of grant, except for
           381,500 options granted in July 1998, to the Company's Chairman of
           the Board of Directors and to its Chief Executive Officer and except
           for 40,000 options granted to employees in December 1999 and 5,000
           options granted to employees in February 2000 which were granted at
           exercise prices lower than the fair value of each share of common
           stock at dates of grant. The options granted in 1998 were issued at
           an exercise price of $0.02 for each share of common stock, while the
           fair value of each share of common stock was $0.72. The fair value of
           each of these options granted was $0.71. These options will vest over
           a period of three years but shall vest immediately upon the
           consummation of an initial public offering or upon the occurrence of
           a corporate sale, as defined in the agreement. These options will
           expire if not exercised after a certain period. The 40,000 options
           granted in 1999 were issued at an exercise price of $3.00 for each
           share of common stock, while the fair value of each share of common
           stock at the dates of grant, was $8.30. The fair value of each of
           these options granted was $5.91. The 5,000 options granted in
           February 2000 were issued at an exercise price of $8.00 for each
           share of common stock, while the fair value of each share of common
           stock at the date of grant, was $14.00. The fair value of each of
           these options granted was $6.00.

       7)  Accounting treatment of the employee stock option plans

           As to the accounting treatment with respect to employee stock option
           grants, see note 1(l).

           In 1998, 1999 and in the three months ended March 31, 2000, the
           Company recorded $268,000, $214,000 and (unaudited) $35,000,
           respectively, of deferred stock compensation for the excess of the
           deemed fair value of a share of common stock over the exercise price
           at the date of grant related to certain options granted to employees
           and directors. The compensation expense is being amortized over the
           vesting period of the options. The compensation costs that have been
           charged to the statements of operations, under "general and
           administrative expenses", in the years ended December 31, 1998 and
           1999

                                      F-23
<PAGE>
                                 NOGATECH, INC.

             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 6--STOCKHOLDERS' EQUITY (CONTINUED)
           and in the period of three months ended March 31, 2000 are $45,000,
           $90,000 and (unaudited) $32,000, respectively.

       8)  Pro forma disclosure

           Had compensation cost for the Company's plans been determined using
           the fair value at the grant dates, consistent with the method of
           FAS 123, the Company's net loss and loss per share of common stock
           would have been increased to the pro forma amounts indicated below:

<TABLE>
<CAPTION>
                                                                                              THREE MONTHS          THREE MONTHS
                                                                                             ENDED MARCH 31,       ENDED MARCH 31,
                                             YEAR ENDED DECEMBER 31,                              1999                  2000
                         ---------------------------------------------------------------   -------------------   -------------------
                                1997                  1998                  1999                UNAUDITED             UNAUDITED
                         -------------------   -------------------   -------------------   -------------------   -------------------
                            AS        PRO         AS        PRO         AS        PRO         AS        PRO         AS        PRO
                         REPORTED    FORMA     REPORTED    FORMA     REPORTED    FORMA     REPORTED    FORMA     REPORTED    FORMA
                         --------   --------   --------   --------   --------   --------   --------   --------   --------   --------
<S>                      <C>        <C>        <C>        <C>        <C>        <C>        <C>        <C>        <C>        <C>
Net loss applicable to
  common stock--in
  thousands............  $(1,762)   $(1,766)   $(2,206)   $(2,225)   $(1,523)   $(1,668)      (929)      (987)    (5,072)    (5,093)
                         =======    =======    =======    =======    =======    =======    =======    =======    =======    =======
Net loss per share of
  common stock--Basic
  and diluted..........  $ (5.86)   $ (5.87)   $ (7.13)   $ (7.19)   $ (4.50)   $ (4.93)     (2.97)     (3.17)     (8.89)     (8.93)
                         =======    =======    =======    =======    =======    =======    =======    =======    =======    =======
</TABLE>

    d.  WARRANTS AND OPTIONS TO NONEMPLOYEES

       1)  In 1998, in order to obtain a credit line, the Company granted a bank
           options to purchase 240,208 shares of common stock at an exercise
           price of $2.08 per share. These options are exercisable during a
           period of three years. According to the agreement, the options will
           expire after a certain period, if not exercised. The Company recorded
           deferred compensation of $37,000 associated with these options based
           on the fair value of these options at the date of grant.

       2)  In December 1998, the Board of Directors granted 75,000 options to a
           consulting company in exchange for marketing services rendered. The
           options which were vested in January 1999 and are exercisable for
           75,000 shares of common stock at an exercise price of $0.72 per
           share. The Company recorded deferred compensation of $16,000
           associated with these options based on the fair value of these
           options at the date of grant.

       3)  In connection with the change of ownership in the Company in 1995,
           the Board of Directors granted 350,000 options to the Company's
           current Chairman of the Board of Directors who did not have an active
           role in the Company at the date of grant. The optionee paid $5,000
           for this right. Each option can be exercised to purchase one share of
           common stock of the Company at an exercise price of $0.125 per share.
           The options expire in June 2000. An expense of $10,000 associated
           with these options, reflecting the

                                      F-24
<PAGE>
                                 NOGATECH, INC.

             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 6--STOCKHOLDERS' EQUITY (CONTINUED)
           fair value of the option at date of grant, net of the amount paid for
           the option, was charged in the statement of operations for the year
           ended December 31, 1995.

        4)  a)  In October 1995, the Company issued 7,500 common stock options
                to a consultant at an exercise price of $0.125 per share. These
                options were exercised in 1999.

           b)  In January 1996, the Company issued 10,000 common stock options
               to a consultant at an exercise price of $0.14 per share. These
               options were exercised in January 2000.

           c)  In August 1999, the Company issued 20,000 common stock options to
               four consultants at an exercise price of $3.00 per share. Two
               consultants' options vest ratably over a period of four years and
               the options issued to the other consultants are fully vested. The
               total deferred expense of $22,000 associated with these options
               reflects the fair value of the options at dates of grant.

       5)  Accounting treatment of options granted to nonemployees.

           As to the accounting treatment with respect to options granted to
           nonemployees, see Note 1(l).

           The fair value of equity instruments issued in exchange for services
           received is charged against income over the vesting period.

           The following weighted average assumptions were used for estimating
           the fair value of the options under Black-Scholes option pricing
           model: dividend yield of 0%; and expected volatility of 55% for the
           years 1998 and 1999, risk free interest of 5.4% and 5.7% for the
           years 1998 and 1999 respectively and average expected life of
           4 years for the years 1998 and 1999.

           Services costs charged against income in respect of equity
           instruments granted to nonemployees were $5,000 and $25,000 in the
           years ended December 31, 1998 and 1999, respectively, and (unaudited)
           $6,000 and (unaudited) $12,000 in the three month periods ended
           March 31, 1999 and 2000, respectively. These costs have been included
           in the consolidated statements of operations under "general and
           administrative expenses" (except for $16,000 charged to "sales and
           marketing expenses" in the year ended December 31, 1999 and
           (unaudited) $4,000 for the three months ended March 31, 1999).

    e.  WARRANTS ISSUED TO SERIES A REDEEMABLE CONVERTIBLE PREFERRED
       STOCKHOLDERS

       1)  In 1997, in connection with the issuance of series A redeemable
           convertible preferred stock, the Company issued to the buyers of
           those shares options to purchase up to 589,171 shares of common stock
           at an exercise price of $3.14 per share. 318,471 of these options
           expired in 1999, 111,464 options were exercised in January 2000 and
           159,236 options will expire in August 2000.

       2)  In 1998, in connection with the issuance of series A redeemable
           convertible preferred stock, the Company granted the buyers of those
           shares options to purchase 432,375 shares of common stock at an
           exercise price of $2.08 per share. These options expire in
           July 2000.

                                      F-25
<PAGE>
                                 NOGATECH, INC.

             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 6--STOCKHOLDERS' EQUITY (CONTINUED)
       3)  According to the applicable agreements, the options described in 1
           and 2 above will expire after a certain agreed period if not
           exercised.

    f.  EMPLOYEE STOCK PURCHASE PLAN

       On March 5, 2000, the Board of Directors adopted the 2000 Employee Stock
       Purchase Plan which permits eligible employees to purchase shares of the
       Company's common stock pursuant to payroll deductions periodically
       applied to the purchase of such shares. A total of 350,000 shares of
       common stock initially have been reserved for issuance under the Purchase
       Plan. The number of shares reserved for issuance will be increased
       automatically on the first day of the Company's fiscal year, commencing
       in 2001, by an amount equal to the lesser of 500,000 shares or 1% of the
       number of outstanding shares on the last trading day of the immediately
       preceeding fiscal year.

    g.  COMMON STOCK RESERVED

       As at March 31, 2000 (unaudited), the Company has reserved shares of
       common stock for future issuance, as follows:

<TABLE>
<CAPTION>
                                                               NUMBER OF
                                                                SHARES
                                                              -----------
                                                              (UNAUDITED)
<S>                                                           <C>
Conversion of series A and B redeemable convertible
  preferred stock...........................................   9,293,310
Employee stock option plans.................................   7,855,801
Warrants and options to nonemployees........................   1,276,818
Employee stock purchase plan................................     350,000
                                                              ----------
                                                              18,775,929
                                                              ==========
</TABLE>

    h.  On March 8, 2000, the note receivable from a stockholder was repaid to
       the Company, including the interest accrued at the annual rate of 5.5%.

NOTE 7--INCOME TAXES:

    A. U.S. INCOME TAXES

    As of March 31, 2000, the Company had federal and state net operating loss
    carryforwards of approximately (unaudited) $5,160,000 and (unaudited)
    $1,673,000, respectively, which expire through 2019 and 2004, respectively.

    As of December 31, 1999, the Company had federal and state net operating
    loss carryforwards of approximately $5,200,000 and $1,700,000, respectively,
    which expire through 2019 and 2004, respectively.

    Utilization of the net operating loss carryforwards may be subject to a
    substantial annual limitation due to the ownership change limitations
    provided by the Internal Revenue Code of 1986, as amended, and similar state
    provisions. The annual limitation may result in the expiration of net
    operating loss carryforwards before utilization.

                                      F-26
<PAGE>
                                 NOGATECH, INC.

             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 7--INCOME TAXES: (CONTINUED)
    b. ISRAELI INCOME TAXES

    Nogatech Israel has been awarded "approved enterprise" status by the Israeli
    government, under the Law for the Encouragement of Capital Investments,
    1959. Under the approved enterprise status, Nogatech Israel is entitled to a
    four-year tax exemption on undistributed earnings commencing in the year in
    which it attains taxable income and a reduced corporate tax rate of 10%-15%
    for the remaining term of the program on the plan's proportionate share of
    income. The period of tax benefits has not yet commenced. In the event of
    the distribution of dividends from income which was tax exempt, the amount
    distributed will be liable to corporate tax of 10%-15%.

    The entitlement to the above benefits is conditional upon the fulfillment of
    conditions stipulated by the law, regulations published thereunder and the
    instrument of approval for the specific investment in approved enterprises.
    In the event of failure to comply with these conditions, the benefits may be
    cancelled and Nogatech Israel may be required to refund the amounts of the
    benefits in whole or in part with the addition of linkage differences and
    interest.

    Nogatech Israel's results for tax purposes are measured on a real basis,
    adjusted for the increase in the Israeli Consumer Price Index (CPI). As
    explained in note 1b, the financial statements of the Israeli subsidiary
    included in consolidation are expressed in U.S. dollars. The difference
    between the changes in the Israeli CPI and the NIS/U.S. dollar exchange
    rate--both on annual and cumulative basis--causes a difference between
    taxable income (loss) and income (loss) reflected in Nogatech Israel's
    financial statements expressed in dollars.

    Israeli taxable income not eligible for "approved enterprise" benefits
    mentioned above is taxed at the regular tax rate of 36%.


    As of December 31, 1999 and as of March 31, 2000, Nogatech Israel has
    Israeli net operating loss carryforwards of approximately $2,300,000 and
    (unaudited) $2,000,000, respectively. The Israeli loss carryforwards have no
    expiration date. The Company expects that during the period these tax losses
    are utilized, most of its income would be tax exempt, and therefore, the
    utilization of the net operating losses will generate no tax benefit.
    Accordingly, deferred tax assets from such losses have not been included in
    the financial statements.


    c. DEFERRED INCOME TAXES

    Deferred income taxes reflect the net tax effects of temporary differences
    between the carrying amounts of assets and liabilities for financial
    reporting purposes and the amounts used for income tax purposes. Significant
    components of the Company's deferred tax assets are as follows:

<TABLE>
<CAPTION>
                                                   DECEMBER 31,        MARCH 31,
                                                -------------------   -----------
                                                  1998       1999        2000
                                                --------   --------   -----------
                                                  (IN THOUSANDS)          (IN
                                                                      THOUSANDS)
                                                                       UNAUDITED
<S>                                             <C>        <C>        <C>
In respect of the U.S. operating loss
  carryforwards...............................  $ 1,500    $ 2,000      $2,000
Valuation allowance...........................   (1,500)    (2,000)     (2,000)
                                                -------    -------      ------
Net deferred tax assets.......................  $    --    $    --      $   --
                                                =======    =======      ======
</TABLE>

                                      F-27
<PAGE>
                                 NOGATECH, INC.

             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 7--INCOME TAXES: (CONTINUED)
    The valuation allowance increased by $400,000, $300,000, $500,000 and
    (unaudited) $0 for the years ended December 31 1997, 1998, 1999 and for the
    three months ended March 31, 2000, respectively. These changes in the
    valuation allowance were charged to expenses.

    FAS 109 provides for the recognition of deferred tax assets if realization
    of such assets is more likely than not. Based upon the weight of available
    evidence, which includes the Company's historical operating performance and
    the reported cumulative net losses in all prior years, management has
    determined that the future realization of the tax benefit is not
    sufficiently assured. Consequently, a full valuation allowance has been
    provided against the net deferred tax assets.


    d. NET LOSS APPLICABLE TO THE ISRAELI AND THE U.S. OPERATIONS.



<TABLE>
<CAPTION>
                                                                               THREE MONTHS
                                                                                   ENDED
                                              YEAR ENDED DECEMBER 31,            MARCH 31,
                                             1997       1998       1999       1999       2000
                                           --------   --------   --------   --------   --------
                                                                                (UNAUDITED)
                                                               IN THOUSANDS
                                           ----------------------------------------------------
<S>                                        <C>        <C>        <C>        <C>        <C>
Net loss (income) applicable to:
  Israeli operations.....................   1,006      1,000      1,805      1,166         30
  U.S. operations........................     400        433       (264)      (188)      (123)
  Eliminations...........................      56        390       (445)      (161)        --
                                            -----      -----      -----      -----      -----
                                            1,462      1,823      1,097        817         93
</TABLE>


    e. ISRAELI TAX ASSESSMENTS

    Nogatech Israel has had no final tax assessments since its incorporation in
    1993.

NOTE 8--RELATED PARTY TRANSACTIONS

    Kenwood Corporation ("Kenwood") is a stockholder in the Company. During
    1997, Kenwood subleased premises from the Company for a specific period of
    time. Rental income earned by the Company from this sublease was $75,000 for
    1997 and at December 31, 1997, Kenwood owed the Company $75,000 pertaining
    to this sublease.

    Tomen Electronics ("Tomen") is a stockholder in the Company. Sales made to
    Tomen were $439,000, $1,324,000 and $1,272,000 in 1997, 1998 and 1999,
    respectively, and (unaudited) $152,000 and (unaudited) $242,000 in the three
    month periods ended March 31, 1999 and 2000, respectively. As of
    December 31, 1998 and 1999, Tomen owed the Company $35,000 and $68,000,
    respectively and $11,000 in the three months ended March 31, 2000. The
    Company purchases certain products from Tomen. Purchases from Tomen
    aggregated $194,000 and $151,000 in 1998 and 1999, respectively and
    (unaudited) $60,000 in the three months ended March 31, 1999. As of
    December 31, 1998 and 1999, the Company owed Tomen $32,000 and $60,000,
    respectively, pertaining to these purchases. Additionally, during 1997, the
    Company entered into an engineering agreement with Tomen, whereunder the
    Company will receive four payments of $50,000 upon the achievement of
    certain milestones, as agreed. The Company recognized $100,000 of revenue
    under this agreement for the year ended December 31, 1997. In 1998, the
    engineering agreement was canceled and it was agreed between the companies
    that there would be no further obligations.

                                      F-28
<PAGE>
                                 NOGATECH, INC.

             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 9--SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION:

    BALANCE SHEETS:

    a. ACCOUNTS RECEIVABLE

<TABLE>
<CAPTION>
                                                                  DECEMBER 31,
                                                               -------------------     MARCH 31,
                                                                 1998       1999          2000
                                                               --------   --------   --------------
                                                                 (IN THOUSANDS)      (IN THOUSANDS)
                                                                                      (UNAUDITED)
   <S>                                                         <C>        <C>        <C>
   1) Trade:
       Open accounts.........................................    $813      $  951        $1,484
       Related party (note 8)................................      35          68
                                                                 ----      ------        ------
                                                                 $848      $1,019        $1,484
                                                                 ====      ======        ======
     The item is net of--
       Allowance for doubtful accounts.......................    $(24)     $ (150)       $ (175)
                                                                 ====      ======        ======
</TABLE>

       The change in the allowance for doubtful accounts in the year ended
       December 31, 1997 was a decrease of expenses of $23,000. The changes in
       the allowance in the years ended December 31, 1998 and 1999 increased the
       expenses by $20,000 and $126,000, respectively. The change in the
       allowance for doubtful accounts in the three months ended March 31, 1999
       was a decrease of expenses of (unaudited) $4,000. The change in the
       allowance in the three months ended March 31, 2000 increased the expense
       by (unaudited) $25,000.

<TABLE>
<CAPTION>
                                                                  DECEMBER 31,
                                                               -------------------     MARCH 31,
                                                                 1998       1999          2000
                                                               --------   --------   --------------
                                                                 (IN THOUSANDS)      (IN THOUSANDS)
                                                                                      (UNAUDITED)
   <S>                                                         <C>        <C>        <C>
   2) Other:
       Employees.............................................    $ 65      $   89        $  127
       Institutions..........................................      36          82            77
       Other receivables.....................................      39          26             9
                                                                 ----      ------        ------
                                                                 $140      $  197        $  213
                                                                 ====      ======        ======
   B. INVENTORIES
       Raw materials.........................................    $413      $  843        $  791
       Finished goods........................................     168       1,266           956
                                                                 ----      ------        ------
                                                                 $581      $2,109        $1,747
                                                                 ====      ======        ======
   C. ACCOUNTS PAYABLE AND ACCRUALS
   1) Trade:
       Open accounts.........................................    $476      $1,907        $  830
       Related party (note 8)................................      32          60
                                                                 ----      ------        ------
                                                                 $508      $1,967        $  830
                                                                 ====      ======        ======
   2) Other and accruals:
       Payroll and related expenses..........................    $149      $   90        $  125
       Provision for vacation................................      95         127           140
       Deferred income.......................................     321          56            16
       Provision for warranty................................      65         177           219
       Distributors..........................................      11         244           252
       Accrued expenses......................................      66         197           124
                                                                 ----      ------        ------
                                                                 $707      $  891        $  876
                                                                 ====      ======        ======
</TABLE>

                                      F-29
<PAGE>
                                 NOGATECH, INC.

             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 9--SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION: (CONTINUED)

    STATEMENTS OF OPERATIONS:

    D. NET LOSS PER SHARE OF COMMON STOCK

    The following table sets forth the computation of historical basic and
    diluted net loss per share of common stock:

<TABLE>
<CAPTION>
                                                                              THREE MONTHS ENDED
                                           YEAR ENDED DECEMBER 31,                 MARCH 31,
                                     ------------------------------------   -----------------------
                                        1997         1998         1999         1999         2000
                                     ----------   ----------   ----------   ----------   ----------
                                                                                  (UNAUDITED)
<S>                                  <C>          <C>          <C>          <C>          <C>
NUMERATOR--IN THOUSANDS:
  Net loss applicable to common
    stock--numerator for basic net
    loss per share of common
    stock..........................  $   (1,762)  $   (2,206)  $   (1,523)        (924)      (4,642)
  Deemed dividend for beneficial
    conversion feature of preferred
    stock..........................          --           --           --           --        4,570
  Accretion of redemption value of
    series A and B redeemable
    convertible preferred stock....         300          383          427          107          165
                                     ----------   ----------   ----------   ----------   ----------
  Numerator for diluted net income
    (loss) per share of common
    stock..........................  $   (1,462)  $   (1,823)  $   (1,096)        (817)          93
                                     ==========   ==========   ==========   ==========   ==========

DENOMINATOR
  Denominator for basic net loss
    per share of common
    stock--weighted average number
    of shares of common stock......     300,709      309,536      338,295      310,995      570,557
  Incremental shares from assumed
    conversions:...................
    Series A and B redeemable
      convertible preferred
      stock........................   5,568,334    7,048,428    8,609,783    8,609,783    9,179,388
    Stock options..................   2,638,257    3,879,996    2,058,358    3,206,664    1,977,721
                                     ----------   ----------   ----------   ----------   ----------
  Denominator for diluted net loss
    per share of common stock--
    adjusted weighted average
    number of shares...............   8,507,300   11,237,960   11,006,436   12,127,442   11,727,666
                                     ==========   ==========   ==========   ==========   ==========
</TABLE>

    The effect of the inclusion of the redeemable convertible preferred stock
    and stock options in the computation of the diluted net loss per share of
    common stock in 1997, 1998 and 1999 is anti-dilutive.

NOTE 10--FAIR VALUE OF FINANCIAL INSTRUMENTS

    The financial instruments of the Company consist of non-derivative current
    assets and liabilities.

                                      F-30
<PAGE>
                                 NOGATECH, INC.

             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 10--FAIR VALUE OF FINANCIAL INSTRUMENTS (CONTINUED)
    In view of their nature, the fair value of financial instruments included in
    working capital of the Company is usually identical or close to their
    carrying value.

NOTE 11--SEGMENT INFORMATION

    The Company adopted the provisions of FAS 131 which sets out disclosure and
    reporting requirements in respect of segments.

    Management identifies two reportable operating segments that are
    differentiated by the locations of the Company's customers: (1) the United
    States and (2) the rest of the world. The Company evaluates performance of
    these two operating segments based on sales only. The Company does not
    evaluate performance based on segment asset information.

    SEGMENT SALES--SALES CLASSIFIED BY GEOGRAPHIC AREA (BASED ON THE LOCATION OF
    THE CUSTOMERS):

<TABLE>
<CAPTION>
                                                                            THREE MONTHS
                                                                                ENDED
                                           YEAR ENDED DECEMBER 31,            MARCH 31,
                                        ------------------------------   -------------------
                                          1997       1998       1999       1999       2000
                                        --------   --------   --------   --------   --------
                                                (IN THOUSANDS)             (IN THOUSANDS)
                                                                             (UNAUDITED)
<S>                                     <C>        <C>        <C>        <C>        <C>
United States--North America..........   $1,230     $1,373     $5,436      $509      $1,462
                                         ------     ------     ------      ----      ------

The rest of the world:
  Japan...............................      836      1,341      1,314       152         282
  Taiwan..............................       93         59       1440       148         495
  Europe..............................      335        356        617        44         347
  Other...............................       57         76         49        17         359
                                         ------     ------     ------      ----      ------
                                          1,321      1,832      3,420       361       1,483
                                         ------     ------     ------      ----      ------
Total.................................   $2,551     $3,205     $8,856      $870      $2,945
                                         ======     ======     ======      ====      ======
</TABLE>

    COMPANY-WIDE DISCLOSURE REGARDING ITS TOTAL ASSETS, LONG-LIVED ASSETS AND
    MAJOR CUSTOMERS:

    A. TOTAL ASSETS AND LONG-LIVED ASSETS

       The Company's total assets and long-lived assets, net of accumulated
       depreciation and amortization, are located in the following geographical
       areas:


<TABLE>
<CAPTION>
                                              DECEMBER 31,                          MARCH 31,
                              ---------------------------------------------   ---------------------
                                      1998                    1999                    2000
                              ---------------------   ---------------------   ---------------------
                               TOTAL     LONG-LIVED    TOTAL     LONG-LIVED    TOTAL     LONG-LIVED
                               ASSETS      ASSETS      ASSETS      ASSETS      ASSETS      ASSETS
                              --------   ----------   --------   ----------   --------   ----------
                                 (IN THOUSANDS)          (IN THOUSANDS)          (IN THOUSANDS)
                                                                                   (UNAUDITED)
<S>                           <C>        <C>          <C>        <C>          <C>        <C>
Israel......................   $1,126       $168       $4,269       $324      $ 4,119       $324
North America...............    4,643         12        2,308         28        6,831         26
                               ------       ----       ------       ----      -------       ----
Total.......................   $5,769       $180       $6,577       $352      $10,950       $350
                               ======       ====       ======       ====      =======       ====
</TABLE>


                                      F-31
<PAGE>
                                 NOGATECH, INC.

             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 11--SEGMENT INFORMATION (CONTINUED)
    B. MAJOR CUSTOMERS

       In the years ended December 31, 1997, 1998 and 1999, and in the periods
       of three months ended March 31, 1999 and 2000, major customers of the
       Company represented the following percentages of sales:

<TABLE>
<CAPTION>
                                                                                        THREE MONTHS
                                                      YEAR ENDED                           ENDED
                                                     DECEMBER 31                         MARCH 31,
                                         ------------------------------------      ----------------------
                                           1997          1998          1999          1999          2000
                                         --------      --------      --------      --------      --------
                                                                                         UNAUDITED
<S>                                      <C>           <C>           <C>           <C>           <C>
Customer A.............................      *             *            24%            *            31%
Customer B.............................     17%           41%           14%           17%            *
Customer C.............................      *             *            13%            *             *
Customer D.............................     32%           20%           11%           33%            *
Customer E.............................      *             *             *             *            12%
Customer F.............................      *             *             *             *            11%
</TABLE>

- ------------------------

    *   Less than 10%.

    MAJOR SUPPLIER

    In the years ended December 31, 1997, 1998 and 1999, a major supplier of the
    Company represented 8%, 10% and 58% of cost of sales, respectively.

    In the periods of three months ended March 31, 1999 and 2000, a major
    supplier of the company represented 41% and 57% of cost of sales,
    respectively.

                                      F-32
<PAGE>

                               INSIDE BACK COVER



    The graphic consists of an AOL.com internet page computer monitor screen
display with four arrows pointing towards the page from the top, bottom and both
sides identifying different transmission methods.

<PAGE>
                                     [LOGO]


    Until           , 2000 (25 days after the date of this offering), all
dealers that effect transactions in these securities, whether or not
participating in this offering, may be required to deliver a prospectus. This is
in addition to the dealers' obligation to deliver a prospectus when acting as
underwriters and with respect to their unsold allotments or subscriptions.

<PAGE>
                                    PART II

                     INFORMATION NOT REQUIRED IN PROSPECTUS

ITEM 13. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION.

    The following table indicates the expenses to be incurred in connection with
the offering described in this Registration Statement, all of which will be paid
by us. All amounts are estimates, other than the registration fee, the NASD
filing fee, and the Nasdaq National Market listing fee.


<TABLE>
<S>                                                           <C>
SEC Registration fee........................................  $   17,002
NASD Filing fee.............................................       6,940
Nasdaq National Market listing fee..........................      83,500
Accounting fees and expenses................................     350,000
Legal fees and expenses.....................................     680,000
Printing and engraving expenses.............................     300,000
Transfer agent fees and expenses............................      20,000
Blue sky fees and expenses..................................       5,000
Miscellaneous fees and expenses.............................     120,000
                                                              ----------
  Total.....................................................  $1,582,442
                                                              ==========
</TABLE>


ITEM 14. INDEMNIFICATION OF DIRECTORS AND OFFICERS.

    Section 102 of the Delaware General Corporation Law, or the DGCL, as
amended, allows a corporation to eliminate the personal liability of directors
of a corporation to the corporation or its stockholders for monetary damages for
a breach of fiduciary duty as a director, except where the director breached his
duty of loyalty, failed to act in good faith, engaged in intentional misconduct
or knowingly violated a law, authorized the payment of a dividend or approved a
stock repurchase in violation of Delaware corporate law or obtained an improper
personal benefit.

    Section 145 of the DGCL provides, among other things, that we may indemnify
any person who was or is a party or is threatened to be made a party to any
threatened, pending or completed action, suit or proceeding (other than an
action by us or in our right) by reason of the fact that the person is or was
our director, officer, agent or employee or is or was serving at our request as
a director, officer, agent, or employee of another corporation, partnership,
joint venture, trust or other enterprise, against expenses, including attorneys'
fees, judgment, fines and amounts paid in settlement actually and reasonably
incurred by the person in connection with the action, suit or proceeding. The
power to indemnify applies (a) if the person is successful on the merits or
otherwise in defense of any action, suit or proceeding, or (b) if the person
acted in good faith and in a manner he or she reasonably believed to be in our
best interest, or not opposed to our best interest, and with respect to any
criminal action or proceeding, had no reasonable cause to believe his conduct
was unlawful. The power to indemnify applies to actions brought by us or in our
right as well, but only to the extent of defense expenses (including attorneys'
fees but excluding amounts paid in settlement) actually and reasonably incurred
and not to any satisfaction of judgment or settlement of the claim itself, and
with the further limitation that in these actions no indemnification shall be
made in the event of any adjudication of negligence or misconduct in the
performance of his or her duties to us, unless the court believes that in light
of all the circumstances indemnification should apply.

    Section 174 of the DGCL provides, among other things, that a director, who
willfully or negligently approves of an unlawful payment of dividends or an
unlawful stock purchase or redemption, may be held liable for these actions. A
director who was either absent when the unlawful actions were approved or
dissented at the time, may avoid liability by causing his or her dissent to
these actions to

                                      II-1
<PAGE>
be entered in the books containing the minutes of the meetings of the board of
directors at the time the action occurred or immediately after the absent
director receives notice of the unlawful acts.

    Our certificate of incorporation includes a provision that eliminates the
personal liability of our directors for monetary damages for breach of fiduciary
duty as a director, except for liability for:

    - any breach of the director's duty of loyalty to us or our stockholders;

    - acts or omissions not in good faith or that involve intentional misconduct
      or a knowing violation of law;

    - unlawful dividends and stock purchases; or

    - any transaction from which the director derived an improper personal
      benefit.

    These provisions are permitted under Delaware law.

    Our bylaws provide that:

    - we must indemnify our directors and officers to the fullest extent
      permitted by Delaware law;

    - we may indemnify our other employees and agents to the same extent that we
      indemnified our officers and directors, unless otherwise determined by our
      board of directors; and

    - we must advance expenses, as incurred, to our directors and executive
      officers in connection with a legal proceeding to the fullest extent
      permitted by Delaware law.

    The indemnification provisions contained in our certificate of incorporation
and bylaws are not exclusive of any other rights to which a person may be
entitled by law, agreement, vote of stockholders or disinterested directors or
otherwise. In addition, we maintain insurance on behalf of our directors and
executive officers insuring them against any liability asserted against them in
their capacities as directors or officers or arising out of this status.

    We have entered into agreements to indemnify our directors and executive
officers, in addition to indemnification provided for in our bylaws. These
agreements, among other things, will provide for indemnification of our
directors and executive officers for expenses, judgments, fines and settlement
amounts incurred by any such person in any action or proceeding arising out of
the person's services as a director or executive officer of us or another entity
at our request. We believe that these provisions and agreements are necessary to
attract and retain qualified persons as directors and executive officers.

ITEM 15. RECENT SALES OF UNREGISTERED SECURITIES.

    Since March 1, 1997, we have sold and issued the following unregistered
securities (the share numbers and per share prices below reflect the one-for-two
reverse stock split of the outstanding common stock to be effected prior to the
completion of this offering:

 (1) Between March 1, 1997 and March 31, 2000, we granted stock options under
     our 1999 Stock Option Plan to 66 of our officers, employees, directors and
     consultants, to purchase an aggregate of 1,162,250 shares of common stock.
     During this period, optionees exercised options to purchase an aggregate of
     233,330 shares of common stock at various exercise prices.

 (2) On August 17, 1997, we issued 318,471 shares of our Series A preferred
     stock at $1.57 per share to Corex Israeli Industries Ltd. for an aggregate
     cash consideration of $500,000.

 (3) On August 17, 1997, we issued a warrant (the "1997 Warrant") to purchase
     159,235 shares of our common stock to Corex Israeli Industries Ltd. at an
     exercise price of $3.14 per share and an aggregate exercise price of
     $500,000.

                                      II-2
<PAGE>
 (4) On June 24, 1998, we issued warrants to purchase an aggregate of 288,249
     shares of our common stock to Hapoalim Nechasim (Menayot) Ltd. and Be'ery
     Investment Bankers at an exercise price of $2.08 per share and an aggregate
     exercise price of $600,000.

 (5) On July 15, 1998, we issued 5,765,003 shares of our Series A preferred
     stock to Docor International BV, Holland Ventures BV, Inventech Ltd., Ophir
     Holdings Ltd. and Ronchal Investments NV, at $1.04 per share and an
     aggregate cash consideration of $6,000,000.

 (6) On July 15, 1998, we issued warrants to purchase 432,375 shares of our
     common stock to Docor International BV, Holland Ventures BV, Inventech
     Ltd., Ophir Holdings Ltd. and Ronchal Investments NV, at an exercise price
     of $2.08 per share and an aggregate exercise price of $900,000.

 (7) On July 15, 1998, we amended the 1997 Warrant and two warrants issued on
     February 4, 1997 to purchase an aggregate of 111,464 shares of our common
     stock to extend the term of the 1997 warrant and the two warrants by one
     year.

 (8) On September 24, 1999, in connection with our reincorporation into
     Delaware, we issued one share of our common stock to one of our executive
     officers who was not a U.S. resident for $1.00 per share.

 (9) On January 13, 2000, we issued 1,196,172 shares of our Series B preferred
     stock to Nomura International plc at $4.18 per share for an aggregate
     consideration of $5,000,000.

    The sales of the above securities were deemed to be exempt from registration
under the Securities Act of 1933, as amended (the "Act") in reliance on Section
4(2) of the Act, Regulation D promulgated under the Act, Regulation S
promulgated under the Act, or Rule 701 promulgated under Section 3(b) of the
Act. In each such transaction, the recipients of securities represented their
intentions to acquire securities for investment only and not with a view to or
for sale in connection with any distribution thereof, and appropriate legends
were affixed to the securities issued in such transactions.

ITEM 16. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.

a.  EXHIBITS


<TABLE>
<CAPTION>
EXHIBIT                 DESCRIPTION
- -------                 -----------
<S>                     <C>
 1.1*                   Form of Underwriting Agreement.

 2.1**                  Agreement and Plan of Merger, by and between Nogatech, Inc.,
                        a California corporation and the Registrant, dated as of
                        December 28, 1999.

 3.1**                  Second Amended and Restated Certificate of Incorporation of
                        the Registrant.

 3.2**                  Bylaws of the Registrant.

 3.3**                  Amendment to the Second Amended and Restated Certificate of
                        Incorporation of the Registrant, as filed with the Delaware
                        Secretary of State on April 14, 2000.

 3.4**                  Amendment to the Second Amended and Restated Certificate of
                        Incorporation of the Registrant, as filed with the Delaware
                        Secretary of State on April 17, 2000.

 4.1                    Specimen common stock certificate.

 5.1                    Opinion of Bay Venture Counsel, LLP.

10.1.1**                Warrant to purchase shares of common stock issued to Corex
                        Industries.

10.1.2**                Warrant to purchase shares of common stock issued to Bank
                        Hapoalim.

10.1.3**                Form of Warrant to purchase shares of common stock issued to
                        certain investors.

10.1.4**                Warrant to purchase shares of common stock issued to Nathan
                        Hod.

10.2**                  Form of Indemnification Agreement for officers of the
                        Registrant.
</TABLE>


                                      II-3
<PAGE>


<TABLE>
<CAPTION>
EXHIBIT                 DESCRIPTION
- -------                 -----------
<S>                     <C>
10.3**                  1999 Stock Option Plan.

10.4**                  2000 Equity Incentive Plan.

10.5**                  2000 Employee Stock Purchase Plan.

10.6**                  Stock Purchase Agreement, by and among DSP Group, Inc.,
                        Scitex Corporation, Ltd., and Noga Technology, Inc., dated
                        as of January 1, 1993.

10.7**                  Stock Purchase Agreement, by and among DSP Group, Kenwood
                        Corporation, Tomen Electronics Corporation and Nogatech,
                        Inc., a California corporation, dated as of June 30, 1995.

10.8**                  Series A Preferred Stock Purchase Agreement by and between
                        the Registrant and Arie Heiman, dated February 28, 1996.

10.9**                  Series A Preferred Stock Purchase Agreement, by and among
                        Registrant and Nathan Hod, dated January 30, 1996.

10.10**                 Series B Preferred Stock Purchase Agreement, by and between
                        the Registrant and Nomura International plc, dated
                        January 13, 2000.

10.11**                 Shareholder Agreement, by and among Nomura International
                        plc., Holland Venture B.V., Ophir Holdings Ltd., Docor
                        International B.V., Inventech Ltd., Ronchal Investments
                        N.V., Challenge Fund-Etgar, L.P., and Corex Israeli
                        Industries Ltd., dated as of January 13, 2000.

10.12**                 Second Amended and Restated Registration Rights Agreement,
                        by and among the Registrant and certain security holders,
                        dated January 13, 2000.

10.13**                 Debenture Agreement by and between Bank Hapoalim and
                        Nogatech Ltd., dated June 16, 1998.

10.14**+                Development Agreement, by and between Supertec Electronics
                        Ltd. and Nogatech, Ltd., dated as of August 1999.

10.15**+                Development Agreement, by and between Supertec Electronics
                        Ltd. and Nogatech, Ltd., dated as of June 24, 1997.

10.16**                 Employment Agreement with Arie Heiman.

10.17**                 Employment Agreement with Yaron Garmazi.

10.18**                 Employment Agreement with Aryeh Gavrieli.

10.19**                 Employment Agreement with Liat Hod.

10.20**                 Series A Preferred Stock Purchase Agreement, by and among
                        the Registrant and Andrew Schonzeit, dated December 27,
                        1995.

21.1                    Subsidiaries of the Registrant.

23.1                    Consent of Kesselman & Kesselman, Independent Accountants.

23.2                    Consent of Bay Venture Counsel, LLP (included at Exhibit
                        5.1).

24.1**                  Power of Attorney (included in signature pages).

27.1                    Financial Data Schedule.
</TABLE>


- ------------------------

*   To be filed by amendment.

**  Previously filed

+   We have requested confidential treatment from the Commission for selected
    portions of this exhibit. The omitted portions have been separately filed
    with the Commission.

                                      II-4
<PAGE>
ITEM 17. UNDERTAKINGS.

    The undersigned Registrant hereby undertakes to provide to the Underwriters
at the closing specified in the underwriting agreements, certificates in such
denominations and registered in such names as required by the Underwriters to
permit prompt delivery to each purchaser.

    Insofar as indemnification for liabilities arising under the Securities Act
of 1933 may be permitted to directors, officers, and controlling persons of the
Registrant pursuant to the provisions described in Item 14, or otherwise, the
Registrant has been informed that in the opinion of the Securities and Exchange
Commission such indemnification is against public policy as expressed in the
Securities Act and is therefore unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by the
registrant of expenses incurred or paid by a director, officer, or controlling
person of the Registrant in the successful defense of any action, suit, or
proceeding) is asserted by such director, officer, or controlling person in
connection with the securities being registered, the Registrant will, unless in
the opinion of its counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against pubic policy as expressed in the Securities Act
and will be governed by the final adjudication of such issue.

    The undersigned Registrant hereby undertakes that:

    (1) For purposes of determining any liability under the Securities Act of
       1933, the information omitted from the form of prospectus filed as part
       of this registration statement in reliance upon Rule 5430A and contained
       in a form of prospectus filed by the Registrant under Rule 424(b) (1) or
       (4) or 497 (h) under the Securities Act shall be deemed to be part of
       this registration statement as of the time it was declared effective.

    (2) For the purpose of determining any liability under the Securities Act of
       1933, each post-effective amendment that contains a form of prospectus
       shall be deemed to be a new registration statement relating to the
       securities offered therein, and the offering of such securities at that
       time shall be deemed to be the initial bonafide offering thereof.

                                      II-5
<PAGE>
                                   SIGNATURES


    Pursuant to the requirements of the Securities Act of 1933, the Registrant
has duly caused this amendment to registration statement to be signed on its
behalf by the undersigned, thereunto duly authorized, in the City of Santa
Clara, State of California, on May 9, 2000.



<TABLE>
<S>                                                    <C>  <C>
                                                       NOGATECH, INC.

                                                       By:              /s/ YARON GARMAZI
                                                            -----------------------------------------
                                                                          Yaron Garmazi
                                                                     CHIEF FINANCIAL OFFICER
</TABLE>


    Pursuant to the requirements of the Securities Act of 1933, this amendment
to registration statement has been signed by the following persons in the
capacities and on the dates indicated.


<TABLE>
<CAPTION>
                   NAME                                      TITLE                         DATE
                   ----                                      -----                         ----
<C>                                         <S>                                       <C>
             /s/ ARIE HEIMAN*               President and Chief Executive Officer      May 9, 2000
    ---------------------------------         and Director (Principal Executive
               Arie Heiman                    Officer)

            /s/ YARON GARMAZI               Chief Financial Officer and Secretary      May 9, 2000
    ---------------------------------         (Principal Financial and Accounting
              Yaron Garmazi                   Officer)

             /s/ NATHAN HOD*                Chairman of the Board                      May 9, 2000
    ---------------------------------
                Nathan Hod

            /s/ GERALD DOGON*               Director                                   May 9, 2000
    ---------------------------------
               Gerald Dogon

           /s/ AVRAHAM FISCHER*             Director                                   May 9, 2000
    ---------------------------------
             Avraham Fischer

             /s/ DAVIDI GILO*               Director                                   May 9, 2000
    ---------------------------------
               Davidi Gilo

             /s/ MOSHE HAREL*               Director                                   May 9, 2000
    ---------------------------------
               Moshe Harel

          /s/ YIRMIYAHU KAPLAN*             Director                                   May 9, 2000
    ---------------------------------
             Yirmiyahu Kaplan

           /s/ YOSSI VINITSKI*              Director                                   May 9, 2000
    ---------------------------------
              Yossi Vinitski

          /s/ ANDREW SCHONZEIT*             Director                                   May 9, 2000
    ---------------------------------
             Andrew Schonzeit
</TABLE>



<TABLE>
<S>   <C>                                                    <C>                             <C>
*By:                    /s/ YARON GARMAZI
             --------------------------------------
                 Yaron Garmazi, ATTORNEY-IN-FACT
</TABLE>


                                      II-6
<PAGE>
                                 EXHIBIT INDEX


<TABLE>
<CAPTION>
EXHIBIT                 DESCRIPTION
- -------                 -----------
<S>                     <C>
 1.1*                   Form of Underwriting Agreement.

 2.1**                  Agreement and Plan of Merger, by and between Nogatech, Inc.,
                        a California corporation and the Registrant, dated as of
                        December 28, 1999.

 3.1**                  Second Amended and Restated Certificate of Incorporation of
                        the Registrant.

 3.2**                  Bylaws of the Registrant.

 3.3**                  Amendment to the Second Amended and Restated Certificate of
                        Incorporation of the Registrant, as filed with the Delaware
                        Secretary of State on April 14, 2000.

 3.4**                  Amendment to the Second Amended and Restated Certificate of
                        Incorporation of the Registrant, as filed with the Delaware
                        Secretary of State on April 17, 2000.

 4.1                    Specimen common stock certificate.

 5.1                    Opinion of Bay Venture Counsel, LLP.

10.1.1**                Warrant to purchase shares of common stock issued to Corex
                        Industries.

10.1.2**                Warrant to purchase shares of common stock issued to Bank
                        Hapoalim.

10.1.3**                Form of Warrant to purchase shares of common stock issued to
                        certain investors.

10.1.4**                Warrant to purchase shares of common stock issued to Nathan
                        Hod.

10.2**                  Form of Indemnification Agreement for officers of the
                        Registrant.

10.3**                  1999 Stock Option Plan.

10.4**                  2000 Equity Incentive Plan.

10.5**                  2000 Employee Stock Purchase Plan.

10.6**                  Stock Purchase Agreement, by and among DSP Group, Inc.,
                        Scitex Corporation, Ltd., and Noga Technology, Inc. 1996,
                        dated as of January 1, 1993.

10.7**                  Stock Purchase Agreement, by and among DSP Group, Kenwood
                        Corporation, Tomen Electronics Corporation and Nogatech,
                        Inc., a California corporation, dated as of June 30, 1995.

10.8**                  Series A Preferred Stock Purchase Agreement by and between
                        the Registrant and Arie Heiman, dated February 28, 1996.

10.9**                  Series A Preferred Stock Purchase Agreement, by and among
                        Registrant and Nathan Hod, dated January 30, 1996.

10.10**                 Series B Preferred Stock Purchase Agreement, by and between
                        the Registrant and Nomura International plc, dated
                        January 13, 2000.

10.11**                 Shareholder Agreement, by and among Nomura International
                        plc., Holland Venture B.V., Ophir Holdings Ltd., Docor
                        International B.V., Inventech Ltd., Ronchal Investments
                        N.V., Challenge Fund-Etgar, L.P., and Corex Israeli
                        Industries Ltd., dated as of January 13, 2000.
</TABLE>


<PAGE>


<TABLE>
<CAPTION>
EXHIBIT                 DESCRIPTION
- -------                 -----------
<S>                     <C>
10.12**                 Second Amended and Restated Registration Rights Agreement,
                        by and among the Registrant and certain security holders,
                        dated January 13, 2000.

10.13**                 Debenture Agreement by and between Bank Hapoalim and
                        Nogatech Ltd., dated June 16, 1998.

10.14**+                Development Agreement, by and between Supertec Electronics
                        Ltd. and Nogatech, Ltd., dated as of August 1999.

10.15**+                Development Agreement, by and between Supertec Electronics
                        Ltd. and Nogatech, Ltd., dated as of June 24, 1997.

10.16**                 Employment Agreement with Arie Heiman.

10.17**                 Employment Agreement with Yaron Garmazi.

10.18**                 Employment Agreement with Aryeh Gavrieli.

10.19**                 Employment Agreement with Liat Hod.

10.20**                 Series A Preferred Stock Purchase Agreement, by and among
                        the Registrant and Andrew Schonzeit, dated December 27,
                        1995.

21.1                    Subsidiaries of the Registrant.

23.1                    Consent of Kesselman & Kesselman, Independent Accountants.

23.2                    Consent of Bay Venture Counsel, LLP (included at Exhibit
                        5.1).

24.1**                  Power of Attorney (included in signature pages).

27.1                    Financial Data Schedule.
</TABLE>


- ------------------------

*   To be filed by amendment.

**  Previously filed.

+   We have requested confidential treatment from the Commission for selected
    portions of this exhibit. The omitted portions have been separately filed
    with the Commission.

<PAGE>


                                                                    Exhibit 4.1


                                       ascii face

COMMON STOCK

COMMON STOCK

NOG

THIS CERTIFICATE IS TRANSFERABLE
IN BOSTON, MA AND NEW YORK, NY

SEE REVERSE FOR CERTAIN DEFINITIONS

CUSIP 654919 10 9

INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE

This Certifies that

is the record holder of

FULLY PAID AND NON-ASSESSABLE SHARES OF COMMON STOCK, $0.001 PAR VALUE, OF
NOGATECH, INC. transferable on the books of the Corporation by the holder
hereof in person or by duly authorized attorney, upon surrender of this
Certificate properly endorsed. This certificate is not valid until
countersigned and registered by the Transfer Agent and Registrar.
     IN WITNESS WHEREOF the Corporation has caused this certificate to be
signed in facsimile by its duly authorized officers and a facsimile of its
corporate seal.
Dated:

CHAIRMAN OF THE BOARD


SECRETARY



COUNTERSIGNED AND REGISTERED:
EQUISERVE TRUST COMPANY, N.A.
TRANSFER AGENT
AND REGISTRAR
BY
AUTHORIZED SIGNATURE


                                       Page 1
<PAGE>


                                      ascii back

NOGATECH, INC.
The Corporation will furnish without charge to each stockholder who so
requests the powers, designations, preferences and relative, participating,
optional, or other special rights of each class of stock or series thereof
and the qualifications, limitations or restrictions of such preferences
and/or rights. Such requests shall be made to the Corporation's Secretary at
the principal office of the Corporation.

The following abbreviations, when used in the inscription on the face of this
certificate, shall be construed as though they were written out in full
according to applicable laws or regulations:

TEN COM -
TEN ENT -
JT TEN -
as tenants in common
as tenants by the entireties
as joint tenants with right of
survivorship and not as tenants
in common

UNIF GIFT MIN ACT-D......................Custodian......................
                                                     (Cust)
                       (Minor)
                                 under Uniform Gifts to Minors
                                 Act....................................
                                                                 (State)
UNIF TRF MIN ACT-D................Custodian (until age............)
                                               (Cust)
                             ....................under Uniform Transfers
                                       (Minor)
                                 to Minors Act............................

Additional abbreviations may also be used though not in the above list.

FOR VALUE RECEIVED,                                                 hereby
sell, assign and transfer unto

PLEASE INSERT SOCIAL SECURITY OR OTHER
IDENTIFYING NUMBER OF ASSIGNEE


                                       Page 1
<PAGE>


                                      ascii back

(PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS, INCLUDING ZIP CODE, OF ASSIGNEE)


Shares

of the common stock represented by the within Certificate, and do hereby
irrevocably constitute and appoint

Attorney


to transfer the said stock on the books of the within named Corporation with
full power of substitution in the premises. Dated

X
X

NOTICE:

THE SIGNATURE(S) TO THIS ASSIGNMENT MUST CORRESPOND WITH THE NAME(S) AS
WRITTEN UPON THE FACE OF THE CERTIFICATE IN EVERY PARTICULAR, WITHOUT
ALTERATION OR ENLARGEMENT OR ANY CHANGE WHATEVER.

Signature(s) Guaranteed
By

THE SIGNATURE(S) MUST BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION
(BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH
MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM), PURSUANT TO
S.E.C. RULE 17Ad-15.

KEEP THIS CERTIFICATE IN A SAFE PLACE. IF IT IS LOST, STOLEN, OR DESTROYED
THE CORPORATION WILL REQUIRE A BOND OF INDEMNITY AS A CONDITION TO THE
ISSUANCE OF A REPLACEMENT CERTIFICATE.


                                       Page 2

<PAGE>
                                                                     Exhibit 5.1

                    [LETTERHEAD OF BAY VENTURE COUNSEL, LLP]


May 9, 2000


Nogatech, Inc.
5201 Great America Parkway
Santa Clara, California 95054

Ladies and Gentlemen:

    This opinion is rendered in connection with the filing by Nogatech Inc., a
Delaware corporation (the "Company"), of its Registration Statement on Form S-1
(the "Registration Statement") with the Securities and Exchange Commission under
the Securities Act of 1933, as amended (the "Act"), with respect to the offer
and sale by the Company (the "Offering") of up to 4,025,000 shares (including
525,000 shares subject to an over-allotment option) of the Company's common
stock, par value $.001 per share (the "Registered Common Stock"), and any
subsequent registration statement the Company may hereafter file with the
Commission pursuant to Rule 462(b) under the Act to register additional shares
of the Company's common stock, par value $.001 per share, in connection with the
Offering (such additional shares, together with the Registered Common Stock, the
"Shares").

    We have acted as counsel to the Company in connection with the preparation
of the Registration Statement. In our capacity as such counsel, we are familiar
with the proceedings taken and to be taken by the Company in connection with the
authorization, issuance and sale of the Shares. In addition, we have made such
legal and factual examinations and inquiries, including examination of originals
(or copies certified or otherwise identified to our satisfaction as being true
reproductions of originals) or such documents, corporate records and other
instruments, and have obtained from officers of the Company and agents thereof
such certificates and other representations and assurances, as we have deemed
necessary or appropriate for the purposes of this opinion. In such examination,
we have assumed the genuineness of all signatures, the authenticity of all
documents submitted to us as originals, the legal capacity of natural persons
executing such documents and the authenticity and conformity to original
documents of documents submitted to us as certified or photostatic copies. We
are opining herein as to the effect on the subject transaction only of the
General Corporation Law of the State of Delaware, including statutory and
reported decisional law thereunder, and we express no opinion with respect to
the applicability thereto, or the effect thereon, of the laws of any other
jurisdiction or, in the case of Delaware, any other laws, or as to any matters
of municipal law of the laws of any local agencies within any state.

    Subject to the foregoing and the other qualifications set forth herein, it
is our opinion that, as of the date hereof, based on the foregoing and the
proceedings to be taken by the Company as referred to above, the Shares have
been duly authorized, and upon issuance, delivery and payment therefor in the
manner described in the Registration Statement, such Shares will be validly
issued, fully paid and nonassesable.

    We consent to your filing this opinion as an exhibit to the Registration
Statement and to the reference to our firm contained under the heading "Legal
Matters" of the prospectus included therein, and to the incorporation by
reference of this opinion and consent into a registration statement filed with
the Commission pursuant to Rule 462(b) under the Act relating to the Offering.

                                          Very truly yours,

                                          /s/ BAY VENTURE COUNSEL, LLP

<PAGE>

                                  Exhibit 21.1

                         Subsidiaries of the Registrant

<TABLE>
<CAPTION>
Name                                       Jurisdiction of Incorporation
- ----                                       -----------------------------
<S>                                        <C>
Nogatech California, Inc.                  California
Nogatech, Ltd.                             Israeli
</TABLE>



<PAGE>
                                                                    Exhibit 23.1

                   CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS

We hereby consent to the use in the prospectus constituting part of this
Registration Statement (Number 333-32372) on Form S-1 of our report dated
February 25, 2000, except for Note 6 the date of which is March 8, 2000,
relating to the financial statements of Nogatech, Inc., which appear in such
Prospectus.

We also consent to the references to our firm under the caption "Experts".


<TABLE>
<S>                      <C>
Tel Aviv, Israel                                  Kesselman & Kesselman
May 9, 2000                       Certified Public Accountants (Israel)
</TABLE>


<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED FINANCIAL STATEMENT OF NOGATECH INC. FOUND ON PAGES F-3,
F-4, F-5 AND F-6 OF THE COMPANY'S FORM S-1 FOR THE YEAR ENDED
DECEMBER 31, 1999, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>              <C>              <C>           <C>             <C>
<PERIOD-TYPE>                   YEAR            YEAR              YEAR          3-MOS           3-MOS
<FISCAL-YEAR-END>               DEC-31-1999      DEC-31-1998      DEC-31-1997    MAR-31-1999    MAR-31-2000
<PERIOD-START>                  JAN-01-1999      JAN-01-1998      JAN-01-1997    JAN-01-1999    JAN-01-2000
<PERIOD-END>                    DEC-31-1999      DEC-31-1998      DEC-31-1997    MAR-31-1999    MAR-31-2000
<CASH>                                2,475            3,791                0              0          6,612
<SECURITIES>                              0                0                0              0              0
<RECEIVABLES>                         1,216              988                0              0          1,697
<ALLOWANCES>                            150               24                0              0            175
<INVENTORY>                           2,109              581                0              0          1,747
<CURRENT-ASSETS>                        169               26                0              0            277
<PP&E>                                  352              180                0              0            350
<DEPRECIATION>                          483              355                0              0            523
<TOTAL-ASSETS>                        6,577            5,769                0              0         10,950
<CURRENT-LIABILITIES>                 2,858            1,215                0              0          1,706
<BONDS>                                   0                0                0              0              0
                 8,243            7,816                0              0         13,408
                               0                0                0              0              0
<COMMON>                                  1                1                0              0              1
<OTHER-SE>                          (4,887)          (3,518)                0              0        (4,556)
<TOTAL-LIABILITY-AND-EQUITY>          6,577            5,769                0              0        10,950
<SALES>                               8,856            3,205            2,551            870         2,945
<TOTAL-REVENUES>                      8,856            3,205            2,551            870         2,945
<CGS>                                 5,111            2,038            1,699            518         1,661
<TOTAL-COSTS>                         5,111            2,038            1,699            518         1,661
<OTHER-EXPENSES>                      4,852            3,080            2,282          1,166         1,179
<LOSS-PROVISION>                        126               20             (23)            (4)            25
<INTEREST-EXPENSE>                       11               90             (32)            (3)          (12)
<INCOME-PRETAX>                     (1,096)          (1,823)          (1,462)          (817)            93
<INCOME-TAX>                              0                0                0              0             0
<INCOME-CONTINUING>                       0                0                0              0             0
<DISCONTINUED>                            0                0                0              0             0
<EXTRAORDINARY>                           0                0                0              0             0
<CHANGES>                                 0                0                0              0             0
<NET-INCOME>                        (1,096)          (1,823)          (1,462)          (817)            93
<EPS-BASIC>                          (4.50)           (7.13)           (5.86)         (2.97)        (8.14)
<EPS-DILUTED>                        (4.50)           (7.13)           (5.86)         (2.97)        (8.14)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission